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Summary 
The first part of my Ph.D research concentrates on the synthesis of the mannoside glycan 
portion of phosphatidylinositol mannosides (PIMs). Initially, PIM-6 was sought to 
provide mechanistic insights into tuberculosis by pathogenic mycobacteria. Preliminarily, 
a convergent approach was attempted towards the pentamannoside. Later a new and 
novel synthetic plan was designed to study all homologues of PIMs in order to fully 
understand the immunogenic roles of PIMs. Accordingly, a linear synthesis of the glycan 
portion was adopted via the in situ glycosylation method with 1,2-orthoester. This linear 
synthesis enabled the synthesis of a series of mannoside glycans of PIM-1, PIM-2, PIM-
3, PIM-4, PIM-5 and PIM-6 all with terminally differentiated protecting groups that 
would facilitate future tagging of desired linkers for immunogenic studies of PIMs. 
The major part of my research work focused on synthetic studies towards the synthesis of 
bielschowskysin macrocycles, a highly oxygenated diterpene cembrane isolated in 2004 
from Pseudopterogorgia kallos. This unprecedented hexacyclic fused ring skeleton 
displays promising antiplasmodial and anticancer properties. We planned the synthesis of 
the bielschowskysin carbon framework through the transannular [2+2] cycloaddition of 
an allene butenolide macrocycle as the key strategy to install the cyclobutane nucleus.  
Our efforts initially focused on synthesizing a transannular [2+2] model macrocycle of 
bielschowskysin (Chapter 2). We recognized a macrocycle encompassing an allene and a 
butenolide would be made via a ring closing metathesis (RCM)-lactonization or 
macrolactonization-RCM sequence from linear precursors. 
 ix 
The aldehyde building block was prepared in 8 steps from (S)-malic acid and the alkyne 
unit from oct-3-yn-1-ol in 3 steps. These building blocks were assembled by acetylide-
aldehyde coupling to give a propargylic alcohol that was subsequently converted to an 
allene by Myers conditions using o-nitrobenzenesulfonylhydrazine (NBSH). After 
introduction of a conjugated ester by Baylis-Hillman coupling, a macrocyclization study 
by RCM was not successful. In order to achieve the macrocycle, a seco-acid was obtained 
by saponification and subsequent Yamaguchi conditions smoothly formed a 
macrolactone. Again, RCM study with Grubbs I/Grubbs II catalyst to install the 
butenolide unit was not successful. 
Chapter 3 of the thesis focused on the synthesis of bielschowskysin based building 
blocks. The target molecule was disconnected into two building blocks. The alkyne 
fragment was synthesized from (S)-malic acid. The conjugated aldehyde synthon was 
prepared from D-glucose and coupled with an alkyne fragment.  
Chapter 4 focused on the synthetic studies of the highly hindered α-(tert)-hydroxy 1,3-
disubstituted allene with quaternary carbon centers on both sides. An allene forming 
reduction protocol was studied on diastereomeric as well as chiral defined propargylic 
ethers. It was found that the unprotected hydroxyl group was necessary for LiAlH4 based 
reductive formation of hindered disubstituted allene from propargylic ethers.  
Chapter 5 concentrated on modified methods for the synthesis of aldehyde intermediates, 
coupling with alkyne synthons, and RCM studies. A terminal alkene was introduced into 
a D-glucose derived building block via Fe-catalyzed sp2-sp3 coupling and eventual 
coupling of the alkyne using Grignard exchange protocol gave the propargylic alcohols as 
 x  
 
a separable mixture of the diastereomers. While the C5-TES ether was found inert during 
RCM conditions, the C5-methyl ether gave the desired 14-membered model macrocycle 
in low yield. RCM reaction with the Grubbs II and Hoveyda-Grubbs II catalysts brought 
about the macrocyclization with equal productivity and reaction pattern. In conclusion, a 
RCM route to the carbon framework of bielschowskysin was achieved. 
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Part A: Synthesis of Mannoside Glycans of Phosphatidylinositol Mannosides (PIMs) 
1 
1 Background and Introduction 
1.1 Phosphatidylinositol Mannosides (PIMs) and Tuberculosis 
Tuberculosis (TB) is one the most deadly infectious diseases among the global population 
and is attributed to cause two million deaths per year. The causative organism of the 
disease is the acid-fast pathogenic bacteria, Mycobacterium tuberculosis. The cell-wall of 
M. tuberculosis is enveloped by a ‘glycocalyx’ which is critical for the integrity of the 
pathogen that allows infection, survival and propagation in the host.1 The key 
components of mycobacterial cell-wall are mycolyl arabinogalactan-peptidoglycan 
complex (mAGP) and the lipoarabinomannan (LAM) associated lipoglycans. LAMs 
contain a phosphatidyl myo-inositol anchor that is extended by mannoses to make up 
phosphatidylinositol “mono”, “di”, “tri”, and “tetramannosides” (PIM-1, PIM-2, PIM-3, 
PIM-4) and can be further extended by α1→2 linked mannose to pentamannosides and 
hexamannosides (PIM-5, PIM-6) (Fig 1). Modification of this lipoglycan backbone with 
additional mannose linkages results in a branched lipomannann which upon further 
arabinosylation, forms LAMs.2 
 
PIMs are present in the cell-walls of mycobacteria mainly in the form of PIM-2 and PIM-
6 (1) and constitute biosynthetic precursors of the lipomannan core and LAMs. This 
specialized, protective envelope gives M. tuberculosis high resilience to external factors 
such as the cytotoxic oxygen radicals that are generated by human macrophages upon 
infection. Additionally, PIMs elicit a range of immune responses and act as agonists of 
toll-like receptor 2 (TLR2) that are involved in innate immunity.3 They are also known to 
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recruit natural killer T-cells3b,4 and cause T-cell expansion via binding to the lipid 
presentation molecule, CD1b.3b,5 
 
 
Fig 1: Structural Features of PIMs, LM, and LAM 
 
1.2 Previous Synthesis of PIMs: Seeberger 4+3 Coupling 
 
There are few reports on the synthesis of PIMs6, among which only the Seeberger group 
has reported a total synthesis of PIM-6 (1) via a 4+3 coupling method of the mannoside 
unit 2 with the myo-inositol part 3.6c 
The tetramannoside building block 2 in turn has been synthesized by reacting mannosyl-
trichloroacetimidate donor 4 with alcohol 5 to get a dimannoside, followed by 
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deprotection of the acetyl group and subsequent iterative glycosylation with the same unit 
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2 PIMs: 1st Generation Synthetic Plan 
To elaborate our understanding of the immunogenic roles of such glycolipids, we started 
the synthesis of PIMs. A new 5+2 coupling protocol was intended as the key strategy to 
construct full length PIMs (Scheme 2) in which pentamannoside 6 will be coupled to 
PIM-1 (7).  
 
 
Scheme 2: A 5+2 Coupling Approach to PIMs 
 
2.1 Mannoside Glycan Synthetic Plan 1: A Convergent 3+2 Approach 
The pentamannoside unit 6 of PIMs has linear α1→2, α1→2, α1→6, α1→6 glycosidic 
linkages between monomeric pyrano-mannoses. Thus, the pentamannoside was 
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envisioned to be built-up via the convergent assembly of trimannoside 9 and dimannoside 
10 through α1→6 glycosylation (Scheme 3).7 The 9 and 10 intermediates could be 




Scheme 3: A Convergent 3+2 Coupling Approach for Pentamannoside Glycan 
 
2.2 Synthesis of Mannose Building Blocks 
2.2.1 Schmidt Donor of Mannose 
Mannose was allylated at the anomeric position to give allyl mannose 14 by using BF3 as 
the catalyst in good yield (Scheme 4). Benzylation of 14 gave the fully protected 
mannose 15 in 90% yield. The allyl group at the anomeric position was isomerized to 
propenyl ether by treating with a strong base (KOt-Bu) and subsequent treatment with 
dilute HCl gave the anomeric free alcohol 16 in quantitative yield. This alcohol was 
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converted to a trichloroacetimidate 11, a Schmidt donor, in good yield by CCl3CN in the 
presence of DBU.7 
 
 
Scheme 4: Synthesis of Mannose as a Protected Schmidt Donor 11 
 
 
2.2.2 Mannose With Accessible C2-Hydroxyl Group 
 
 
Scheme 5: Synthesis of C2-Hydroxyl Mannose 12 
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A stable 6-membered benzaldehyde-dioxane 17 was formed between the C4 and C6 
hydroxyl groups by treating allyl mannose 14 with benzaldehyde dimethyl acetal. From 
the remaining two hydroxyl groups, protection of the C3-hydroxyl group as its 
corresponding benzyl ether with stoichiometric reagents (NaH/BnBr) gave all three 
benzylated possible products. The major product isolated was desired C3-OBn 12 in 47% 
yield (Scheme 5). The free hydroxyl group of this mannose acceptor 12 was later 
engaged in Schmidt glycosylation with the trichloroacetimidate 11. 
 
2.3 Glycosylation Attempt Towards Dimannoside 
With both coupling partners in the hand, the first glycosylation was set as per designed. 
Thus, Lewis acid mediated glycosyl bond formation between the trichloroacetimidate 
donor 11 and slight excess of alcohol acceptor 12 (1.1 eq) proceeded with complete 




Scheme 6: Glycosylation to Make Dimannoside 18 
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All attempts to purify the dimannoside, however, led to elution of both the dimannoside 
and acceptor compounds during silica gel column chromatography. Separation at the 
dimannoside stage and further removal of the allyl group in the presence of the acid 
sensitive benzylidene acetal ring hampered synthetic progress towards the desired 
pentamannoside. 






Scheme 7: PIMs: 2nd Generation Synthetic Plan 
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In the meantime, we were planning to study the immunogenic roles of PIMs 
immunogenic roles of all homologues of PIM-1, PIM-2, PIM-3, PIM-4, PIM-5 and PIM-
6 in order to fully understand the immunogenic roles of PIMs. Accordingly, a new plan 
for PIMs was formulated so as to make all homologues of PIMs (Scheme 7). This idea 
required several different mannoside glycan units: monomannoside, dimannoside, 
trimannoside, tetramannoside and pentamannoside. Such glycan units could be 
synthesized in a linear fashion using monomeric mannoside synthons. Importantly, the 
linear addition of mannose units would require an efficient glycosylation method.8 
3.1 Seeberger in situ Glycosylation Method 
Seeberger et al. in 2006 reported the application of glycosyl phosophates 20 generated in 
situ from 1,2-orthoesters 19 as an efficient glycosylation coupling method.9 1,2-
Orthoesters upon treatment with dibutyl phosphate generate a stable (and isolable) 
anomeric phosphate 20 with C2-ester group. During the second step of this one pot 
reaction, the phosphate in the presence of a Lewis acid, TMSOTf, and molecular sieves at 
low temperature, initiates glycosyl bond formation with an alcohol (e.g. 21), furnishing a 
diglycoside 22 with a C2-ester group, typically in excellent yield (Scheme 8). 
 
 
Scheme 8: Seeberger in situ Glycosylation Method9 
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3.2 Synthetic Plan 2: Iterative in situ Coupling of Mannose 1,2-Orthoesters  
Due to practical difficulties in the purification of dimannosides, a new synthetic plan for 
all variations of PIMs was formulated as depicted in Scheme 9. 
Here, the dimannoside would be made by regular Schmidt glycosylation between the 
acetimidate 25 and alcohol 26. Thereafter, in situ dibutyl phosphate mediated coupling 



















































R = Bn (23)
R = TBS (24)
R = Bn (11)





























Scheme 9: Linear Synthetic Plan for Mannoside Glycan of PIMs 
 
Ultimately, either acetimidate intermediate 11 or 25 could be used in the final 
glycosylation coupling step with a tetramannoside to complete a pentamannoside glycan 
(23 or 24), where the case with 24 would lead to a full length PIMs with a selectively 
accessible hydroxyl group at the primary carbon of the mannose chain. 
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3.3 Synthesis of Mannose Building Blocks 
3.3.1 Mannose with Accessible 1,6-Hydroxyl Groups 
In order to synthesize all di-, tri-, tetra- and pentamannosides the simplest building blocks 
were synthesized with differential protecting groups from commercially available D-
mannose.  
The mannose acceptor 26 and acetimidate 30 with selectively accessible C6-silyl 




































R = Allyl (28)











i. KOt-Bu, DMSO, 80 °C;
ii. 1N HCl-acetone, 40 °C









Scheme 10: Synthesis of Mannose Intermediates 
 
 
Initially, the relatively bulky and stable TBS group was used to selectively protect the C6 
hydroxyl group of allyl mannose 14; however, this lead to a mixture of products, possibly 
due to over silylation, therefore a more bulky trityl group was employed at the C6-
hydroxyl of allyl mannose to give the allyl-trityl mannose 27 in 85% yield. Blocking all 
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remaining three hydroxyls with benzyl groups gave a fully protected mannose, which 
upon treatment with CSA mediated removal of the primary O-trityl group giving the 
acceptor intermediate 26 (Scheme 10).  
Subsequent protection of the primary hydroxyl group with TBS group 28, followed by 
removal of the allyl group produced the anomeric hydroxyl intermediate 29. From here 
tagging with trichloroacetonitrile furnished the Schmidt donor 30 in good yield. 
 
3.3.2 Synthesis of Methoxy-1,2-Orthoester of Mannose 
 
 
Scheme 11: Synthesis of Mannose 1,2-Orthoester10 
 
 
The 1,2-orthoester of mannose 19 that would be used for iterative amplification of 
mannose units by in situ dibutyl phosphate mediated glycosylation was constructed from 
bromo-mannose (Scheme 11) following a reported protocol.9 Perbenzoyl mannose 31 
was obtained by treating D-mannose with benzoyl chloride (as the solvent) in the 
presence of pyridine base. The anomeric benzoyl group of the perbenzoyl mannose was 
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displaced with HBr to give the bromide 32. Orthoester formation by methanol in the 
presence of 2,6-lutidine gave the 1,2-orthoester intermediate 33. Deprotection of the three 
benzoate groups to the trihydroxy mannose 34 and reprotecting with more stable benzyl 
groups furnished the desired 1,2-orthoester of mannose 19. 
 
3.4 Optimizing in situ Coupling Method; Synthesis of a Model Trimannoside  
Having all building blocks in the hand, optimization of the in situ dibutylphosphate 
mediated coupling method was pursued. Particularly, the coupling method was tested at 
an advanced stage. To this end, a slight excess of azeotropically pre-dried orthoester 
intermediate 19 (1.2 eq) in the presence of dibutyl phosphate and molecular sieves was 
converted to the anomeric glycosyl phosphate, which was utilized for in situ 
glycosylation with acceptor 26 in the presence of excess Lewis acid, TMSOTf (3.6 eq). 
This method of glycosylation cleanly produced the dimannoside 35, but with incomplete 
conversion during the second event (Scheme 12).  
 





Scheme 12: Optimizing in situ Glycosylation 
 
 
Thereafter, the C2-benzoyl group was removed quantitatively from the C2-position of the 
dimannoside to give the alcohol 36 using NaOMe/MeOH in DCM. This alcohol was 
treated again under similar dibutylphosphate mediated coupling conditions with 19 to 
give the trimannoside 37. Here again, the reaction was incomplete, possibly due to the 
high sensitivity of the reaction to moisture and dilution of reaction. Nevertheless, the 
reaction was productive for making the pentamannoside. 
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3.5 Synthesis of Mannoside Glycan Units of PIMs 
3.5.1 Synthesis of Dimannoside of PIMs 
The planned glycan synthesis commenced with Schmidt glycosylation of the acetimidate 
donor 30 with the acceptor 26 to afford α1→6 linked dimannoside 38 in 70% yield 
(Scheme 13). Deprotection of the silyl ether with TBAF11 gave 39 for the next coupling 
step to build the mannose units in a linear fashion. 
 
 
Scheme 13: Synthesis of Dimannosides 
 
 
3.5.2 Iterative Glycosylation: Synthesis of Tri-, Tetramannoside Glycan Units 
of PIMs 
A slight excess of the mannose 1,2-orthoester intermediate (19; 1.2 eq) in the presence of 
dibutyl phosphate generated an anomeric glycosyl phosphate in situ which was α1→6 
glycosidated with the dimannoside acceptor 39 in the presence of excess TMSOTf to 
yield the trimannoside 40 in quantitative yield.9 Releasing the C2-hydroxyl group of this 
trimannoside by transesterification of benzoate to 41, and repeating a similar in situ 
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glycosylation afforded the tetramannoside 42 in near quantitative yield. Upon opening the 
C2 hydroxyl group furnished a tetramannoside-acceptor 43 that was suitable for a final 





Scheme 14: Synthesis of Tri- and Tetramannosides 
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3.5.3 Synthesis of Petamannosides of PIMs 
TMSOTf promoted Schmidt glycosylation between acetimidate-donor 11 and 
tetramannoside 44 furnished the fully benzyl protected pentamannoside 44 with an 
anomeric allyl group (Scheme 15). 
Subsequent removal of the allyl group using KOt-Bu followed by treatment with 1M HCl 
in acetone-H2O afforded the pentamannoside 45 with a free anomeric hydroxyl group. 
Glycan 45 is ready to couple with PIM-1 to afford the eventual target, PIM-6 (Scheme 
15). 
 
Scheme 15: Synthesis of Diversified Pentamannosides 
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Alternatively, Schmidt glycosylation of C6-silyl protected 30 with the tetramannoside 
acceptor 43 generated the pentamannoside 46 with distinctly accessible protecting 
groups; a silyl ether at the primary ‘top’ hydroxyl group and allyl group at the ‘bottom’ 
anomeric position. This differential protecting group would facilitate future tagging of 
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4 Summary (Part A) 
In this chapter, I summarized the synthesis of the mannoside glycan portion of 
phosphatidylinositol mannosides (PIMs). Initially, PIM-6 was sought to provide 
mechanistic insights into tuberculosis by pathogenic mycobacteria. Preliminarily, a 
convergent approach was attempted towards pentamannoside (8). Later a new and novel 
synthetic plan was designed to study all homologues of PIMs in order to fully understand 
the immunogenic roles of PIMs.  Accordingly, a linear synthesis of glycan portion was 
adopted via the in situ glycosylation method. This linear synthesis enabled the synthesis 
of a series of mannoside glycans of PIM-1, PIM-2, PIM-3, PIM-4, PIM-5 and PIM-6 all 
with terminally differentiated protecting groups that would facilitate future tagging of 
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General Techniques and Methods: 
All non aqueous reactions were performed in flame dried glassware under nitrogen or 
argon atmosphere unless stated otherwise. All solvents used in the reactions were purified 
before use. Dichloromethane (CH2Cl2) was distilled over CaH2 and dry diethyl ether 
(Et2O), tetrahydrofuran (THF) was distilled from sodium/benzophenone. All 
commercially available compounds were used as received without further purification. 
4Å molecular sieves were activated by heating at 120-140 °C under high vacuum for 4h 
before storing in a dry desiccator. The reactions were monitored by thin layer 
chromatography (TLC) carried out on 0.25 mm 2E Merck silica gel plates (60F-254) 
under 254 nm UV lamp and stained by aqueous ceric ammonium molybdate solution or 
KMnO4 solution. Flash chromatography was performed on silica gel 60 (0.040 – 0.063 
mm). 1H and 13C NMR spectra were recorded on Bruker ACF (300 MHz) and Bruker 
AMX500 (500 MHz) NMR spectrometers. 2D NMR was performed on a Bruker 
AMX500 (500 MHz) NMR spectrometer. Chemical shifts are reported in δ (ppm) and 
calibrated using residual undeuterated solvents as an internal reference. The following 
abbreviations were used to explain the multiplicities: s = singlet, d = doublet, t = triplet, q 
= quartet, dd = doublet of doublet, dt = doublet of triplet, td = triplet of doublet, m = 
multiplet, br = broad. 1H NMR coupling constants (J) are reported in Hertz (Hz), Mass 
spectra were obtained on Finnigan MAT95XL-T and Micromass VG7035 double 
focusing mass spectrometer. High resolution ESI mass spectra were obtained on a 
Shimadzu LCMS-IT-TOF spectrometer. Infra-red spectra were recorded on Perkin-Elmer 
FT 1600 spectrometer. 




trichloroacetimidate (11): D-Mannose (20 g, 111 mmol) was 
heated at 80 °C for 4h in the presence of BF3·Et2O (1 ml, 7.7 
mmol) in allyl alcohol (230 mL). After neutralization with Et3N, excess allyl alcohol was 
removed under reduced pressure and the residue was purified by flash column 
chromatography (gradient 10-20% MeOH/CH2Cl2) to afford α/β-mixture of allyl-D-
mannopyranoside 14 (19.5 g, 80%) as viscous semi solid. To a stirring solution of above 
allyl mannose 14 (2 g, 9.5 mmol) in DMF (40 mL) was added BnBr (6 mL, 50.4 mmol), 
and NaH (60 % dispersion in mineral oil, 1.9 g, 49 mmol) portion wise at 0 °C and stirred 
for 4h at room temperature. After the reaction was completed, excess NaH was quenched 
by slow addition of methanol, diluted with water and extracted with ether (3x). The 
combined organic layers were washed with saturated NH4Cl solution, brine, dried over 
anhydrous Na2SO4 and concentrated in vacuo. The residue was purified by flash column 
chromatography (gradient 10-20%, EtOAc/hexanes) to furnish allyl-2,3,4,6-tetra-O-
benzyl-α-D-mannopyranose 15 (4.96 g, 90%) as a viscous pale yellow liquid. 
The above obtained allyl-2,3,4,6-tetra-O-benzyl-α-D-mannopyranose 15 (1.05 g, 1.76 
mmol) was dissolved in DMSO (15 mL) and KOt-Bu (1.9 g, 17.6 mmol) added and 
stirred at 80 °C for 4h. After completion, the reaction mixture was diluted with ethyl 
acetate (30 mL) and poured on to ice. The biphasic mixture was separated; the organic 
layer was washed with brine (30 mL) and concentrated in vacuo. The residue was 
dissolved in acetone-water (9:1 v/v, 15 mL) and treated with 1N HCl (2 mL) and the 
reaction mixture was stirred at 40 °C for 30 min. Brine solution (15 mL) was added to the 
reaction mixture and extracted with ether (3x20 mL), concentrated and purified by flash 
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column chromatography (gradient 10-20%, EtOAc/hexanes) to afford 2,3,4,6-tetra-O-
benzyl-α-D-mannopyranose 16 (913 mg, 96%) as faint yellow oil. 
The above obtained 2,3,4,6-tetra-O-benzyl-α-D-mannopyranose 16 (1 g, 1.84 mmol) was 
dissolved in anhydrous toluene (2x) and dried azeotropically by removing solvent under 
reduced pressure. The compound was dissolved in dichloromethane (15 mL) under argon 
and cooled to 0 °C. Subsequently, trichloroacetonitrile (740 μL, 7.4 mmol) and DBU (50 
μL, 0.37 mmol) were sequentially added and the reaction mixture was stirred at room 
temperature for 1h. The solvent was removed under reduced pressure and the residue was 
purified by flash column chromatography (gradient 10-15%, EtOAc/hexanes) to give 
2,3,4,6-tetra-O-benzyl-α-D-mannopyranosyl trichloroacetimidate 11 (945 mg, 75%) as a 
faint yellow oil. The NMR data is in agreement with that reported in the literature.1 1H 
NMR (CDCl3, 300 MHz): δ 8.62 (s, 1H, NH), 7.45-.7.26 (m, 20H, aromatic), 6.47 (d, J = 
3.05 Hz, 1H), 4.99 (d, J = 17.8 Hz, 1H), 4.87 (s, 2H), 4.79-4.58 (m, 2H), 4.29-4.22 (m, 
1H), 4.09-3.96 (m, 3H), 3.93 (dd, J = 7.1, 18.6 Hz, 1H), 3.83 (dd, J = 2.75, 18.65 Hz, 
1H). 13C NMR (CDCl3, 75 MHz): δ 160.40, 138.27, 138.21, 138.06, 137.88, 129.00, 
128.35, 128.32, 128.26, 128.19, 128.14, 127.91, 127.88, 127.78, 127.69, 127.46, 125.26, 
96.04, 78.87, 75.31, 74.78, 74.16, 73.48, 73.35, 72.59, 72.30, 68.72. 
 
Allyl-3-O-benzyl-4,6-O-benzylidene-α-D-mannopyranoside 
(12): The 2-hydroxyl mannose derivative 12 was synthesized 
following a reported procedure.2 Allyl-D-mannopyranose 14 
(1.99 g, 9 mmol), benzaldehyde dimethyl acetal (2.32 mL, 10.1 mmol) in anhydrous 
                                                 
1 Ali, A.; Gowda, D. C.; Vishwakarma, R. A. Chem. Commun. 2005, 519-521. 
2 Ali, A.; Gowda, D. C.; Vishwakarma, R. A. Chem. Commun. 2005, 519-521. 
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acetonitrile were stirred in the presence of camphorsulfonic acid (262 mg, 0.19 mmol) at 
room temperature for 18h. The reaction contents were neutralized by addition of 
triethylamine (5 mL) and concentrated under reduced pressure. The residue was dissolved 
in ethyl acetate (20 mL) and washed successively with saturated NaHCO3 solution, brine, 
dried over anhydrous Na2SO4 and concentrated in vacuo. The residue was purified by 
flash column chromatography (gradient 40-50%, EtOAc/hexanes) to yield allyl-4,6-O-
benzylidene-α-D-mannopyranoside 17 (1.66 g, 60 %) as a white foamy solid.  
To a solution of above obtained 17 (3.92 g, 12.7 mmol) in anhydrous DMF (100 mL) was 
added benzyl bromide (2.17 mL, 22.5 mmol) and NaH (390 mg, 12.7 mmol) at 0 °C and 
the reaction mixture was stirred at room temperature for 4h. Then excess of NaH 
destroyed by addition of MeOH, and diluted with EtOAc. The mixture was washed with 
saturated aq. solution of NaHCO3, brine and water, dried over anhydrous NaSO4 and 
concentrated. Flash column chromatography (gradient 5-10%, EtOAc/hexanes) afforded 
compound allyl-3-O-benzyl-4,6-O-benzylidene-α-D-mannopyranoside 12 (2.38 g, 47%). 
 
Allyl-6-O-trityl-α-D-mannopyranose (27): To a solution of allyl-
D-mannopyranoside 14 (2.5 g, 11.35 mmol) in anhydrous pyridine 
was added trityl chloride (4.74 g, 17.0 mmol) and the reaction 
mixture was stirred at 80 °C for 24h. After completion, the reaction was quenched with 
addition of saturated NH4Cl solution and extracted with ether (3x). The combined organic 
layers were washed with water, brine solution, dried over anhydrous Na2SO4 and 
concentrated in vacuo. The residue was purified by flash column chromatography 
(gradient 25-50%, EtOAc/hexanes) to give allyl-6-O-trityl-α-D-mannopyranose 27 (2.2 g, 
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85%) as a foamy yellow solid. 1H NMR (CDCl3, 500 MHz): δ 7.47-7.44 (m, 6H), 7.31-
7.29 (m, 6H), 7.26-7.23 (m, 3H), 5.98-5.87 (m, 1H), 5.33-5.27 (m, 1H), 5.25-5.20 (m, 
1H), 4.87 (d, J = 1.3 Hz, 1H), 4.21-4.16 (m, 1H), 4.02-4.00 (m, 1H), 3.96-.3.94 (m, 1H), 
3.86-3.82 (m, 1H), 3.73-3.72 (m, 1H), 3.52-3.39 (m, 3H). MS (ESI): m/z 461.0 [M-H]- , 
485.1 [M+Na]+. HRMS (ESI): m/z calcd for C28H30NaO6 485.1940 [M+Na]+; found 
485.1931. 
Allyl-2,3,4,-tri-O-benzyl-α-D-mannopyranose (26): To a 
solution of allyl-6-O-trityl-α-D-mannopyranose 27 (4 g, 9.84 
mmol) in DMF (50 mL) was added BnBr (4.75 mL, 40 mmol) 
and NaH (60% dispersion in mineral oil, 1.8 g, 45 mmol) portion-wise at 0 °C. After 4h 
at room temperature, excess NaH was quenched by slow addition of methanol, diluted 
with water (50 mL) and extracted with ether (3x). The combined organic layers were 
washed with saturated NH4Cl solution, brine, dried over anhydrous Na2SO4 and 
concentrated in vacuo. To the crude product in dichloromethane (30 mL) was added CSA 
(0.46 g, 3 mmol) and the reaction mixture was stirred overnight at room temperature. The 
solvent was distilled in vacuo, and the residue was purified by flash column 
chromatography (gradient 20-35%, EtOAc/hexanes) to furnish allyl-2,3,4,-tri-O-benzyl-
α-D-mannopyranose 26 (4.4 g, 91%, 2 steps). 1H NMR (CDCl3, 500 MHz): δ 7.37-7.27 
(m, 15H), 5.87-5.79 (m, 1H), 5.16 (dd, J = 1.25, 10.1 Hz, 1H), 4.95 (d, J = 10.7 Hz, 1H), 
4.86 (d, J = 1.9 Hz, 1H), 4.79 (d, J = 12.6 Hz, 1H), 4.71-4.65 (m, 4H), 4.14-4.10 (m, 1H), 
4.00 (d, J = 9.45 Hz, 1H), 3.97-3.96 (m, 1H), 3.95-3.90 (m, 1H), 3.86-3.77 (m, 3H), 3.69-
3.77 (m, 1H); 13C NMR (CDCl3, 125 MHz): δ 138.45, 138.36, 138.21, 133.59, 128.40, 
128.36, 128.06, 127.83, 127.72, 127.70, 127.59, 127.56, 117.35, 97.40, 80.19, 75.24, 
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74.88, 72.96, 72.26, 72.24, 67.89, 62.36; MS (ESI): m/z 513.2 [M+Na]+; HRMS (ESI): 
m/z calcd for C30H34NaO6 513.2253 [M+Na]+; found 513.2249. 
 
2,3,4-Tri-O-benzyl-6-O-tert-butyldimethylsilyl-α-D-mannopyranose (29): To a 
solution of allyl-2,3,4,-tri-O-benzyl-α-D-mannopyranose 26 (1.89 g, 
3.86 mmol) in THF (20 mL), was added TBSCl (0.87 g, 5.8 mmol) 
and imidazole (0.52 g, 7.7 mmol); and the contents were stirred 
overnight at room temperature. After the reaction was completed, quenched with 
saturated NH4Cl solution and extracted with ether (3x). The combined organic layers 
were washed with brine solution, dried over anhydrous Na2SO4 and concentrated in 
vacuo and subsequently, the residue was dissolved in DMSO (25 mL) and KOt-Bu (4.33 
g, 38 mmol) was added and stirred at 80 °C for 4h. After completion, the reaction was 
diluted with ethyl acetate and poured on to ice. The organic layer was washed with brine 
and concentrated in vacuo. The residue was dissolved in acetone-water (9:1 v/v, 15 mL) 
and stirred with 1N HCl (2 mL) at 40 °C for 30 min. The reaction mixture was then 
diluted with brine and extracted with ether (3x), concentrated and purified by flash 
column chromatography (gradient 10-20%, EtOAc/hexanes) to afford 2,3,4-tri-O-benzyl-
6-O-tert-butyldimethylsilyl-α-D-mannopyranose 29 (2.1 g, 90%, 2 steps). 1H NMR 
(CDCl3, 300 MHz): δ 7.38-7.26 (m, 15H, aromatic), 5.24-5.22 (m, 1H), 4.92 (d, J = 11.01 
Hz, 1H), 4.78-4.62 (m, 4H), 3.95-3.78 (m, 6H), 3.00 (d, J = 3.3 Hz, 1H), 1.64 (s, 1H), 
0.89 (s, 9H, TBS), 0.06 (d, J = 3.96 Hz, 6H, TBS). 13C NMR (CDCl3, 5 MHz): δ 166.56, 
155.75, 138.71, 138.59, 138.52, 128.32, 128.26, 127.98, 127.70, 127.66, 127.57, 127.52, 
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127.48, 92.70, 79.61, 75.39, 75.02, 74.89, 73.38, 72.64, 72.25, 63.07, 25.98, 18.45, -5.12, 
-5.29. 
2,3,4-Tri-O-benzyl-6-O-tert-butyldimethylsilyl-α-D-
mannopyranosyl trichloroacetimidate (30): 2,3,4-Tri-O-
benzyl-6-O-tert-butyldimethylsilyl-α-D-mannopyranose 29 (1.3 
g, 2.3 mmol) was dissolved in anhydrous toluene and dried azeotropically (2x) by 
removing the solvent under reduced pressure. The compound was dissolved in 
dichloromethane (20 mL) under argon and cooled to 0 °C. Subsequently 
trichloroacetonitrile (700 μL, 7 mmol) and DBU (68 μL, 0.5 mmol) were sequentially 
added; and the reaction mixture was stirred at room temperature for 1h. The solvent was 
removed under reduced pressure and the residue was purified by flash column 
chromatography (gradient 5-10%, EtOAc/hexanes) to give 2,3,4,-tri-O-benzyl-6-O-tert-
butyldimethylsilyl-α-D-mannopyranosyl trichloroacetimidate 1.30 (1.22 g, 75%) as a 
yellow syrup. 1H NMR (CDCl3, 500 MHz): δ 8.48 (s, 1H, NH), 7.42-7.27 (m, 15H, 
aromatic), 6.33 (s, 1H), 4.94 (d, J = 10.7 Hz, 1H), 4.75 (dd, J = 12, 18.3 Hz, 2H), 4.71-
4.66 (m, 3H), 4.62 (d, J = 11.35 Hz, 1H), 4.16 (t, J = 10.1 Hz, 1H), 3.95-3.93 (m, 2H), 
3.86 (d, J = 10.7 Hz, 2H), 3.82-3.79 (m, 1H), 0.90 (s, 9H, TBS), 0.08 (d, J = 5.05 Hz, 6H, 
TBS). 13C NMR (CDCl3, 75 MHz): δ 160.45, 138.55, 138.20, 138.02, 128.37, 128.34, 
128.24, 128.11, 127.95, 127.75, 127.69, 127.66, 127.57, 96.25, 78.85, 75.91, 75.32, 
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3,4,6-Tri-O-benzyl-1,2-O-(α-methoxybenzylidene)-β-D-mannopyranose (19):  
The orthoester 19 was synthesized following a reported 
procedure.3 To a stirring solution of ice-cold α-D-mannose (7 g, 
39 mmol) in CH2Cl2 (30 mL) and pyridine (30 mL) was added 
benzoyl chloride (30 mL, 280 mmol) dropwise over 30 min. The reaction was held at 
room temperature for 24h after which the yellow reaction mixture was neutralized by 
slow addition of dil. HCl at 0 °C, extracted with CH2Cl2 (3x) and the combined organic 
layers were washed with dil.HCl, H2O, and saturated NaHCO3 followed by brine solution 
and dried over anhydrous Na2SO4. The solvent was removed in vacuo and the crude 
penta-O-benzoyl-D-mannose was dissolved in CH2Cl2 that was subsequently treated with 
a solution of 30% HBr-AcOH (100 mL) dropwise at 0 °C. The reaction mixture was 
stirred at room temperature for 12h after which the reaction found to be completed. The 
reaction was diluted with CH2Cl2 and neutralized by slow addition of saturated Na2CO3 
solution at 0 °C, solids were filtered-off, and extracted with CH2Cl2 (2x) and the 
combined organic layers were washed with saturated NaHCO3, H2O, dil.HCl, and brine 
solution and dried over anhydrous Na2SO4 and the solvent was removed in vacuo to give 
2,3,4,6-tetrabenzoyl-α-D-mannopyranosyl bromide as a brownish viscous syrup which 
was dried under high vacuum for 3h and used without further purification. To a solution 
of above obtained 2,3,4,6-tetrabenzoyl-α-D-mannopyranosyl bromide in CH2Cl2 (100 
mL) was added MeOH (6 mL) and 2,6-lutidine (10 mL, 117 mmol) and the reaction was 
stirred at room temperature for 3 days. The solution was then quenched with water and 
                                                 
3 (a) Ness, R. K.; Fletcher, H. G.; Hudson, C. S. J. Am. Chem. Soc. 1950, 72, 2200-2205. (b) Hölemann, A.; 
Stocker, B. L.; Seeberger, P. H. J. Org. Chem. 2006, 71, 8071-8088. 
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diluted with Et2O (100 mL). The layers were separated and the aqueous layer was 
extracted with Et2O. The combined organic layers were washed with brine, dried over 
anhydrous Na2SO4 and the solvent was removed in vacuo. The resulting clear oil was 
further dried for 2 days under high vacuum to give 1,2-O-(α-methoxybenzylidene)-3,4,6-
tri-O-benzoyl-β-D-mannopyranose as a foamy solid. The crude residue of 1,2-O-(α-
methoxybenzylidene)-3,4,6-tri-O-benzoyl-β-D-mannopyranose was dissolved in CH2Cl2 
(100 mL) and MeOH (4 mL) and treated with NaOMe (200 mg, 3.9 mmol). The resulting 
solution was stirred at room temperature for 24h. The solvent was then removed under 
reduced pressure and the residue was purified by flash column chromatography (gradient 
5-10% MeOH/CH2Cl2) to give 34 (5.58 g, 48%, 4 steps) as a colorless semisolid. 
To a solution of above obtained 1,2-O-(α-methoxybenzylidene)-β-D-mannopyranose 34 
(5.48 g, 18.37 mmol) in DMF (50 mL) was added imidazole (120 mg, 1.8 mmol), benzyl 
bromide (10 mL, 82 mmol) and NaH (60% dispersion in mineral oil, 2.64 g, 110 mmol) 
portion wise. The resulting suspension was stirred at room temperature for 2.5h. Excess 
NaH was then cautiously quenched by the addition of water and the solution diluted with 
Et2O (150 mL). The organic extract were washed with H2O, saturated NaHCO3 solution 
(2x), brine and dried over Na2SO4. The solvent was removed under reduced pressure and 
the residue was purified by flash column chromatography to give 3,4,6-tri-O-benzyl-1,2-
O-(α-methoxybenzylidene)-β-D-mannopyranose 19 (7 g, 82%) as a faint yellow solid. 1H 
NMR (CDCl3, 500 MHz): δ 7.68-7.67 (m, 2H), 7.43-7.41 (m, 2H), 7.36-7.20 (m, 16H), 
5.49 (d, J = 3.15 Hz, 1H), 4.88 (d, J = 11.35 Hz, 1H), 4.85 (d, J = 11.95 Hz, 1H), 4.80 (d, 
J = 12 Hz, 1H), 4.67 (t, J = 3.15 Hz, 1H), 4.62 (d, J = 10.7 Hz, 1H), 4.40 (dd, J = 4.38, 
12.0 Hz, 2H), 3.92 (t, J = 8.85, 1H), 3.84 (dd, J = 3.75, 9.45, 1H), 3.65 (dd, J = 5.05, 10.7 
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Hz, 1H), 3.57-3.54 (m, 1H), 3.51-3.48 (m, 1H), 3.26 (s, 3H). 13C NMR (CDCl3, 75 
MHz): δ 138.31, 138.21, 137.85, 136.56, 128.97, 128.45, 128.31, 128.17, 127.99, 127.91, 
127.89, 127.67, 127.42, 127.32, 126.69, 122.44, 97.8, 78.44, 76.27, 75.02, 74.28, 73.16, 
72.03, 69.10, 51.31. MS (ESI): m/z 591.2 [M+Na]+. HRMS (ESI): m/z calcd for 




Tri-O-benzyl-α-D-mannopyranose acceptor 26 (50 mg, 0.0956 
mmol) and 3,4,6-tri-O-benzyl-1,2-O-(α-methoxybenzylidene)-β-
D-mannopyranose donor 19 (65 mg, 0.115 mmol) were dried together by azeotropic 
distillation with anhydrous toluene (3x5 mL) and kept under an argon atmosphere. 
Activated 4Å MS were added under the flush of argon and the starting materials 
dissolved in dichloromethane (5 mL) and dibutylphosphate (66 μL, 0.34 mmol) was 
added. The reaction mixture was stirred at room temperature for 1h during which all the 
donor converted to glycosyl phosphate (TLC monitoring). Then the reaction mixture was 
cooled to –30 °C and treated with TMSOTf (62 μL, 0.34 mmol), warmed-up to room 
temperature and stirred for a further 2h. After completion of the reaction, the solvent was 
removed under vacuum and the residue was purified by flash column chromatography 
(gradient 10-15% EtOAc/hexanes) to give 35 (46 mg, 47%) as a transparent viscous 
colorless liquid while recovering acceptor 26 (25 mg, 53% of used amount). 1H NMR 
(CDCl3, 300 MHz): δ 8.06-8.06 (m, 2H, aromatic), 7.55-7.15 (m, 32H), 5.87-5.70 (m, 
1H), 5.74 (s, 1H), 5.26-5.09 (m, 3H), 4.93-4.85 (m, 3H), 4.74-4.4.70 (m, 4H), 4.69 (s, 
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2H), 4.61-4.41 (m, 4H), 4.12-4.02 (m, 3H), 3.94-3.66 (m, 10H).13C NMR (CDCl3, 75 
MHz): δ 165.46, 138.61, 138.52, 138.44, 138.29, 137.89, 133.64, 132.95, 130.04, 129.95, 
128.32, 128.28, 128.21, 128.15, 127.87, 127.81, 127.68, 127.65, 127.60, 127.47, 127.40, 
127.36, 117.41, 98.02, 96.79, 80.27, 77.66, 75.08, 75.00, 74.71, 74.63, 74.19, 73.32, 
72.67, 72.04, 71.61, 71.26, 71.08, 68.96, 68.70, 67.75, 66.65. MS (ESI): m/z 1049.3 




tri-O-benzyl-α-D-mannopyranoside (36): The dimannoside 1.35 
(45 mg, 0.045 mmol) was dissolved in dichloromethane-methanol 
(9:1 v/v, 3 mL) and NaOMe (26 mmol, 0.049 mg) was added. 
The reaction mixture was stirred at room temperature for 24h after which the solvent was 
removed under reduced pressure. Purification of the residue by flash column 
chromatography (gradient 15-30% EtOAc/hexanes) afforded the titled dimannoside 36 
(45 mg, quantitative) as a colorless viscous syrup. 1H NMR (CDCl3, 300 MHz): δ 7.37-
7.22 (m, 28H, aromatic), 7.16-7.13 (m, 2H, aromatic), 5.88-5.75 (m, 1H), 5.23-5.06 (m, 
3H), 4.92-4.43 (m, 13H), 4.10-4.06 (m, 2H), 3.93-3.58 (m, 12H), 2.38 (s, br, 1H, OH). 
13C NMR (CDCl3, 75 MHz): δ 138.51, 138.44, 138.26, 137.83, 133.64, 128.44, 128.32, 
128.25, 128.20, 127.93, 127.84, 127.78, 127.74, 127.71, 127.63, 127.55, 127.46, 117.44, 
99.57, 96.81, 80.21, 79.58, 75.03, 74.93, 74.62, 74.20, 73.34, 72.74, 72.09, 71.59, 71.46, 
71.04, 68.83, 68.04, 67.77, 66.24. MS (ESI): m/z 921.0 [M-H]- , 945.3 [M+Na]+. HRMS 
(ESI): m/z calcd for C57H62NaO11 945.4190 [M+Na]+; found 945.4190. 





benzyl-α-D-mannopyranoside (37): Here the same one pot 
glycosylation procedure as mentioned earlier for the synthesis of 36 
was adopted. Dimannoside acceptor 36 (45 mg, 0.049 mmol) and 1,2-
orthoester donor 19 (33 mg, 0.059 mmol) were dried together by 
azeotropic distillation with anhydrous toluene (3x5 mL) and kept under an argon 
atmosphere. Activated 4Å MS were added under the flush of argon and starting material 
was dissolved in dichloromethane (4 mL) subsequently dibutylphosphate (34 μL, 0.18 
mmol) was added. The reaction mixture was stirred at room temperature for 1h during 
which all the donor converted to glycosyl phosphate (TLC monitoring). Then the reaction 
mixture was cooled to –30 °C and treated with TMSOTf (31 μL, 0.18 mmol), warmed-up 
to room temperature and stirred for an additional 2h. After completion of the reaction, the 
solvent was removed under vacuum and the residue was purified by flash column 
chromatography (gradient 15-25% EtOAc/hexanes) to give 37 (29 mg, 33%) as a 
transparent viscous colorless liquid while recovering acceptor 36 (4 mg). 1H NMR 
(CDCl3, 300 MHz): δ 8.08-8.05 (m, 2H), 7.56-7.51 (m, 1H), 7.37-7.01 (m, 47H), 5.86-
5.73 (m, 1H), 5.76 (s, 1H), 5.21-5.01 (m, 4H), 4.89-4.83 (m, 4H), 4.75-4.69 (m, 4H), 
4.64-4.40 (m, 11H), 4.12-4.02 (m, 5H), 3.92-3.57 (m, 15H). 13C NMR (CDCl3, 75 MHz): 
δ 165.42, 138.69, 138.64, 138.59, 138.47, 138.25, 138.19, 138.14, 133.67, 132.92, 
130.13, 129.95, 128.35, 128.32, 128.29, 128.23, 128.17, 128.06, 127.89, 127.86, 127.74, 
127.69, 127.63, 127.28, 127.53, 127.49, 127.46, 127.41, 127.37, 127.28, 117.43, 99.57, 
99.09, 96.89, 80.36, 79.11, 78.18, 77.20, 75.09, 74.96, 74.83, 74.65, 74.53, 74.34, 73.33, 
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73.17, 72.67, 72.09, 71.82, 71.61, 71.49, 69.21, 67.69, 66.61. MS (ESI): m/z calcd for 
C91H94NaO17 1481.6389 [M+Na]+; found, 1481.4. 
 
Allyl (2,3,4-tri-O-benzyl-α-D-mannopyranosyl)-(1→6)-2,3,4-tri-O-benzyl-6-O-tert-
butyldimethylsilyl-α-D-mannopyranoside (38): The glycosyl 
donor, 2,3,4-tri-O-benzyl-6-O-tert-butyldimethylsilyl--D-
mannopyranosyl trichloroacetimidate 30 (1.72 g, 2.43 mmol) and 
the allyl-2,3,4-O-benzyl--D-mannopyranoside acceptor 26 (1.08 
g, 2.2 mmol) were dried through azeotropic distillation with anhydrous toluene (2x) 
before being kept under an argon atmosphere. Then the mixture was dissolved in 
anhydrous diethyl ether (30 mL) under argon and treated with TMSOTf (25 μL, 0.11 
mmol). The reaction mixture was stirred at room temperature for 2h followed by 
neutralization with Et3N. Subsequently, distillation of the solvent and flash column 
chromatography (gradient 10-15% EtOAc/hexanes) of the residue gave the desired 
dimannoside compound 38 (1.6 g, 70%) as a colorless viscous oil. 1H NMR (CDCl3, 300 
MHz): δ 7.42-7.26 (30H, aromatic), 5.92-5.80 (m, 1H), 5.27-5.16 (m, 2H), 5.09 (s, 1H), 
4.99-4.89 (m, 3H), 4.79-4.52 (m, 10H), 4.15-3.65 (m, 14H), 0.93 (s, 9H, TBS), 0.09 (d, J 
= 4.08 Hz, 6H, TBS). 13C NMR (CDCl3, 75 MHz): δ 139.03, 138.82, 138.50, 138.27, 
133.67, 128.33, 128.29, 128.20, 128.12, 127.80, 127.65, 127.62, 127.54, 127.41, 127.35, 
127.23, 117.40, 97.91, 96.92, 80.33, 79.46, 77.42, 75.32, 75.06, 74.91, 74.68, 73.09, 
72.83, 72.32, 72.14, 71.78, 71.58, 67.67, 65.85, 62.57, 29.68, 25.93, 18.28, -5.10, -5.33. 















tri-O-benzyl-α-D-mannopyranoside (39): Dimannoside 38 (1.6 
g, 1.7 mmol) was dissolved in THF (20 mL) and treated with a 
drop of acetic acid followed by TBAF (1N in THF, 2 mL, 2 
mmol). The reaction mixture was stirred for 3h at room temperature. After completion of 
the reaction, the solvent was removed under reduced pressure, and the residue was 
purified by flash column chromatography (gradient 15-30% EtOAc/hexanes) to give the 
titled dimannoside 39 (1.28 g, 90%) as a colorless liquid. 1H NMR (CDCl3, 500 MHz): δ 
7.37-7.18 (m, 30H, aromatic), 5.85-5.77 (m, 1H), 5.21-5.12 (m, 2H), 5.05 (s, 1H), 4.95-
4.89 (m, 2H), 4.84 (s, 1H), 4.73-4.61 (m, 7H), 4.58 (d, J = 12 Hz, 1H), 4.53 (d, J = 12 
Hz, 1H), 4.48 (d, J = 11.35 Hz, 1H), 4.09-4.06 (m, 1H), 3.98-3.86 (m, 7H), 3.81 (s, br, 
1H), 3.75-3.64 (m, 6H). 13C NMR (CDCl3, 125 MHz): 138.54, 138.51, 138.38, 138.27, 
138.15, 133.57, 128.34, 128.31, 128.27, 127.92, 127.83, 127.74, 127.72, 127.70, 127.62, 
127.57, 127.55, 127.50, 117.42, 98.23, 96.97, 80.24, 79.35, 75.07, 75.01, 74.77, 74.65, 
74.54, 72.85, 72.68, 72.11, 71.58, 67.74, 66.07, 62.23. MS (ESI): m/z calcd for 
C57H62NaO11 945.4190 [M+Na]+; found 945.3. 
Allyl (2,3,4-tri-O-benzyl-α-D-mannopyranosyl)-(1→6)-(2,3,4-tri-
O-benzyl-α-D-mannopyranosyl)-(1→6)-2-benzoyl-3,4,6-tri-O-
benzyl-α-D-mannopyranoside (40): Dimannoside acceptor 39 (0.4 g, 
0.43 mmol) and 1,2-orthoester donor 19 (0.3 g, 0.52 mmol) were 
together dried by azeotropic distillation with anhydrous toluene (3x) 
and flushed with argon. Activated 4Å MS were added under the flush 
of argon and organic content was dissolved in dichloromethane (20 mL), and 
Experimental Procedures (Part A) 
36 
 
dibutylphosphate (300 μL, 1.6 mmol) was added. The reaction mixture was stirred at 
room temperature for 1h during which all the donor converted to glycosyl phosphate 
(according to TLC analysis). Then the reaction mixture was cooled to –30 °C and treated 
with TMSOTf (300 μL, 1.6 mmol), and the contents warmed-up to room temperature and 
stirred for further 2h. After completion of the reaction, the solvent was removed under 
vacuum, and the residue was purified by flash column chromatography (gradient 10-20% 
EtOAc/hexanes) to give the titled trimannoside 40 (0.63 g, quantitative) as a transparent 
viscous colorless liquid. 1H NMR (CDCl3, 500 MHz): δ 8.15-8.14 (m, 2H, aromatic), 
7.60-7.57 (m, 1H, aromatic), 7.47-7.21 (m, 47H, aromatic), 5.91-5.85 (m, 1H), 5.82 (s, 
1H), 5.28-5.15 (m, 4H), 5.02-4.92 (m, 4H), 4.79-4.64 (m, 8H), 4.58-4.49 (m, 6H), 4.16-
3.93 (m, 12H), 3.88-3.68 (m, 8H). 13C NMR (CDCl3, 125 MHz): δ 165.41, 138.82, 
138.70, 138.60, 138.50, 138.35, 138.26, 137.95, 133.67, 132.94, 130.17, 130.03, 128.38, 
128.34, 128.30, 128.20, 128.18, 127.93, 127.88, 127.85, 127.73, 127.67, 127.61, 127.58, 
127.55, 127.50, 127.49, 127.41, 127.39, 127.29, 117.43, 98.26, 98.01, 97.03, 80.38, 
79.49, 77.68, 75.11, 75.09, 74.90, 74.60, 74.36, 74.20, 73.36, 72.87, 72.48, 72.19, 71.82, 
71.67, 71.38, 71.22, 71.06, 68.96, 68.70, 67.76, 66.50, 66.07, 65.85. MS (ESI): m/z calcd 




mannopyranoside (41): The trimannoside 40 (451 mg, 0.31 mmol) 
was dissolved in dichloromethane-methanol (10 mL, 9:1 v/v) and 
NaOMe (16 mg, 0.3 mmol) was added. The reaction mixture was 
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stirred at room temperature for 24h after which the solvent was removed under reduced 
pressure followed by purification of the residue by flash column chromatography 
(gradient 20-30% EtOAc/hexanes) to afford the titled trimannoside 41 (398 mg, 95%) as 
a colorless syrup. 1H NMR (CDCl3, MHz): δ 7.38-717 (m, 45H, aromatic), 5.88-5.80 (m, 
1H), 5.25-5.21 (m, 1H), 5.16 (dd, J = 1.25, 10.1 Hz, 1H), 5.10 (s, 2H), 4.95-4.82 (m, 
4H), 4.77-4.46 (m, 15H), 4.12-4.09 (m, 2H), 3.99-3.82 (m, 11H), 3.59 (dd, J = 1.9, 10.7 
Hz, 1H). 13C NMR (CDCl3, 75 MHz): δ 138.66, 138.58, 138.50, 138.37, 138.23, 138.10, 
137.86, 133.54, 128.37, 128.31, 128.27, 128.20, 128.16, 128.13, 127.88, 127.83, 127.81, 
127.77, 127.65, 127.59, 127.51, 127.50, 127.42, 127.28, 117.42, 99.64, 97.81, 96.94, 
80.28, 79.48, 79.31, 77.43, 75.02, 74.89, 74.84, 74.76, 74.52, 74.29, 74.14, 73.30, 72.85, 
72.51, 72.12, 71.71, 71.44, 71.37, 71.26, 71.01, 68.76, 67.86, 67.68, 65.99, 65.90. MS 





mannopyranoside (42): Trimannoside acceptor 41 (200 mg, 0.35 
mmol) and 1,2-orthoester donor 19 (397 mg, 0.3 mmol) were dried 
together by azeotropic distillation with anhydrous toluene (3x5 mL) 
and flushed with argon. Activated 4Å MS were added under the flush of argon and the 
organic content was dissolved in dichloromethane (7 mL) and subsequently 
dibutylphosphate (200 μL, 1 mmol) was added. The reaction mixture was stirred at room 
temperature for 1h during which all the donor converted to glycosyl phosphate (according 
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to TLC analysis). Then the reaction mixture was cooled to –30 °C and treated with 
TMSOTf (190 μL, 1 mmol), the contents were warmed-up to room temperature and 
stirring continued for further 2h. After completion of the reaction, the solvent was 
removed under vacuum, and the residue was purified by flash column chromatography 
(gradient 15-30% EtOAc/hexanes) to give tetramannoside 42 (549 mg, 99%) as a viscous 
colorless syrup. 1H NMR (CDCl3, 300 MHz): δ 8.16-8.14 (m, 2H, aromatic), 7.63-7.58 
(m, 1H, aromatic), 7.43-7.18 (m, 62H, aromatic), 5.93-5.80 (m, 1H), 5.87 (s, 1H), 5.28-
5.10 (m, 4H), 5.00-4.90 (m, 5H), 4.84-4.46 (m, 20H), 4.19-4.10 (m, 5H), 4.03-3.57 (m, 
21H). 13C NMR (CDCl3, 75 MHz): δ 165.35, 138.73, 138.62, 138.53, 138.38, 138.23, 
138.09, 133.56, 132.89, 130.06, 129.92, 128.30, 128.18, 128.12, 128.10, 128.05, 127.86, 
127.81, 127.76, 127.64, 127.61, 127.54, 127.44, 127.37, 127.23, 127.18, 117.36, 99.47, 
99.22, 98.08, 96.96, 80.29, 79.50, 78.96, 78.15, 77.20, 75.02, 74.92, 74.76, 74.49, 74.38, 
74.24, 74.16, 73.29, 73.11, 72.79, 72.42, 72.10, 72.04, 71.73, 71.54, 71.41, 71.32, 69.12, 






mannopyranoside (43): The titled compound was synthesized by 
the same procedure of debenzoylation as described for the synthesis 
of 40. 1H NMR (CDCl3, 500 MHz): δ 7.46-7.19 (m, 60H, aromatic), 
5.91-5.83 (m, 1H), 5.27-5.16 (m, 4H), 5.10 (s, 1H), 4.97 (dd, J = 4.4, 10.75 Hz, 2H), 4.91 
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(s, br, 1H), 4.88 (dd, J = 5, 10.7 Hz, 2H), 4.79-4.46 (m, 20H), 4.18 (d, J = 10.7 Hz, 2H), 
4.15-4.12 (m, 1H), 4.04-3.88 (m, 14H), 3.85 (dd, J = 3.8, 10.7 Hz, 1H), 3.76-3.66 (m, 
6H), 3.58-3.55 (m, 2H). 13C NMR (CDCl3, 75 MHz): δ 138.77, 138.71, 138.63, 138.59, 
138.54, 138.42, 138.40, 138.27, 138.24, 138.16, 138.14, 138.09, 138.07, 133.58, 128.35, 
128.31, 128.26, 128.23, 128.18, 128.14, 128.10, 128.07, 127.90, 127.83, 127.80, 127.74, 
127.72, 127.64, 127.61, 127.53, 127.49, 127.48, 127.42, 127.35, 127.27, 127.18, 127.13, 
117.35, 101.05, 99.25, 98.12, 96.97, 80.30, 79.96, 79.52, 78.91, 77.20, 75.00, 74.94, 
74.85, 74.67, 74.50, 74.46, 74.27, 74.18, 73.29, 73.10, 72.82, 72.48, 72.11, 72.01, 71.80, 
71.75, 71.41, 71.36, 71.31, 69.05, 68.90, 68.59, 67.68, 66.50, 66.08, 65.78. MS (ESI): 






mannopyranoside (44): Glycosyl donor 11, (0.125 g, 0.18 mmol) 
and tetramannoside acceptor 43 (0.27 g, 0.15 mmol) were dried 
through azeotropic distillation with anhydrous toluene (2x) before 
being kept under an argon atmosphere. Then the mixture was dissolved in anhydrous 
diethylether (15 mL) under argon and TMSOTf (4 μL, 0.02 mmol) was added. The 
reaction mixture was stirred for 2h at room temperature which was followed by 
neutralization with Et3N, removal of the solvent in vacuo. The residue was purified by 
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pentamannoside 44 (332 mg, 96%) as a faint yellow solid. 1H NMR (CDCl3, 500 MHz): 
δ 7.34-7.08 (m, 80H, aromatic), 5.81-5.73 (m, 1H), 5.20-5.09 (m, 4H), 5.05 (d, J = 1.35 
Hz, 1H), 4.97 (d, J = 1.35 Hz, 1H), 4.89-4.84 (m, 2H), 4.82-4.79 (m, 3H), 4.69-4.51 (m, 
11H) , 4.49-4.28 (m, 3H), 4.16-4.10 (m, 2H), 4.07-4.04 (m, 2H), 3.93-3.76 (m, 17H), 
4.67-4.42 (m, 11H). 13C NMR (CDCl3, 125 MHz): δ 138.85, 138.81, 138.80, 138.75, 
138.69, 138.67, 138.64, 138.61, 138.28, 138.46, 138.43, 138.39, 138.36, 138.29, 138.26, 
138.18, 138.06, 128.53, 128.48, 128.42, 128.32, 128.32, 128.28, 128.23, 128.21, 128.18, 
128.15, 128.11, 128.08, 128.07, 127.99, 127.85, 127.84, 127.81, 127.80, 127.77, 127.75, 
127.73, 127.68, 127.64, 127.62, 127.58, 127.56, 127.52, 127.47, 127.44, 127.40, 127.35, 
127.29, 127.26, 127.25, 127.21, 127.10, 117.35, 100.60, 99.29, 99.24, 98.15, 96.99, 
80.31, 79.88, 79.80, 79.63, 78.91, 75.03, 74.93, 74.92, 74.86, 74.83, 74.70, 74.64, 74.52, 
74.47, 74.28, 74.22, 73.31, 73.24, 73.13, 72.81, 72.51, 72.41, 72.30, 72.14, 72.08, 71.97, 
71.81, 71.30, 71.16, 69.32, 69.02, 68.90, 67.68, 66.48, 66.03. MS (ESI): m/z calcd for 






mannopyranoside (45): Pentamannoside 44 (223 mg, 0.097 mmol) 
was dissolved in DMSO (10 mL) to which KOt-Bu (112 mg, 1 
mmol) was added and stirred at 80 °C for 4h. After completion of 
the reaction, the contents were diluted with ethyl acetate and poured on to ice. The layers 
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were separated; and the organic layer was washed with brine and concentrated in vacuo. 
The crude residue was dissolved in acetone-water (9:1 v/v, 5 mL) and 1N HCl (2 mL) 
was added and the reaction was held at 40 °C for 30 min. Then H2O was added to the 
reaction mixture and extracted with ether (3x), concentrated and purified by flash column 
chromatography (gradient 30-50%, EtOAc/hexanes) to afford the titled pentamannoside 
45 (176 mg, 80%) as a white foamy solid. 1H NMR (CDCl3, 500 MHz): δ 7.32-7.14 (m, 
80H), 5.20-5.13 (m, 3H), 5.06-4.96 (m, 2H), 4.88-4.78 (m, 5H), 4.69-4.42 (m, 24H), 
4.34-4.30 (m, 2H), 4.23-4.16 (m, 2H), 4.09-4.03 (m, 2H), 3.90-3.75 (m, 17H), 3.69-3.63 
(m, 6H), 3.57-3.53 (m, 3H). 13C NMR (CDCl3, 125 MHz): δ 138.73, 138.68, 138.62, 
138.59, 138.54, 138.46, 138.43, 138.33, 138.10, 128.48, 128.43, 128.29, 128.28, 128.25, 
128.21, 128.17, 128.09, 128.04, 127.91, 127.79, 127.76, 127.72, 127.67, 127, 64, 127.58, 
127.56, 127.53, 127.48, 127.44, 127.42, 127.36, 127.31, 127.28, 127.23, 100.72, 99.32, 
98.73, 97.40, 92.46, 89.87, 79.78, 79.69, 78.87, 75.23, 75.04, 74.93, 74.80, 74.71, 74.63, 
73.30,73.26, 73.18, 73.11, 72.78, 72.51, 72.34, 72.29, 72.13, 72.08, 72.00, 71.85, 71.60, 
71.43, 71.32, 71.25, 70.98, 69.29, 69.16, 68.99, 66.54, 65.45. MS (ESI): m/z calcd for 






butyldimethylsily-α-D-mannopyranoside (46): The glycosylation 
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(300 mg, 0.17 mmol) were dried together through azeotropic distillation with anhydrous 
toluene (2x) before being kept under an argon atmosphere. Then the mixture was 
dissolved in anhydrous diethylether (10 mL) under argon after which TMSOTf (3 μL, 
0.01 mmol) was added and stirred at room temperature for 2h. Then the reaction mixture 
was neutralized with Et3N and concentrated in vacuo and the residue was purified by 
flash column chromatography (gradient 15-25% EtOAc/hexanes) to obtain the desired 
pentamannoside 46 (310 mg, 80 %) as a colorless solid. 1H NMR (CDCl3, 500 MHz): δ 
7.41-7.11 (m, 75H, aromatic), 5.87-5.80 (m, 1H), 5.25-5.13 (m, 5H), 5.01-4.85 (m, 7H), 
4.75-4.64 (m, 9H), 4.61-4.41 (m, 13H), 4.45-4.41 (m, 3H), 4.22-4.16 (m, 3H), 4.12-4.08 
(m, 1H), 4.01-3.81 (m, 18H), 3.74-3.66 (m, 7H), 3.64-3.61 (dd, J = 4.4, 11.35 Hz, 1H), 
3.53-3.47 (dd, J = 10.1, 20.2 Hz, 2H), 0.91 (s, 9H, TBS), 0.06-0.05 (d, J = 5.65 Hz, 6H, 
TBS). 13C NMR (CDCl3, 125 MHz): δ 139.19, 138.78, 138.68, 138.64, 138.60, 138.58, 
138.53, 138.41, 138.33, 138.23, 138.15, 137.90, 133.58, 128.46, 128.30, 128.26, 128.21, 
128.14, 128.099, 128.04, 127.99, 127.84, 127.80, 127.75, 127.73, 127.699, 127.66, 
127.61, 127.57, 127.53, 127.48, 127.41, 127.36, 127.27, 127.21, 127.13, 127.08, 117.33, 
100.64, 99.22, 98.88, 98.14, 96.97, 80.29, 79.93, 79.80, 79.61, 78.94, 75.17, 75.01, 74.93, 
74.89, 74.83, 74.61, 74.49, 74.42, 74.19, 73.86, 73.35, 73.24, 73.11, 72.81, 72.45, 72.37, 
72.33, 72.14, 71.84, 71.79, 71.74, 71.44, 71.28, 71.15, 69.32, 69.01, 67.68, 66.44, 65.99, 














































































































































































































































































































































































































































































































































































































13C Standard AC300 ma03SRK1064 
ma03srk(exp 2)
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































*** Acquisition  Parameters ***
BF1 :    500.1300000 MHz
LOCNUC : 2H
NS :              8
O1 :        3088.51 Hz
PULPROG : zg30
SFO1 :    500.1330885 MHz
SOLVENT : CDCl3
SW :        20.6557 ppm
*** Processing Parameters ***
LB :           0.30 Hz
PHC0 :         89.229 degree
PHC1 :         -0.482 degree



































































































































































































































































































































































































































































































1H normal range AC300




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































1175_ Bn ortho ester (ja11srk exp 2)









































































































































































































































































































































































































1H normal range AC300







































































































































































































































































































































































































































































































































































































































































































































































































































1H normal range AC300
































































































































































































































































 srk 1159-OH-disaccharide (oc27srk exp 2)
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1 Background and Introduction 
1.1 Bielschowskysin: Isolation, Structural Characterization and Biological 
Properties 
The gorgonian octocorals of the Caribbean Sea encompass a variety of sea plumes, sea 
whips and sea pans. Specifically, the sea plume genus Pseudopterogorgia is a profound 
source of natural secondary metabolites1,2 of terpenoids, steroids, and acetogenins. 
Among several of these are biologically active compounds, exhibiting anti-inflammatory, 
anti-malarial, anti-tumor, and anti-mycobacterial properties.  
 
The Rodrίguez group has contributed enormously towards the isolation of gorgonian 
metabolites1b-g,2b-d in recent years and has reported the highly oxygenated natural product 
of regular cembrane of the diterpene family, called bielschowskysin (1.1)1e in 2004 from 




Bielschowskysin was isolated from 1.07 kg of air-dried specimen collected near the Old 
Providence Island, Columbia, located in the Caribbean Sea. By employing thorough 
extraction techniques, 39.6 mg of pure natural product was isolated as a colorless 
crystalline solid. 
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The structure of bielschowskysin (molecular formula: C22H26O9) and relative 
stereochemistry were elucidated by spectroscopic and single crystal X-ray diffraction 
analysis and confirmed to be an unprecedented, highly strained, 
tricyclo[9.3.0.02,10]tetradecane ring system. This regular diterpene metabolite belongs to 
the cembranes and comprises a γ-lactone moiety encompassing C10–C12 carbons with a 
relative S-configuration. Other highlighting features include two hemiacetals, one of 
which is a transfused cyclic lactol with an exo-cyclic methylene group and a spirocyclic 
hemiacetal constituted between C3-C6 with a transannular ether linkage. A tetra 
substituted cyclobutane nucleus embedded in the natural product is a result of 
transannular bonds between C7-C11 and C6-C12 of the 14-membered cembrane. Two 
isolated C=C bonds, one acetate group and 11 chiral centers with relative stereochemistry 
as 1S*,2S*,3S*,6S*,7S*,8S*,10S*,11S*,12R*,13R* are other structural features of 
bielschowskysin (1.1). 
In terms of biological activity, bielschowskysin exhibits antiplasmodial activity against 
malarial causative organism Plasmodium falciparum with IC50=10 μg/mL, as well as 
profound and specific in vitro cytotoxicity against two human cancer cell lines; EKVX 
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1.2 Furanocembrane Family: Related Octocoral Diterpenoids 
 
 
Scheme 1.1: Diterpene Natural Products from Pseduopterogorgia sp. 
 
 
Diterpenes isolated from Pseudopterogorgia sp. feature a variety of ring sizes and site 
specific variable oxidation patterns1a-f,2b-d,3. There are several categories of diterpenes 
which are interrelated by different rearrangement patterns. The major structural families 
are classified to be furanocembranoid, pseudopterane, gersolane, ciereszkane, etc., all 
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with a macrocyclic skeleton. The typical features among different structural families are a 
γ-lactone, and a substituted furan. Besides that, internal double bonds or epoxides, e.g., 
providencin (1.5)1c, pseudopterolide (1.9); exocyclic isoprenyl appendage e.g., bipinnatin 
J (1.2)4, rubifolide (1.3)5, acerosolide (1.4)6, gorgiacerone (1.6)6, kallolide A (1.7) and 
kallolide B (2.8)1a; or as a fused ring system, e.g., bielschowskysin (2.1)1e, providencin 
(1.5)1c, ciereszkolide (1.10)1d are some of the commonly observed features. 
Fundamental features of the basic macrocyclic core further reorganizes with the 
formation of additional transannular bonds across the core making the architecturally 
complex polycyclic diterpene metabolites, e.g., intricarene (1.11)1f, verrillin (1.12)1b, 
plumarellide (1.13)7. 
 
1.3 Biological Evolution of Diterpene Skeletons: Interrelation Pattern 
The basic isoprene appended 14-membered macrocyclic cembrane skeleton (1.15) has 
been proposed to originate biosynthetically from geranylgeranyl pyrophosphate, GGPP 
(1.14). Pseudopterane (1.16)8, gersolane (1.17), ciereszkane (1.18)1d with 12, 13 and 13 
membered macrocyclic skeletons, respectively, have been proposed to originate from 
different modes of ring contraction of cembrane 1.15. C2-C17 cyclisation with external 
isoprenyl group results in the providenciane (1.19) skeleton with a bicyclic 14+4 fusion; 
whereas transannular bonds across macrocyclic ring generate new classes of fused ring 
motifs. Tricyclic [6-7-5] ring-system of intricarene (1.20) skeleton is generated by 
transannulation at C6-C11 and C2-C12. Cyclization by forming the C7-C11 transannular 
bond gives the bicyclic 5+11 verrillane skeleton (1.21)1b, while simultaneous/consequent 
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1.4 Bielschowskysin: Proposed Biosynthesis 
 
 
Scheme 1.3: Biosynthetic Origin of Bielschowskysin (1.1) 
 
Polycyclic cembrane metabolites are derived from simple furanocembranoids such as 
bipinnatin J (1.2) or rubifolide (1.3).3 Enzymatic oxidations together with transannulation 
have been proposed to account for the formation of bielschowskysin (1.1). The 2(5H)-
furanone-enol-ether 1.26 is conceived to be a potential intermediate, which itself is 
derived from enzymatic oxidations, though little is known, for example, by cytochrome 
P450 oxygenase. The origin of the enol-ether 1.26 can be substantiated in 2 ways. 
Oxidation of Δ7,8 olefin 1.23 to give epoxide 1.24 followed by ketal intermediate 1.26 
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formation by double vinylogous hydrolysis (Path A, Scheme 1.3). Alternatively, 
oxidative cleavage of trisubstituted furan 1.23 to an ene-dione 1.25 followed by 
hydrolysis with concomitant cyclization would give the ketal 1.26 (Path B, Scheme 1.3). 
Eventual transannular [2+2] cyclization between Δ6,7 enol-ether and Δ11,12 of γ-lactone 
1.26 would deliver the [5-4-9] fused ring motif, bielschowskysin (1.1). 
 
1.5 Gorgonian Diterpenes: Established Synthetic Methods 
A significant amount of work has been established towards the synthesis of the growing 
family of diterpenoid cembranes and related natural products.3,9 Yet, aesthetically 
pleasing synthetic methods are still emerging to construct the structurally complex 
skeletons. The following methods briefly summarize the major methodologies towards 
these diterpene molecules. 
1.5.1 Paquette Methodology towards Cembranoid Skeletons10 
The pioneering furanocembranoid chemistry was reported by the Paquette group with the 
synthesis of gorgiacerone (1.6) completed in 1992.10b The key methods to build the 
psuedopterane skeleton comprise construction of the furan ring by glyceraldehyde-
acetonide 1.27 condensation with malonate 1.28; Grignard addition to extend furfural 
1.29; conjugate addition of allyl stannane 1.30 to an aldehyde 1.31 with concomitant one 
pot transesterification to γ-lactone 1.32. Stille sp2-sp3 cross coupling at the remaining side 
of the furan 1.32 was used to stitch the allyl bromide unit to make-up the furan-lactone 
1.33 with all skeletal carbons (Scheme 1.4). 




Scheme 1.4: Paquette Methodology: Gorgiacerone (1.6) Synthesis 
 
Eventual cyclization of aldehyde-allyl bromide 1.33 afforded a macrolide with a highly 
diastereoselective CrCl2 mediated metallo-ene NHK (Nozaki-Hiyama-Kishi) reaction. 
Subsequent oxidation of the resulting allylic secondary alcohol to the carbonyl group by 
Swern oxidation accomplished the pseduopterane diterpene natural product, gorgiacerone 
(1.6).  
The Paquette group successfully employed similar building blocks with conceptually 
comparable disconnection patterns to construct both furanocembranoid and 
psuedopterane skeletons. Both skeletons have been achieved by tuning the conditions of 
addition of allyl stannane 1.30 to the aldehyde 1.31 (Scheme 1.4). BF3 activation of the 
reaction proceeds through C-C bond forming conjugate addition at the allylic position of 
primary allyl stannane; whereas, SnCl4 mediates rearrangement of the primary allyl 
stannane 1.30 to a secondary stannane. Next, bond formation at the primary carbon with 
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the carbonyl of aldehyde 1.34 lead to the furanocembranoid skeleton, 1.35, e.g., 
acerosolide10e (Scheme 1.5). Paquette further exploited this methodology to other 
furanocembranoid natural products. 
 
 
Scheme 1.5: Paquette Methodology: Acerosolide (1.4) Synthesis 
 
1.5.2 Marshall Methodology towards Cembrane/Pseudopterane Skeletons11 
The Marshall group is another leading contributor towards the synthesis of macrocyclic 
diterpenes. They developed a conceptually new methodology to build key elements of 
these natural products. Both furan11a and γ-lactone scaffolds were derived pleasingly 
from an allene (Schemes 1.6 and 1.7). 
Macrocyclization by etherification of alcohol-halide 1.40 followed by [2,3]-Wittig ring 
contraction in a macrocycle (e.g., 1.41) have been employed to build-up psuedopterane 
macrolides, e.g., the enantiomer of kallolide B 1.8b (Scheme 1.6)11b,c. With similar 
transformations, the macrocyclization of allenyl tin-aldehyde 1.46 gave the 14-membered 
cembrane macrocycles; e.g., ent-rubifolide 1.3b (Scheme 1.7). The substituted furans 
(1.39/1.48) were derived from allenones at earlier stages. Lastly, diastreoselective 
butenolide construction was developed from either the sterically defined allenoate 1.43 or 
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1.48; which in turn was obtained from stereospecific propargylic alcohol intermediates 
1.42 or 1.47 (Schemes 1.6 and 1.7). 
 
 
Scheme 1.6: Marshall Methodology to Pseudopterane Skeleton 
 
 










1.5.3 Donohoe RCM Method for Butenolide of Deoxypukalide 
 
The Donohoe group in 2008 demonstrated the tactical application of RCM to construct 
both the furan and γ-lactone rings found in the furanocembranoid (-)-(Z)-deoxypukalide12 
1.54a, an enantiomeric form of the natural product (Scheme 1.8). 
 




Scheme 1.8: Donohoe Synthesis of (-)-(Z)-Deoxypukalide (2.54a) 
 
Diene precursor 1.49 was obtained from (S)-perillyl alcohol in 4 steps. RCM of diene 
with Grubbs II catalyst 1.50 smoothly formed a cyclic olefin 1.51, which was 
subsequently aromatized to furan by acid catalysis effectively in one pot. The linear chain 
with adequately substituted aromatic furan 1.52 was attained by exploiting the 
regioselective Negishi cross-coupling as the key step. From here, the key 
macrolactonization of seco-acid 1.52 was best implemented by Shiina protocol to furnish 
the macrolactone 1.53 in good yield. Finally, RCM with Grubbs II under dilute 
conditions effected the γ-lactone formation, while exclusively establishing the total 
synthesis of the target molecule (-)-(Z)-deoxypukalide (1.54a).  
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1.5.4 Pattenden RCM-CM Method for Cembranoids 
 
Scheme 1.9: Pattenden Synthesis of (+)-(Z)-Deoxypukalide (1.54b) 
 
The Pattenden group13 is another leading contributor towards the synthesis of 
furanocembrane/ pseudopterane members and recently, the macrocyclic furanocembrane 
(+)-(Z)-deoxypukalide (1.54b) was constructed via the practical and concise 
functionalization of lactones by exploiting a one pot RCM and cross-metathesis (CM) 
approach.13j The RCM-CM sequence not only builds the butenolide ring (by RCM) but 
also gives access to extend the chain further by CM with allyl alcohol 1.58 (Scheme 1.9). 
The remaining components of the synthesis were well-established Stille sp2-sp2 cross-
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coupling to bring-in aromatic portion, and the Cr-mediated NHK method for 
macrocyclization. Eventual oxidation at the final stage furnished the natural product. The 
broad disconnection pattern is conceptually analogous with known synthetic sequences of 
furanocembranoids, while the butenolide segment was specifically functionalized with a 
remarkable RCM-CM protocol. 
 
1.5.5 Trauner Method to Bipinnatin J and Intricarene 
The Trauner group has established a concise platform to prepare furanocembranoids via 
bipinnatin. This group achieved an expedient synthesis of the prototypical gorgonian 
furanocembranoid, (±)-bipinnatin J in 2006 within 9 linear steps without any protecting 
group and with high chemoselectivity (Scheme 1.10).14 The highlights of their synthesis 
are a strategic ruthenium-catalyzed Trost-Alder-ene reaction of the propiolate 1.62 with 
allyl alcohol and a subsequent one-pot acid catalyzed intramolecular transesterification to 
form the butenolide-aldehyde 1.63. The [Ru]-catalyzed Alder-ene transformation not 
only installed the butenolide but also allowed further functionalization. Stille sp2-sp2 
cross coupling, with a furan moiety gathered all carbons of the natural product. Finally, 
diastereoselective CrCl2-NiCl2 mediated NHK reaction delivered bipinnatin J (1.2) in 
good yield. The basis of the diasteroselectivity (dr > 9:1) of anti-alcohol formation 
during the macrocyclization can be rationalized by conformational rigidity of precursor 
1.65, as defined by the remote stereocenter of butenolide driving the metallo-ene reaction 
via an energetically favored 6-membered chair transition state (1.66). 




Scheme 1.10: Trauner Synthesis of Bipinnatin J (1.2) and Conversion to Intricarene 
(1.11) 
 
Shortly after Trauner’s report, Rawal15 and Pattenden13e independently published similar 
strategies in the final stage macrocyclization method to bipinnatin J. 
In further exploratory studies on cembranoid congeners, Trauner modulated the 
appropriate stereocenter of lactone by an oxidation–reduction protocol and synthesized 
pure enantiomer of bipinnatin J (1.2).16 He further converted bipinnatin J (1.2) 
successfully to intricarene (1.11)16 by a biosynthetically proposed transannular [3+2]-
cycloaddition (Scheme 1.10); the same method to intricarene has also been applied 
independently by Pattenden13e. 
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1.6 Progress towards Bielschowskysin: Synthetic Reports 
 
1.6.1 Sulikowski Synthesis of Tetracyclic Core  
The first report documented towards bielschowskysin was the construction of the 
tetracyclic core by the Sulikowski group in 2006 by exploiting an intramolecular [2+2] 






















































Scheme 1.11: Sulikowski Synthesis of Tetracyclic Core of Bielschowskysin 
 
The synthetic sequence consists of converting the (S)-malic acid derived ester 1.68 to 
mesitylene acetal 1.69 with the 1°-alcohol accessible for a subsequent oxidation/Still-
Genneri olefination sequence. Experience guided them to delay butenolide closure to a 
late stage, after making the γ-alkylidene butenolide. Sonogashira cross-coupling followed 
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by oxidization gave the conjugate acid 1.70. Treatment with AgNO3 catalysis under 
Negishi conditions affected cyclization to the alkylidene butenolide 1.71 as a single 
geometric isomer. The precursor 1.72 for photochemical reaction was obtained by an in 
situ acetal opening-lactonization sequence through transesterification. The key 
stereoselective intramolecular [2+2] photocycloaddition of sterically congested 5-
alkylidene-2(5H)-furanone (1.72) under a sun lamp in acetone afforded a 5:1 mixture of 
the tetracyclic core 1.74 of bielschowskysin in 50% yield for the favored isomer, which 
was a crystalline solid upon purification (Scheme 1.11). 
The anticipated stereo-control during [2+2] cyclization could be defined by the geometry 
of the exocyclic C4-C5 internal-double bond. Selective formation of the desired 
diastereomer was hypothesized via intermediacy of a dynamically-favored 1,4-biradical 
species 1.73 in which electrostatic and dipole interactions favor closure to a cyclobutane 
as compared to other ring series. 
1.6.2 Lear Synthesis of Tricyclic Core 
Our research group independently reported synthesis of a tricyclic core of 
bielschowskysin (1.1) relying on the photochemical [2+2] cycloaddition between an 
allene appended on a tertiary carbinol and double bond of γ-butyrolactone (Scheme 
1.12).18 This work demonstrated the selective involvement of the internal π-bond of 1,2-
cumulated double bonds of the allene 1.79 during [2+2] cycloaddition (rule of five19) 
leading to the cyclobutane containing γ-lactone 1.80 (Scheme 1.12). 
 
































Scheme 1.12: Lear Synthesis of Tricyclic Core of Bielschowskysin 
 
Dioxalane-aldehyde 1.75 was derived from (S)-malic acid in 3 steps. From here, the 
benzylidene acetal 1.76 was attained by successive Grignard additions and 
transacetalization. Oxidation and Wittig homologation afforded a conjugate ester 1.77 
which was then transformed to the γ-butyrolactone 1.78 via acetal cleavage. The ethynyl 
carbinol was homologated to the terminal allene 1.79. The allene anchored butenolide 
1.79 upon irradiation with UV light by conventional UV lamps smoothly underwent a 
substrate-controlled, diastereospecific [2+2] cycloaddition to the tricyclic core 1.80 of 
bielschowskysin. 
1.6.3 Nicolaou Synthesis of Tetracyclic Skeleton  
Recently, the Nicolaou group synthesized a tetracyclic core skeleton of bielschowskysin 
by a transannular [2+2] cyclization as the key step (Scheme 1.13).20 This route provided a 
five-step enantioselective synthesis of [9.3.0.0] carbocyclic ring framework of the natural 
product.  




Scheme 1.13: Nicolaou Synthesis of Tetracyclic Skeleton of Bielschowskysin 
 
The synthetic sequence began with asymmetric reduction of acyl furan 1.81 by Noyori 
catalyst to give alcohol 1.82. Subsequent ceric ammonium nitrate (CAN) mediated 
coupling between the furan and the beta keto ester 1.83 provided access to the enol ether 
motifs 1.84a and 1.84b as separable diastereomers. Treatment of enol ether 1.84a with 
Grubbs I catalyst resulted in the RCM keto-product 1.85a with a trans double-bond 
predominantly. Attempts to induce a transannular [2+2] cyclization at this keto stage 
were unsuccessful. However, NaBH4 reduction of ketone 1.85a to alcohol 1.86a and 
subsequent photochemical transannular [2+2] cyclization of macrocycle 1.86a formed 
tetracyclic framework 1.87a of bielschowskysin as a single diastereomer exclusively. The 
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relative stereochemistry of the [9.3.0.0] core 1.87a was assigned by X-ray crystal analysis 
of its corresponding 3,5-dintrobenzoate derivatives. Interestingly, the enantiomeric enol-
ether 1.84b was also converted to the tetracyclic core 1.87a employing the same 
sequence of reactions.  
It is noteworthy that the key transannular [2+2] cyclization in 1.86a/1.86b is also 
presumed to follow the ‘rule of five’ via a diradical species (c.f. 1.73) suggesting 
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1.7 Summary: Chapter 1 (Part B) 
In this chapter, I introduced the diterpene furanocembrane natural products of marine 
origin, discussed the common structural features, and described the proposed biosynthetic 
origin of bielschowskysin (1.1). Also summarized were some established methodologies 
developed towards the synthesis of these diterpene natural products and published 
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2.1 Bielschowskysin: Transannular [2+2] Based Synthetic Plan 
Bielschowskysin (1.1) is a highly oxygenated member of the furanocembranoid family. It 
has an unprecedented tricyclo[9.3.0.02,10]tetradecane ring system. It exhibits a hexacyclic 
structure with a spirocyclic furan ring, a butenolide moiety and a cyclobutane ring. 
Additionally, the γ-lactone moiety is conformationally locked in such a way as to be 








































































Scheme 2.1: Synthetic Overview to Bielschowskysin (1.1) 
 
With these points in consideration, and upon evaluating possible disconnections of 
bielschowskysin, the formation of a macrocycle first and successively annulating via 
transannular bonds was chosen as the central strategy to our synthesis. As illustrated in 
Scheme 2.1, we visualized the ‘cyclobutane’ core to be introduced via a transannular 
[2+2] cycloaddition between an allene and a butenolide in a 14-membered macrocycle 
2.2. [2+2] cycloaddition involving allenes has literature precedence2,3,4 and previously a 
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model tricyclic core has been synthesized from allene appended butenolide (c.f. Scheme 
1.12)2d in our group. Such a transannular strategy is conceptually analogous to the 
biosynthetic pathway of the natural product in which the tetrasubstituted four-membered 
cyclobutane nucleus is implanted by [2+2] cyclization between an enol-ether and 
butenolide5 (c.f. Scheme 1.3). Further, there is a literature precedence to construct the 
tetracyclic core of bielschowskysin as established by the Sulikowski group6 (Scheme 
1.11) and a tetracyclic core skeleton by the Nicolaou group7 (Scheme 1.12). Such a 
transannulation technique is envisaged to quickly construct polycyclic ring systems in a 
desired way. Functionalization of diene 2.1 to the spirocyclic-dihydrofuran would be 
achieved at a later stage (Scheme 2.1). Hence, an allene was chosen as an appropriate 
functional element in a [2+2] cyclization approach. The remaining double bond of the 
allene after transannulation would then enable later transformations to the dihydrofuran 
moiety. 
Mechanistically an intramolecular photochemical [2+2] cyclization could proceed 
through a concerted or stepwise fashion.6,7 This becomes a case of interest, particularly, 
when a stepwise mechanism progresses through a diradical intermediate (c.f. 1.73, 
Scheme 1.11). The stability of this diradical intermediate could be a key factor in 
determining the regioselectivity of allene attack, order of transannular bond formation 
and feasibility of a [2+2] cyclization. In addition, conformational and geometrical 
requirements could drive inversion of the planar sp2-radical intermediate of [2+2] 
addition reaction. 
Accordingly the transannular construction of a [5-4-9] fused-ring motif was targeted as a 
preliminary synthetic study of bielschowskysin, i.e., a ‘model macrocycle’ 2.3 
Chapter 2: Bielschowskysin: Transannular [2+2] Model (Part B) 
87 
  
encompassing a butenolide and an allene moiety to mimic the natural product was 
initially planned in this project. 
Our prime objectives of the transannular study were thus:  
 to install the cyclobutane core in a [2+2] addition between the double bonds of a 
butenolide and an allene. 
 to probe the mechanism of [2+2] cyclization providing insights into 
o the preferable allene stereochemistry for [2+2] reaction. 
o the regioselective involvement of allene double bond2a,2d. 
o the geometrical outcome of double bond in the product. 
To this end, the construction of a model macrocycle 2.3 became essential for the intended 
transannular studies.  
 
2.2 Strategy I: Butenolide Construction Followed by Macrocyclization 
Initially, the ‘butenolide’ part was recognized to be prepared by reductive 
hydroalumination of γ-hydroxypropiolates (e.g., 2.5) and tandem addition onto the 
aldehyde 2.6 (Scheme 2.2). This strategy forms the butenolide 2.4 and enables assembly 
of the remaining carbons in one step. Aldehyde would be obtained from 2.4 after 
deprotection of terminal alcohol and oxidation. The late stage macrocyclization was 
opted by acetylide addition onto aldehyde. Eventually, after macrocyclization, allene 2.3 
evolves from resulting propargylic alcohol in a macrocycle. 
 





Scheme 2.2: Strategy I: Reductive Hydroalumination to γ-Lactone 
 
 
2.2.1 Butenolide Construction Studies 
2.2.1.1 Background: Reductive Hydroalumination-Addition onto Aldehydes 
The idea of reducing propiolates 2.7 by hydroalumination at low temperature and 
subsequent addition of the resulting α-metallated (E)-acrylates 2.8a onto aldehydes at 
room temperature to give allylic alcohols 2.9 has literature precedence by Tsuda and co-
workers8 (Scheme 2.3a). This method is a useful option9 for aliphatic aldehydes when 
Baylis-Hillman conditions failed and has been extended to β-substituted propiolates10. 
Encouraged by this novel methodology, we considered transforming the γ-
hydroxypropiolate 2.5 to the butenolide 2.4 in an expedient fashion (Scheme 2.3b).  





Scheme 2.3: Reductive Hydroalumination 
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2.2.1.2 Synthesis of γ-Hydroxy Propiolate 
Synthesis of the left fragment begun with monoprotection of butane-1,4-diol 2.11 
(Scheme 2.4). It was monoprotected as its TBDPS-ether 2.12 under stoichiometric 
control of reagents followed by PCC oxidation of the terminal alcohol to aldehyde 2.13 in 
good yield. Ethylpropiolate addition to the aldehyde 2.13 produced racemic propargylic 
alcohols 2.14 in 60% yield. 
 
 
Scheme 2.4: Synthesis of γ-Hydroxypropiolate 
 
 
2.2.1.3 Hydroalumination-Addition onto Aldehyde Studies 
Although DIBALH mediated reductive addition via hydralumination is reported to be 
smooth in the presence of HMPA8, NMO11 is an environmentally benign alternative. 
NMO in our preliminary attempts was unproductive, so, we swapped to HMPA (Scheme 
2.5). The results are summarized in Table 2.1. 
 




Scheme 2.5: Hydroalumination-Addition 
 
Table 2.1: Hydroalumination-Addition Study 
R Additive (eq) R′CHO Remarks 
1 H (2.14) NMO11 (2) 2.13 No reaction 
2 H (2.14) HMPA8 (3) PhCHO No reaction 
3 MOM (2.15) NMO (2) PhCHO No reaction 
4 MOM (2.15) NMO (2) PhCHO No reaction 
5 H (2.14) HMPA (3) (Bu)2BOTf (0.2)12 
PhCHO No reaction 
6 MOM (2.15) HMPA (3), (Bu)2BOTf (0.2) 
PhCHO Trace product by crude NMR 
 
 
When γ-hydroxy propiolate 2.14 was treated with DIBALH in the presence of either 
NMO (entry 1) or HMPA (entry 2), no reaction took place possibly due to interference by 
the free alcohol during the initial hydroalumination process. Thus, the propargylic 
alcohol 2.14 was protected as its MOM ether 2.15 before the reduction-addition sequence 
was attempted. Both HMPA (entry 3) and NMO (entry 4) as additives at low 
temperatures on protected 2.15 also failed. 
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Careful survey of the literature revealed reports using electrophilic boranes as additives12 
in combination with HMPA that dramatically enhance the reaction for γ-substituted 
propiolates at -78 °C. Catalytic amounts of (Bu)2BOTf along with excess HMPA as 
additives gave trace amount of allyl alcohol product 2.10b by NMR analysis (entry 6) of 
crude reaction mixtures. Unfortunately, the allylic alcohol 2.10b could not be fully 
characterized and several attempts to improve the yield of the product failed. 
 
2.3 Strategy II: RCM of allylic Acrylates Followed by Macrocyclization 
A RCM approach was planned as a parallel strategy to make the 5-membered lactone ring 
2.4 (Scheme 2.6). 
 
Scheme 2.6: Strategy II: RCM Method for γ-Lactone 
 
This cyclization technique by alkene metathesis has been successfully used in 
construction of lactones of various ring sizes in numerous natural product syntheses.13 
[Ru]-carbene complexes are particularly significant owing to their wide-range of 
functional group tolerance and ready availability. Synthetic application using RCM of 
acrylates was first introduced by Ghosh et al.14 in 1998 to form γ-and δ-lactones 
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conveniently. Recent successful RCM-based reports describing the total synthesis of 
deoxypukalide by Donohoe (Scheme 1.8)9 and Pattenden (Scheme 1.9)15 are noteworthy. 
However, the functional reactivity of the RCM precursor 2.16 was uncertain at this time 
as well as the choice of protecting groups (R, R', and R"). 
 
2.3.1 Synthesis of Allylic Alcohol Building Block 
Protection of 5-hexen-1-ol 2.17 by MOMCl under TBAI catalysis gave the MOM ether 
2.18 in good yield (Scheme 2.7). SeO2 mediated Riley allylic oxidation then gave 
secondary allylic alcohol 2.19 along with corresponding over oxidized product, the 
conjugated ketone 2.20. Initially, the same oxidation conditions were employed for the 
TBS ether of 5-hexen-1-ol (c.f. 2.18), but the TBS group was found to be cleaved during 
oxidation. 
 
Scheme 2.7: Allylic Oxidation 
 
2.3.2. Synthesis of Alkynal Synthons 
Alkyne-aldehyde 2.23 was prepared in two steps from commercially available 3-octyn-1-
ol 2.21 (Scheme 2.8). At first the internal alkyne was isomerized to the terminal position 
2.22 in good yield by amide-mediated alkyne-zipping reaction described by Macaulay.16 
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The resulting primary alcohol 2.22 was oxidized by PCC in appreciable yields to afford 
the alkynal 2.23. A portion of the aldehyde was also masked as its corresponding acetal 




Scheme 2.8: Synthesis of Alkynal Synthons 
 
2.3.3 Synthesis of RCM Precursor 
Allylic alcohol 2.25 derived from the alkynal 2.23 was first accessed via Baylis-Hillman 
reaction17 with excess acrylate and DABCO (Scheme 2.9). Alternatively, addition of the 
vinylalane derived from DIBALH reduction of methyl propiolate8a allowed a quick 
method for preparation of the Baylis-Hillman adduct 2.25 in good yield which was 
subsequently protected (Table 2.2). 




Scheme 2.9: Synthesis of RCM Precursor 
 
Table 2.2: Protection of Allylic Alcohol (2.25) 
R Conditions Remarks 
1 Bn (2.26) NaH/BnBr THF, 0 °C 
complex mixture 
no product 
2 Bn (2.26) BnOTCA, CSA DCM, 0 °C 
complex mixture 
no product 
3 Me (2.27) NaH/MeI THF, 0 °C 
complex mixture 
7% product 
4 Me (2.27) Ag2O/MeI DCM, RT 
complex mixture 
10% product 
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The clean protection of the secondary allylic alcohol 2.25 as its corresponding benzyl 
ether 2.26 was found difficult both under NaH/BnBr (entry 1) and BnOC(=NH)CCl3 
(entry 2) conditions. Making the methyl ether 2.27 was also inefficient under various 
conditions (NaH/MeI, entry 3; Ag2O/MeI, entry 4) and suffered from poor yields with 
unidentified side products. The complex reactions could be reasoned as a possible 
consequence of the strong bases employed. Interesting for future studies, etherification 
with MOMCl/DIPEA (entry 5) was found effective at this location to give the MOM 
ether 2.28 in good yield.  
Subsequent saponification of the methyl ether of the Baylis-Hillman alcohol 2.27 with 
LiOH smoothly gave the acid 2.29 in moderate yield. Esterification of the acid 2.29 and 
alcohol 2.19 by the DCC method led only to decomposition of the reactants. Eventually, 
the allylic acrylate 2.16a was obtained reproducibly under Mitsunobu conditions 
(Scheme 2.9). 
 
2.3.4 RCM Study to Butenolide 
With the dialkene 2.16a in hand, RCM attempts were carried out towards closing to the 
butenolide 2.4b (Scheme 2.10; Table 2.3). Mechanistically, the first metathesis event of 
Ru-carbene formation should take place at the allylic terminal, which is sterically and 
electronically favored. The next metathesis event with the conjugated double bond should 
then enable cyclization to the lactone. 




Scheme 2.10: RCM Attempts to Butenolide 
 
Table 2.3: RCM Conditions 
Catalyst (eq) Solvent Remarks 
1 Grubbs I-polymer bound (0.2) DCM No reaction 
2 Grubbs I (0.2) DCM Decomposed 
3 Grubbs II (0.1) DCM No reaction 
4 Grubbs II (0.1) toluene No reaction 
 
Grubbs I precatalyst 2.30 was first chosen for RCM reaction. There was no reaction with 
polymer bound Grubbs I (20 mol%) in refluxing DCM (entry 1) and 20 mol% of Grubbs 
I, reaction decomposed (entry 2). The more efficient Grubbs II 1.50 (10 mol%, entry 3) 
catalyst in refluxing DCM was found equally ineffective. Grubbs II in refluxing toluene 
also resulted in no reaction (entry 4). 
Although slower than internal alkynes, terminal alkynes were recognized to involve in 
enyne metathesis with internal [Ru] alkylidene. In retrospect, we suspect the possibility 
of alkyne involvement in the catalytic cycle of [Ru] alkylidene, which should be 
protected. 
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2.4 Strategy III: Allene Making Followed by Macrocyclization 
At this juncture, we re-evaluated our synthetic sequence under the concept of RCM for 
the butenolide ring and followed by the macrocyclization (Scheme 2.6) by changing to 
acetylide addition onto an aldehyde first (Scheme 2.11). Intermolecular acetylide addition 
followed by macrocyclization with either RCM or macrolactonization was visualized as a 
better choice (Scheme 2.11). Here, an early stage allene formation and macrocyclization 
either by RCM18 or by macrolactonization would be a versatile choice and further allow 












R = H (2.31)

















Scheme 2.11: Strategy III: Macrocyclization by RCM/Macrolactonization 
Furthermore, the C10 chiral center on the butenolide may help govern a stereoselective 
[2+2] cycloaddition to form tetra-substituted cyclobutanes. Keeping this in mind, we 
intended to define the C-10 pivotal chiral center in the aldehyde 2.35 from (S)-malic acid 
via the triol 2.36 (Scheme 2.12). 




Scheme 2.12: Chiral Aldehyde 2.35 from (S)-Malic acid 
 
2.4.1 Synthesis of Chiral Allylic Alcohol 
 
 
Scheme 2.13: Synthesis of Alkene 2.39 
Fischer esterification19 of (S)-malic acid followed by NaBH4 reduction gave triol 2.36. 
C1-alcohol was left unprotected through 1,3-dioxane ring 2.37 formation using 
benzaldehyde dimethyl acetal.20 The aldehyde 2.38 obtained after Swern oxidation was 
then immediately used for Wittig olefination (Scheme 2.13). In spite of product formation 
(30%) with the preformed Wittig ylide (Ph3P=CH2), isolation of the highly nonpolar 
product 2.39 from the Ph3P=O byproduct hindered large scale handling. To improve 
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practical issues, metallic zinc powder with CH2I2 in the presence of Ti(i-OPr)4 were 






























Scheme 2.14: Nozaki-Takai Olefination 
 
The reproducibility of olefination was eventually improved by addition of lead (II) 
chloride that accelerates formation of the key geminal dizinc species 2.41 (Path B, 
Scheme 2.14) and addition of Ti(OiPr)4.22 In practice, slow addition of diiodomethane to 
a stirring solution of freshly activated zinc-dust/PbCl2 along with CH2I2 in THF initiates 
an exotherm that eventually reaches a reflux. Next, the addition of Ti(Oi-Pr)4 followed by 
aldehyde21-23 exclusively forms the alkene 2.39. By virtue of the high sensitivity of Ti-
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based intermediates (e.g., 2.42), this methylenation proceeded with variable yields. 
Nevertheless this procedure was found optimal for a maximum scale of 3g (15 mmol). 
 
 
Scheme 2.15: Reductive Opening of Benzylidene Acetal 2.39 
 
Reductive opening of benzaldehyde acetal 2.39 was less selective with LiAlH4/AlCl3 in 
diethylether24 and gave the internal allyl benzyl ether 2.45 and terminal benzyl ether 2.46 
in 4:1 respectively (Condition A, Scheme 2.15). Nevertheless, DIBALH of reliable 
quality reduced the acetal 2.39 exclusively to the benzyl allyl ether with free terminal 
alcohol 2.46 in excellent yields (Condition B, Scheme 2.15).25  
Mechanistically, the selectivity originates from differentiation of the acetal-oxygen atoms 
by solvated Lewis acid aggregates, AlCl3·(Et2O)n by means of steric environment 
(Scheme 2.16). Lewis acid coordinates to one of acetal oxygens as shown in 2.47, thereby 
cleaving the acetal to give the zwitter-ionic alumnioxide 2.48. Finally, benzyl ether 2.45 
forms through reduction by hydride transfer from LiAlH4. Poor selectivity is attributed to 
little difference in steric imposition for the approaching AlCl3·(Et2O)n, i.e., between the 
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‘vinyl group’ and ‘hydrogen’ in the system of interest 2.39 (Scheme 2.16). On the other 
hand, the dual property of DIBALH as a Lewis acid, and as a hydride source permits this 
bulky reagent to efficiently differentiate the less hindered ‘acetal oxygen’. 
 
 
Scheme 2.16: Reductive Benzylidene Ring Opening-Mechanism 
 
Next, Dess-Martin oxidation of the terminal alcohol 2.45 gave aldehyde 2.50 which was 
homologated by one carbon by converting to enol-ether with the Wittig ylide 
MeOCH=PPh326 in THF. The homologated aldehyde 2.35 was then obtained by 
hydrolysis of crude mixture of E/Z-enol-ethers using mineral acid (1M HCl) in refluxing 
THF in moderate yield (Scheme 2.17). 
 




Scheme 2.17: Synthesis of Aldehyde Building Block 2.35 
 
2.4.2 Assembly of Fragments, Allene Formation and Baylis Hillman Homologation 
With both building blocks in hand, the alkyne-acetal 2.24 as its lithium acetylide was 
added to the aldehyde 2.35 to give the racemic propargyl alcohol 2.34 (Scheme 2.18) n-
BuLi solution was used for the neat acetylide generation; whereas LHMDS produced 
unidentified side-products. Myers condition of employing o-nitrobenzenesulphonyl 
hydrizide (NBSH) and PPh3 in combination with DEAD effectively converted the 
propargylic alcohol 2.34 in a single step to the internal allene 2.51 in good yield. 
Mechanistically, the propargylic alcohol gets inverted by substitution by NBSH under 
Mitsunobu conditions at low temperature to an alkynyl hydrizide that spontaneously 
undergoes sigmatropic elimination of N2 to form the allene upon warming to ambient 
temperatures.27 It should be noted that both NBSH28 and PPh3 need to be freshly 
recrystallized for reproducible formation of allene.  






























R = H (2.53)
R = MOM (2.54)
NaH, TBAI, THF, RT
or
DIPEA, DCM, 0 °C-RT
n-BuLi, THF
- 78 °C, 2h
quantitative
R,R = OCH2CH2O (2.51)



















Scheme 2.18: Synthesis of Macrocyclization Precursor 2.32 
 
Aldehyde 2.52 was released from its acetal 2.51 by acidic hydrolysis and the crude 
mixture directly subjected to neat Baylis-Hillman conditions employing methyl acrylate 
and DABCO. Excess reagents were used to speed-up the coupling reaction and a single 
drop of methanol was used to make a homogeneous reaction mixture. With protecting 
group experience from previous studies (c.f., Scheme 2.9), the Baylis-Hillman alcohol 
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2.53 was converted to its MOM ether 2.54 using DIPEA or NaH as the base. Both bases 
enabled smooth MOM etherification in good yield (Scheme 2.18). 
Benzyl group removal from the allylic position was studied next. Although the oxidative 
cleavage of benzyl ether with DDQ in DCM/H2O was clean and completed in 2h, larger 
scales suffered from incomplete reactions regardless of excess reagents and longer 
reaction times (6h). Also, allylic oxidation advanced with time to give the vinyl ketone 
2.55 together with the debenzylated allylic alcohol 2.32 (Scheme 2.18). 
 























Scheme 2.19: Tentative RCM Pathway for Macrocyclization-Lactonization 
 
RCM macrocyclization of 2.32 at this point, with an unprotected allylic alcohol and a 
conjugated ester, was speculated to be (Z)-selective (c.f., 2.56), if so, it would facilitate a 
Chapter 2: Bielschowskysin: Transannular [2+2] Model (Part B) 
106 
 
spontaneous transesterification to readily install a γ-lactone (Scheme 2.19). However, if 
the reaction pathway is concerted, transesterification parallels RCM, and thus, γ-lactone 




Scheme 2.20: RCM for Macrocyclization 
 
With implementation of the proposed idea, a terminal, (electron-rich) allylic olefin in the 
presence of an internal allene was attempted with Grubbs I catalyst (Scheme 2.20). This 
turned out to be ineffective with complete decomposition of dialkene 2.32. The flexible 
long alkyl chain with a distant, less reactive, electron poor 1,1-disubstituted alkene 
presumably could not achieve correct C-shape conformation for macrocyclization. 
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2.4.4 Macrolactonization: Synthesis of Macrolactone 
Since a direct RCM macrocyclization was ineffective, we first pursued to make the 
macrolactone 2.33. This would conceivably align olefin partners for subsequent RCM 
more appropriately (Scheme 2.21). 
According to the modified synthetic plan, the seco-acid 2.31 was obtained by LiOH 
mediated saponification of the methyl ester 2.32 (Scheme 2.21). Macrolactonization was 
next accomplished under Yamaguchi conditions by in situ mixed anhydride formation 
with excess 2,4,6-trichlorobenzoyl chloride (TCBC) and triethylamine. Excess DMAP 
(10 eq) finally promoted the macrolactonization event under dilute conditions.29 
Although the macrocyclization suffered from low yields, macrolactone formation to 2.33 
was found to be reproducible. 
 
 
Scheme 2.21: Macrolactonization 
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2.4.5 Butenolide Installation: RCM Study of Macrolactone  
 
The RCM study with Grubbs catalysts are summarized in Table 2.4. Grubbs I (20 mol%), 
in refluxing toluene for 16h gave 3 major spots (entry 1). However, purification and 
characterization of spots was hindered by trace amounts of products being formed. As a 
next choice, Grubbs II (10 mol%) in refluxing DCM for 20h gave no reaction and 
recovered starting material (entry 2). 
 
 
Scheme 2.22: RCM for γ-Lactone Formation 
 
Table 2.4: RCM Conditions in a Macrolactone 
 Catalyst (eq) Additive Solvent/Temp Remarks 
1 Grubbs I (0.2) - toluene, reflux, 16h  
Complex reaction/ 
decomposed 
2 Grubbs II (0.1) - DCM, reflux, 20h  SM recovered 




4 Grubbs II (0.1) Ti(i-PrO)4 (2 eq) DCM, reflux, 16h  
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It is postulated that the ester carbonyl of allylic acrylate (e.g., 2.33) may form a stable 6-
membered chelation ring 2.58 with an internal [Ru] species (Scheme 2.23). This would 
compete with the formation of a metallacyclobutane intermediate 2.57 and thus, the 
desired metathesis event to form γ-lactone, e.g., 2.3. Such interference can be overcome 
by addition of an external Lewis acid, e.g., Ti(i-OPr)4.14 Hence, Ti(i-OPr)4 was added 
along with 20 mol% of Grubbs I in refluxing DCM for 24h (entry 3). Again the reaction 
mixture was complex and formed trace amounts of unidentified products. Even with 10 
mol% of Grubbs II along with Ti(i-OPr)4 in refluxing DCM (entry 4) the ring closing 
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2.5 Summary: Chapter 2 (Part B) 
In this chapter, I explored routes to the alicyclic 14 membered allene macrocyclic model 
2.3 of bielschowskysin for future transannular [2+2] cycloaddition studies. Initially, a 
reductive hydroalumination strategy to a γ-lactone was found unsuccessful. An 
alternative route to the lactone was attempted via RCM of functionalized allylic acrylate 
2.16a. Then, an internal allene 2.51 was synthesized from propargylic alocohol 2.34 
employing Myers conditions.  Baylis Hillman was used for homologation. Eventually, the 
synthetic scheme evolved into implementing the RCM of a macrolactone 2.33. A 15-
membered macrolactone 2.33 was synthesized under Yamaguchi conditions. RCM 
attempts by Grubbs I or Grubbs II catalysts to give 2.3 were unfruitful. Titanium based 
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3.1 Towards Bielschowskysin 
3.1.1 Bielschowskysin: Retrosynthesis I 
As discussed in Chapter 2 (Scheme 2.1), the highly oxygenated, fused hexacyclic 
scaffold of bielschowskysin was envisioned to be constructed via the transannular [2+2] 
cycloaddition between a Δ6,7 double bond of allene and Δ11,12 double bond of butenolide 
as key element.1 Such a transannular strategy is conceptually analogous to a bio-synthesis 
of the natural product, in which the tetrasubstituted cyclobutane nucleus would be 
implanted by [2+2] cyclization between enol-ether and butenolide functionalities (c.f. 
Scheme 1.3).2 Our preliminary synthetic plan towards bielschowskysin is shown in 
Scheme 3.1.  
The key issues to consider from a mechanistic basis are the stereochemistries of the C5-
C7 allene and the geometry of the trisubstituted C3-C4 double bond. These factors 
together can impose ring strain and influence conformational and steric preferences in a 
14-membered macrocycle (e.g., 2.2). Eventually, conformation of macrocycle 2.2 would 
not only dictate the feasibility of the [2+2] cycloaddition reaction, but also the 
configurational orientation of conjugated double bonds in the [2+2] adduct. 
Functionalization of the spirocyclic-dihydrofuran portion of bielschowskysin thereafter 
would be performed after [2+2] cyclization. Conceivably, the [4+2] cycloaddition of 
conjugated diene 2.1 with singlet-oxygen would result in an endo-peroxide 3.1 which 
could be transformed to the dihydrofuran portion using a metal mediated reduction. 





Scheme 3.1: Bielschowskysin: Retrosynthesis I 
 
In light of our primary focus on bio-mimetically inspired transannulation methods, 
construction of an appropriate 14-membered macrocycle was envisioned to be pivotal for 
later stage functionalization. We recognized transition metal catalyzed ring-closing olefin 
metathesis (RCM) as an appropriate choice for macrocyclization at C11-C12 of a γ-
lactone. RCM is a popular technique in modern organic synthesis. [Ru]-carbene 
complexes are particularly significant owing to their wide-range of functional group 
tolerance and ready availability. Enormous synthetic applications of this catalytic process 
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have emerged in crafting a wide variety of small to large rings of diverse natural 
products.3 Recent independent reports describing synthesis of deoxypukalide (1.54b) by 
Donohoe4 (Scheme 1.8) and Pattenden5 (Scheme 1.9) to directly install the butenolide 
moiety evidently provide the potential of RCM routes over other methods2b,6 available to 
prepare furanocembrane congeners. 
Herein, two alternative sequences of RCM-(macro)lactonization were envisioned from a 
linear precursor (3.2). An early stage macrolactonization would facilitate RCM to close 
conformationally near-located olefins into a γ-lactone. On the other hand, an initial 
macrocyclization via RCM by a contemporary transition metal catalyzed reaction enable 
a subsequent γ-lactonization. 
The allene linear precursor for macrocyclization would be formed by converging alkyne 
3.3 with the conjugated aldehyde 3.4. As such, a C-C bond forming acetylide addition of 
an alkyne unit onto the carbonyl of a conjugated aldehyde building block would afford a 
propargylic alcohol that could be transformed subsequently into an allene. Thereafter, a 
Baylis-Hillman reaction would furnish the diene precursor 3.2 for a macrocyclization 
step. This diene-conjugated ester 3.2 serves as a common intermediate for RCM, as well 
as a seco-acid for macrolactonization studies (Scheme 3.1).  
3.1.2 Alkyne Synthon: 1st Generation Synthesis 
 
The fully functionalized allyl ether building block 3.3 was visualized to be made from a 
chiral malic acid (Scheme 3.2).7 (S)-malic acid is appropriately predisposed with the 
correct chiral secondary alcohol and a terminal carboxyl groups that allows 
functionalization via its corresponding triol (2.36). 




Scheme 3.2: Alkyne Building Block: Retrosynthesis I 
In earlier considerations, it was intended to develop the 3°-alcohol by consecutive 
Grignard C-C bond formation (Scheme 3.2). A potential advantage of using Grignard 
reactions is the control of diasteroselectivity through chelation control via the existing 
chiral center in a locked acetonide 3.6.1d 
 
 
Scheme 3.3: Alkyne-Benzylidene 3.9 Synthesis 
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Scheme 3.3 illustrates the synthesis of alkyne-benzylidene 3.9. 1,3-Dioxolane of 
acetonide 3.5 was formed from triol 2.36 by protection in acetone with CuSO4 and p-TSA 
catalyst. PCC oxidation of the distant C4-primary alcohol, followed by nucleophilic 
addition using MeMgBr and subsequent PCC oxidation gave the methyl ketone 3.6. 
Addition of ethynylmagnesium bromide gave a separable mixture of diastereomeric 3°-
propargylic alcohols in a 4:1 preference to the desired diasteromer 3.7. 
Diasteroselectivity can be rationalized via chelation control of an acetal ring as illustrated 
earlier. The 1,3-dioxolane ring of acetonide was transformed to the more stable 1,3-
dioxane 3.8 using benzaldehyde dimethyl acetal under the influence of an organic acid, 
CSA. Lastly, methylenation was achieved through a Swern oxidation-Nozaki-Takai 
reaction sequence to furnish the benzylidene alkyne 3.9. 
 
Scheme 3.4: Reductive Opening Study of Benzylidene Acetal Ring 3.9 
 
As proposed, the sequence of early Grignard additions followed by methylenation 
worked well, however, the selective reductive opening of benzylidene 1,3-dioxane 3.9 
was problematic. Benzyl ethers 3.10/3.11 failed to form with both DIBALH8 and 
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NaCNBH3/dry-HCl9 conditions (Scheme 3.4). An alternative plan to maintain orthogonal 
protections was to form the diol 3.12 and then protect differentially. 
 
Scheme 3.5: Synthesis of Alkyne Building Block 
 




DCM/MeOH (1:1), RT, 4 days 
<30% 
2 
Conc. HCl (pH=1)  
THF/H2O (1:1), 2 days, 50 °C 
<30% 
3 
Conc. H2SO4, (pH=1)  
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Hydrolytic cleavage of dioxane 3.9 was incomplete despite long reaction times with p-
TSA in methanol (Table 3.1; entry 1) and even with conc. HCl at pH=1 (entry 2). Harsh 
conditions using dibasic mineral acid conc. H2SO4 (pH=1) in refluxing THF-H2O 
mixture10 (entry 3) more efficiently hydrolyzed the strong acetal ring to its corresponding 
1,3-diol 3.12 (Scheme 3.5). 
However, benzylation of 1,3-diol 3.12 was not selective as it gave all possible mono and 
dibenzylated products. The bulky pivaloyl ester group was therefore selected to protect 
the secondary alcohol selectively as a temporary protecting group, which would be 
changed to a more robust group at advanced stages. 
Diol 3.12 upon treating with pivaloyl chloride with excess pyridine in DCM suffered 
from sluggish reaction times (10% conversion overnight). However, the use of 
triethylamine as a base pushed the reaction to completion overnight with exclusive 
formation of the monoprotected alcohol 3.13, even when excess pivaloyl chloride was 
used. The differential efficiency of bases can be rationalized from their basic strengths: 
triethylamine (pKa=10.78) and pyridine (pKa=5.25). 
Protection of 3°-alcohol as its corresponding TMS ether 3.14 was not effective with 2,6-
lutidine (pKa=6.99) and again, triethylamine (pKa=10.78) was found favorable to 
complete the reaction.  
Due to the poor overall protecting group economy, inability of bringing tolerant 
protecting groups and trace amounts of available material, an alternate scheme was 
pursued to the alkyne building block. 
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3.1.3 Alkyne Synthon: 2nd Generation Synthesis 
Under an alternative scheme, the aldehyde 2.50 previously synthesized (Scheme 2.17) 
from (S)-malic acid during [2+2] model study was used to form protected alkyne building 
block. From this aldehyde 2.50, the modified scheme began with addition of MeMgBr to 
give an inseparable mixture (1:1) of diastereomeric alcohols 3.15. Methyl ketone 3.16 
was obtained by PCC oxidation and HC≡CMgBr addition gave the ethynyl carbinols 3.17 























































MnO2, 2days, RT: 10% conv.  
Scheme 3.6: Synthesis of Alkyne Building Block 3.3 
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To investigate the selectivity from chelation control1d the Grignard addition sequence was 
reversed. Thus, HC≡CMgBr was added first onto the aldehyde 2.50 to give 
diastereomeric propargylic alcohols 3.20. Mild oxidation to alkynone 3.21 with MnO2 
failed. So, we reserved to conventional Dess-Martin oxidation to obtain alkynone 3.21. 
Interestingly, the selectivity of MeMgBr addition onto the alkynone 3.21 was equally 
reversed (10:35) to that of Path A (Path B; Scheme 3.6). This evidence supports a 
chelation mode of nucleophilic addition from the sterically more favored conformer. 
Conviniently, the diastereomeric 3°-alcohols separated well by TLC, and could be 
purified by flash column chromatography without difficulty. However, the selectivity 
could be further improved using additional metal-salts.11 
To confirm the stereochemistry at the propagylic alcohol positions, the benzyl ethers 3.17 
and 3.18 were separately transformed to the benzylidene acetals 3.9 and 3.22 by treating 
with DDQ in dry DCM (Scheme 3.7). The resulting benzylidene acetals were compared 
to authentic sample prepared previously (c.f. Scheme 3.3) This confirmed the 1H-NMR of 
only one acetal 3.9 to exactly match the authentic material. 
 
Scheme 3.7: Confirmation of Stereochemistry  




Subsequently, each tertiary alcohol 3.17 and 3.18 was protected as its corresponding 
TMS ether 3.3 and 3.19 in good yield to afford the desired alkyne synthons. 
 
3.1.4 Conjugated Aldehyde Synthon: 1st Generation Synthesis 
 
 
Scheme 3.8: Aldehyde building block 3.4: Retrosynthesis I 
 
The trans-fused cyclic lactol portion of the natural product 2.1 was visualized to be 
developed from a conjugated aldehyde e.g., 3.4 as depicted in Scheme 3.1. Conjugated 
aldehyde in turn would be synthesized from D-glucose by a reported procedure via the 
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diacetal 3.24 and PMB ether 3.23.12 Final selective removal of the exocyclic acetal would 
then facilitate elaboration towards the conjugated aldehyde13 3.4 (Scheme 3.8). 
 
Scheme 3.9: Synthesis of PMB Ether 3.23 
 
To this end, ketone 3.25 was synthesized as shown in Scheme 3.9 using modified 
procedures. The diacetal glucose 3.24 was formed by treating D-(+)-glucose with acetone 
in the presence of conc.H2SO4 as the catalyst. Recrystallization of crude product from 
chloroform afforded bright, white, needle-like crystals. Collins oxidation by 
CrO3/pyridine in combination with acetic anhydride gave the crude ketone 3.25. Wittig 
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homologation with the in situ generated stabilized ylide 3.26 yielded the conjugated ester 
3.27. Pd-catalysed hydrogenation proceeded in quantitative yield under high pressure of 
H2 gas to give 3.28 stereoselectively with (R)-configuration at the C3 position. In 
addition to X-ray crystallography analysis, the relative stereochemistry was established 
by NOE correlation between HC3-HC2 & HC2-HC1. We note here that C3-relative 
stereochemistry is regenerated efficiently under this oxidation-Wittig-hydrogenation 
sequence (Scheme 3.9). Thereafter, the methyl ester 3.28 was reduced quantitatively by 
LiAlH4 to terminal alcohol 3.29 which was subsequently protected as its PMB ether 3.23 
for a later stage Baylis-Hillaman coupling. 
To elaborate to the conjugated aldehyde 3.4, the exocyclic acetal in 3.23 was selectively 
cleaved in 75% yield to a diol 3.30 employing 60% aqueous acetic acid keeping the 
internal acetal intact. Oxidative cleavage of the vicinal diol afforded a sensitive aldehyde 
3.31. Attempts to purify by column chromatography failed due to decomposition. Thus 
the aldehyde was quickly used for Wittig homologation with the preformed ylide 3.32 in 
DCM to afford the (E)-trisubstituted alkene 3.33 in 72% yield over 2 steps. The 
conjugated ester 3.33 was next reduced to the allylic alcohol 3.34 by DIBALH in 
excellent yield with little over reduction of the double bond. Both the products were 
luckily separable by flash column chromatography. Subsequent allylic oxidation by DMP 
furnished the desired conjugated aldehyde synthon 3.4 in excellent yield. 





Scheme 3.10: Synthesis of Conjugated Aldehyde 3.4 
 
3.2 Assembly of Building Blocks: Alkyne Addition onto Aldehyde 
3.2.1 Carreira Asymmetric Addition Study  
The stereochemistry at the resulting C5-propargylic alcohol (c.f. Scheme 3.11) would 
determine the chirality of allene. Based on our understanding from minimized energy 
conformations of appropriate macrocycles by DFT calculations, together with 3-D 
models, the geometry of allene was conceived to be a crucial aspect for forthcoming 
events. The specific geometry of the allene would not only conceivably control 
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macrocyclization, but also direct [2+2] cycloaddition to follow either a concerted or 
stepwise pathway. The pathway of [2+2] cyclization would eventually guide the 
geometry of the remaining unreacted double bond of the allene after cycloaddition (c.f. 
Scheme 3.1). In addition, the geometry of the allene would also be a determining factor in 
a macrocycle with a specific ground state conformation. 
Under this reasoning, the stereochemical course of C-C bond formation during alkyne 




Scheme 3.11: Proposed Carreira Alkyne Addition 
 
Although challenging in multifunctional substrates, several auxiliary controlled methods 
have emerged for stereoselective additions forming propargylic alcohol. Amongst these 
Carreira’s Zn-acetylide method using N-methylephedrine (3.38) auxiliary14 is attractive 
(Scheme 3.12). 
 




Scheme 3.12: Carreira Asymmetric Alkynylation 
 
 
Scheme 3.13: Carreira Alkynylation Study on Model System (I) 
 
To test this method, commercially available hex-5-yn-1-ol (3.40) and cinnamaldehyde 
(3.41a) were adopted as coupling partners. With little excess of alkyne the reaction was 
performed in toluene without a chiral auxiliary. Zn(OTf)2 in combination with Et3N gave 
no observable reaction after 14h at room temperature and even after an additional 8h at 
65 °C. After careful analysis of initial reports, toluene was substituted with acetonitrile14a, 
but, this gave similarly no reaction (Scheme 3.13). 
 




Scheme 3.14: Carreira Alkynylation Study on Model Systems (II) 
 
Suspecting the free unprotected alcohol hindered the reaction, the coupling was tested 
with the alkyne 2.2 and cinnamaldehyde (3.41a) in the presence of N-methylephedrine 
(3.38). Even after 30h, only trace amounts of propargylic alcohol 3.42b was observed 
(Scheme 3.14). Alkyne 3.38 and an aliphatic conjugated aldehyde 3.41b were also tested 
under reported coupling conditions without success. 
3.2.2 Base Mediated Methods 
Next, base mediated methods of acetylide addition onto aldehyde were studied. As a first 
choice, LHMDS was chosen for acetylide generation from alkyne 3.3 and the base was 
added at -78 °C, followed by addition of the conjugated aldehyde 3.4 after 1h. Despite 
the raising to room temperature (-78 °C-RT), both reactants were recovered. As a next 
choice, the base was replaced with n-BuLi and the reaction executed at -78 °C (Scheme 
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3.15). Unfortunately, [2,3]-Wittig rearrangement paralleled acetylide formation. 
Ultimately, this competing process hampered formation of the secondary propargylic 
alcohol 3.35, which was isolated in 21% yield. The diasteromeric propargylic alcohols 
(10:7) were inseparable by silica gel column chromatography techniques.  
 
 
Scheme 3.15: Alkyne Addition by n-BuLi 
 
Eventually, EtMgBr was found effective as the base to generate alkynyl magnesium 
bromide in situ without [2,3]-Wittig rearrangement. This will be described later in 
Scheme 5.13, chapter 5. 
Chapter 3: Synthesis of Building Blocks (Part B) 
131 
 
3.3 Summary: Chapter 3 (Part B) 
In this chapter, I explored synthetic studies aiming at transannular [2+2] cycloaddition 
towards a macrocycle core of bielschowskysin (1.1). A Convergent synthesis of the 
macrocycle was designed by disconnecting the C5-C6 and C11-C12 bonds. Routes to the 
alkyne synthon 3.3 were further developed from (S)-malic acid via Nozaki-Takai 
methylenation and a consecutive Grignard addition reactions. The requisite conjugated 
aldehyde synthon 3.4 was synthesized from D-Glucose in 11 steps. Eventually, alkyne 
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4.1 Allene Formation Studies 








































































Scheme 4.1: Bielschowskysin: Synthetic Plan 
 
As previously discussed, our central synthetic strategy towards the synthesis of 
bielschowskysin was based on a transannular [2+2] cycloaddition reaction between an 
allene and the olefin of a butenolide. As illustrated in Scheme 4.1, we visualized the 
‘cyclobutane’ core to be introduced via a transannular [2+2] cycloaddition in a 14-
membered macrocycle 2.2. A model tricyclic core 1.80 has been synthesized from allene-
butenolide (c.f. Scheme 1.12)1. Stereochemistry of allene would be one of the 
determining factors for the conformational orientation of the macrocycle. A concerted or 
stepwise mechanism would be speculated for intramolecular photochemical [2+2] 
cyclization.2,3 This becomes a case of interest, particularly, when a stepwise mechanism 
occurs; which could be a key factor in determining the regioselective involvement of the 
allene double bond1,4, the order of transannular bond formation and the eventual 
feasibility of the [2+2] cyclization. With these points in consideration, we were interested 
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in the synthesis of chiral defined α–hydroxy allene with quaternary carbon centers at both 
sides. 
4.1.2 Allenes: Introduction 
Allenes were first synthesized in 1887 and are found in as many as 150 natural products 
of biological origin5 (Fig 4.1). Owing to their unique properties, they have become 
attractive synthons and extensive chemistry of allenes in several synthetic methods has 
been developed.4b,4e,6 
 
Fig 4.1: Allenes Containing Natural Products 
Allenes can be synthesized in various ways.6f These methods would be broadly 
categorized as: 
1. Transition Metal-Catalyzed Reactions. 
2. Metal-Mediated Syntheses.  
3. Isomerization Reactions. 
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Based on the proposed synthetic route to bielschowsksysin, a propargylic synthon 4.1 
would be advantageous to convert to allene moiety 4.2. In general, allenes could be 
derived conveniently employing a variety of methods from propargylic systems (Scheme 
4.2). Previously, in a model study project, the allene 2.51 was synthesized reproducibly in 
good yields employing Myers condition7 using NBSH, PPh3 along with DEAD (c.f. 
Scheme 2.18). 
OH PPh3, DEAD, NBSH
propargylic alcohol
OR
R = Ac, Phosphate
SmI2, Pd(PPh3)4
OR



















Scheme 4.2: Allene from Propargylic Alcohol: Synthetic Methods 
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R = H (3.8)
















4.6 4.7  
Scheme 4.3: Allene Synthesis Study from Alkynol 
 
 
On the basis of the proposed route, propargylic alcohol 4.6 was obtained by addition of 
alkyne 4.5 onto the conjugated aldehyde 3.6 in good yield (Scheme 4.3). The resulting 
propagylic alcohol was treated with different allene-forming conditions as summarized in 
Table 4.1. The recently developed protocol by Ready et al. with the Schwartz reagent 
Cp2Zr(H)Cl without a base (entry 1) or in the presence of a Grignard reagent as a base 
(entry 2, 3) gave no observable reaction. An alternate choice of using Myers method with 
NBSH, PPh3 and DEAD was also found ineffective (entry 4). 
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Table 4.1: Allene from Alkynol 
Conditions Yield 
18 Cp2Zr(H)Cl, toluene, 24h - 
28 







47 NBSH, PPh3, DEAD, THF - 
 
At this stage, a model reaction was attempted on a propargylic alcohol 4.10 (Scheme 4.4) 
to validate the allene formation via the hydrozirconation of alkynes with the Schwartz 
reagent Cp2Zr(H)Cl in combination with a Grignard reagent as a base. Here, despite the 
slow reaction, the expected allene 4.11 was observed while recovering unreacted 
propargylic alcohol 4.10. From these comparisons, we anticipated, the sterically highly 
hindered alkyne flanked with quaternary carbon center (c.f. 4.6) would become difficult 
for approaching reagents. Such a quaternary system would be too bulky and thus it would 
be difficult to obtain the α-hydroxy allene-ene. 
 
Scheme 4.4: Allene Synthesis by Schwartz Reagent 
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4.1.4 Allene Formation by Keck Conditions 
Seeking alternative routes to vinyl-allenes6f, we found an efficient preparation of 
sensitive vinyl-allenes by LiAlH4 as developed by Keck et al.9 from ethynyl carbinol 4.12 
(Scheme 4.5). The free hydroxyl group in alkynol 4.12 facilitates LiAlH4 to come closer 
to the sterically hindered alkyne and forms an alanate intermediate 4.13 by reductive 
hydroalumination. Simultaneous antiperiplanar elimination of the alkoxy group together 
with the aluminum species results in the stereoselective10 formation of a chiral 
hydroxymethylvinyl allene 4.14. 
  
 
Scheme 4.5: Allene Formation by LiAlH410 
Anticipating allene formation from γ-hydroxy propargylic ether (c.f. 4.17), the 
diastereomeric propargylic alcohol mixture 4.16 was converted to its corresponding 
methyl ether (Scheme 4.6). Subsequently, the crude product was desilylated to obtain an 
inseparable mixture of diastereomeric methyl ethers 4.17. At this stage, allene formation 
from the unprotected γ-hydroxy propargylic ether under Keck conditions was studied 
(table 4.2). 




Scheme 4.6: Allene from Methyl Ether of γ-Hydroxy Alkynol 
Table 4.2: Allene Formation Conditions from Methyl Ether 
Conditions Remarks 
1 
a) LiAlH4 (3 eq), Et2O or THF, rt 
b) Solid I2, -78 °C 
Allene 4.18 (30%); 
Incomplete conversion 
2 
a) LiAlH4 (5 eq), Et2O, rt 
b) Solid I2, -78 °C 
Allene 4.18 (30%); 
Complete conversion. 
3 
LiAlH4 (10 eq) 
Et2O, rt 
Clean allene 4.18 (34%) 
Incomplete conversion 
4 Red-Al No reaction 
5 NBSH, PPh3, DEAD, THF No reaction 
 
As described earlier, Keck conditions were tested on the γ-hydroxy propargylic ether 
4.17. Either Et2O or THF as solvent did not affect the reaction course and α-hydroxy 
allene formation (entry 1), also reaction remained incomplete. When amount of LiAlH4 
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was increased (entry 2), the starting material was completely consumed with no 
improvement in the yield. When, I2 was not used, clean formation of the allene 4.18 was 
observed, although in an incomplete fashion. The unreacted methyl ether 4.17 was 
isolated and treated to same conditions, however, to result no observable reaction. Based 
on the mechanism of allene formation required an anitperiplanar elimination of methoxy 
group, we anticipated that due to high steric crowd around alkyne, only one diastereomer 
could interact favorably with Keck conditions to form allene. 
 
4.1.5 Keck Conditions with Stereodefined Propargylic Alcohols 
In order to investigate the assumed reactivity of one single diastereomeric propargylic 
alcohol, the catalytic chiral reduction of ynones was planned to form propargylic alcohols 
diastereoselectively. With a view to adopt CBS promoted chiral reductions, ynone 4.19 
was obtained quantitatively as a single diastereomer by treating propargylic alcohol 4.16 
with MnO2 at room temperature (Scheme 4.7). Reduction of ynone 4.19 with the (S)-CBS 
catalyst in combination with BH3 gave (S)-diastereomer 4.16a and (R)-CBS catalyst 
afforded (R)-diastereomer 4.16b (c.f. 4.20 and 4.21).11 
 

















































































Scheme 4.7: Stereodefined Alkynols by CBS Reduction 
 
The stereodefined propargylic systems 4.17a/4.17b under modified Keck conditions were 
next examined. It was found only the (S)-diasteremer 4.17a reacted to produce the α–
hydroxy allene 4.18a in moderate yield with complete conversion of starting material; 
whereas, the remaining (R)-diastereomer 4.17b was inert to Keck conditions. Based on 
the mechanism of allene formation with LiAlH4, the resulting allene from (S)-propargylic 
ether 4.17a would be postulated to be an (R)-allene (Scheme 4.8).9 
 





















R1 = H, R2 = TES (4.16a)
R1 = Me, R2 = H (4.17a)
a. NaH/MeI
b. TBAF
R1 = H, R2 = TES (4.16b)
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4.2 Allene Formation and Photochemical [2+2] Cycloaddition Studies 
4.2.1 Allene Formation Studies on Allyl Terminated Propargylic Alcohol 
Here again, with the encouraging results obtained previously to obtain allene with 
quaternary carbon centers on both sides, the catalytic chiral reduction of ‘ynones’ was 
planned to produce propargylic alcohols diastereoselectively. In order to adopt CBS 
promoted chiral reductions, the propargylic alcohol 3.37 was oxidized with MnO2 at 
room temperature to obtain ynone 4.23 quantitatively as a single diastereomer (Scheme 
4.9). Here, reduction with the CBS catalyst in combination with BH3 however, gave no 
better selectivity (10:7) than the C-C bond forming assembly (10:7) of synthons. The 
poor selectivity could be due to the high flexibility of the system around the alkynone. 
 
 
Scheme 4.9: Chiral Reduction of Ynone  
 
To move forward, the diasteromeric mixture was, used for subsequent allene formation. 
As described earlier, the alkynol 3.35 was protected as its methyl ether 4.24 and the silyl 
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group was removed by TBAF to obtain the tertiary alcohol 4.25 (Scheme 4.10). Using 
modified Keck conditions the addition of LiAlH4 alone produced the allene 4.26 
relatively pure in a low yield (18%) from the γ–hydroxy propargylic ether 4.26, whereas 
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Scheme 4.11: [2+2] Cycloaddition: Tricyclic Core of Bielschowskysin1 
 
Previously, a tricyclic core of bielschowskysin (1.80) was reported by our group 
photochemical [2+2] cycloaddition between an allene appended on a tertiary carbinol and 
double bond of γ-butyrolactone as a key step (Scheme 4.11).1 The allene anchored 
butenolide 1.79 upon irradiation with UV light by conventional UV lamps smoothly 
underwent a substrate-controlled, diastereospecific [2+2] cycloaddition to the tricyclic 
core 1.80 of bielschowskysin. The selective formation of five membered ring during 
[2+2] cycloaddition (rule of five13) leading to the cyclobutane containing γ-lactone 1.80 
was demonstrated (Scheme 1.12). 
 
 
Scheme 4.12: Photochemical [2+2] Cyclization Attempt 




At this juncture, photochemical [2+2] cyclization was attempted on the allyl appended 
internal allene 4.26 to form the cyclobutane system 4.27. Thus the allene-olefin 4.26 in 
degassed DCM/hexane (1:1 v/v) mixture was irradiated with two conventional UV lamps 
(2x6W, λ = 254 nm) over 7h (Scheme 4.12). Unfortunately, this photochemical reaction 
led to decomposition of the substrate. In retrospect, protection of the free carbinol 4.26, 
may have given less problems during this photochemical reaction.1 
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4.3 Summary: Chapter 4 (Part B) 
In this chapter, I explored synthetic studies to syntheses of a α-(tert)-hydroxy 1,3-
disubstituted allene with quaternary carbon centers flanking both sides of the allene. 
Conjugated aldehyde unit 3.6 from D-(+)-glucose and an alkyne building block 4.15 from 
(S)-(-)-malic acid were independently prepared and C-C bond forming alkyne addition 
onto aldehyde resulted required propargylic alcohol 4.16. Allene forming reduction 
protocol was studied on diastereomeric as well as chiral defined propargylic ethers 
(4.16a/4.16b). A highly functionalized α-(tert)-hydroxy 1,3-disubstituted allene 4.18a 
was synthesized by reduction of monoprotected propargylic diol employing LiAlH4. The 
free hydroxyl group found to be necessary for reducing agent such as LiAlH4 to chelate 
sterically hindered alkyne. In addition, only (S)-diasteromer of propargylic ether formed 
(R)-allene, while the other diasteromer was inert to allene forming reduction conditions.  
Propargylic alcohol 3.37 was converted to an allene 4.26 under LiAlH4 conditions. 
Eventual photochemical [2+2] cyclization of the allene, however, failed to yield the 
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5.1 Convergent Synthetic Plan to Macrocyclic Framework of 
Bielschowskysin 
5.1.1 Bielschowskysin: Retrosynthesis II 
 
Scheme 5.1: Bielschowskysin: Retrosynthesis II 
 
During our previous RCM study, Baylis-Hillman homologation gave a diene 2.53 (c.f. 
Scheme 2.18), which was found unsuitable for macrocyclic ring closure during RCM (c.f. 
Scheme 2.20 and Scheme 2.22). As a consequence, the synthetic scheme was revised, so 
that the adjacent oxidation sites at the olefin were modified (Scheme 5.1). This 
modification at alkyl chain terminus was envisioned to be a better choice to drive RCM, 
after which manipulation of the oxidation states would be implemented at a later stage. 
Thus the olefins were simplified to be un-branched as an allylic alkene in the western 
alkyne synthon 3.3 and a 1-alkene in the eastern aldehyde synthon 5.4. 
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5.2 ‘Modified Conjugated Aldehyde’ Synthon 
5.2.2 ‘Modified Conjugated Aldehyde’ Synthon: 1st Generation Synthesis 
In our new scheme, a direct sp2-sp3 cross-coupling vinylation method was sought to 
obtain substrate 5.4 (Scheme 5.2). There are several methods available for C-C bond 
formation among which, Kumada-type cross-coupling between sp2-sp3 carbons by 
transition metal catalysis is a prime example.1 Recently, environmentally benign, 
inexpensive, Fe-catalyzed direct cross-coupling method has attracted much attention2, 
particularly by the Kochi group.3 Notably, the Cahiez group has developed convenient 
systems using Fe(acac)3 and FeCl3 in the presence of hexamethylenetetramine (HMTA) 
and TMEDA as ligands.4 While using readily accessible alkenyl-magnesium reagents, 
unactivated n or s-alkyl halide coupling partners can be used in reactions tolerating a 
variety of functional groups. We thus studied the vinylation to form the modified 
conjugated aldehyde synthon 5.4 (Scheme 5.2). 
 
 
Scheme 5.2: Aldehyde-Alkene Unit 5.4 from PMB Ether 3.34 
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To this end, the allylic alcohol 3.34 was protected as its corresponding TBS ether and 
subsequent PMB cleavage by DDQ in DCM-H2O (9:1 v/v) occurred in 30 min at room 
temperature to afford the primary alcohol 5.5 in good yield (Scheme 5.3). Further 
functional group interconversion methods with either Appel halogenation5 by CBr4/PPh3 
(entry 1, Table 5.1) or NBS/PPh3 (entry 2) to convert the alcohol 5.5 to the alkyl bromide 
5.6 resulted in simultaneous cleavage of the delicate TBS group. Re-protection of 5.7 
with a TBDPS group to 5.8 also suffered from purification issues. In retrospect, a TBDPS 
version of 5.5 should be used for this halogenation reaction. 
 
 
Scheme 5.3: Synthesis of Alkyl Bromide 
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Table 5.1: Bromination of Alcohol 5.5 















Thus the TBDPS appended alcohol 5.9 was prepared from the allylic alcohol 3.34 by 
silylation and PMB cleavage (Scheme 5.4). 
 
 
Scheme 5.4: Synthesis of Alkyl Halide 
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With the TBDPS ether 5.9 in hand, halogenation of alcohol was eventually achieved in an 
efficient manner with molecular iodine in combination with imidazole and PPh3 to form 
alkyl iodide 5.10.6 It is noteworthy that the iodination process was not practical on small 
batches (10 mg) perceivably due to moisture sensitivity of the active reagent/reaction; 
however, the iodination was smooth and exclusive at a relatively large scale. 
Now the stage was set to study the cross-coupling reaction of the alkyl iodide 5.10 with 
vinylmagnesium reagent (Scheme 5.5).4 The reported catalytic system 
Fe(acac)3(5mol%)/HMTA/TMEDA in a 1:1:1 composition at 0 °C in 30-45min was first 
tried with a reasonable excess (1.5-2 eq) of Grignard reagent. Modification of this 
procedure by adding vinyl magnesium bromide in THF solution slowly via syringe pump 
over 10min at 0 °C to stirring solution of the iodide containing HMTA and TMEDA was 
also tried. Both attempts of vinylation were unsuccessful and starting material was only 
recovered. Nevertheless, pre-drying of HMTA and the alkyl iodide 5.10 with TMEDA 
and 10 mol% of catalyst gave consistent results to furnish the terminal alkene 5.11 in 
good yield.  
After vinylation, the silyl ether 5.11 was deprotected by TBAF to obtain the allylic 
alcohol 5.12 (Scheme 5.5). During silyl group cleavage, some decomposition could not 
be avoided even when buffered by AcOH. Finally, DMP oxidation of the allylic alcohol 
5.12 gave the conjugated aldehyde 5.4 in good yield. 
 




Scheme 5.5: Synthesis of Conjugated Aldehyde 5.4 
 
Also during the course of our studies, the α,β-unsaturated ester 5.13 was prepared (from 
3.33 by deprotection of PMB group followed by iodination), but was found inappropriate 
under the [Fe]-cross coupling conditions. Although tolerating ester functionality in 
general, this cross coupling technique is perhaps unsurprisingly not applicable to a 
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5.2.4 ‘Modified Conjugated Aldehyde’ Synthon: 2nd Generation Synthesis 
 
Scheme 5.6: Conjugated Aldehyde-Alkene 5.4: Retrosynthesis I 
To expedite the formation of aldehyde 5.4, a more convergent synthesis was briefly 
attempted (Scheme 5.6). To this end, a soft Cu-nucleophile would need to be generated in 
situ. The Mamdapur group, for example, has converted the secondary alicyclic bromide 









X = OTs, Br R = alkyl
5.14 5.15
5.16 5.17
A. Mamdapur Report for sp3-sp3 Coupling
B. Proposed sp3-sp3 Coupling with RMgX  
Scheme 5.7: Csp3 - Csp3 Coupling 
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Accordingly, the tosylate 5.18 and iodide8 5.19 were (Scheme 5.8) prepared and 
alkylation studies performed (Table 5.2) 
 
 
Scheme 5.8: Attempted Csp3 - Csp3 Coupling Study on the Ring 
 
Table 5.2: Csp3 - Csp3 Coupling Study 
 X 
Catalyst 
system RMgX Remarks 






I (5.19) Li2CuCl4 EtMgBr 
3 OTs (5.18) CuI 









In all cases, either under Cu (I) or Fe (III)-mediation, no reaction or a complex mixture 
was obtained.  
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Scheme 5.9: Conjugated Aldehyde-Alkene 5.4: Retrosynthesis II 
 
As elongation by nucleophilic substitution directly by sp3-sp3 coupling failed, a new 
convergent strategy was formulated to first combine a Wittig homologation then a [Fe]-
catalyzed sp2-sp3 vinylation step (Scheme 5.9). Such a plan would eliminate use of 
PMB/TBDPS protection steps (c.f. Scheme 3.9 and Scheme 3.23). 
 
 
Scheme 5.10: Csp2-Csp3 Cross-coupling 




To this end the previously synthesized alcohol 3.29 was converted to the n-alkyl iodide 
5.21 in excellent yield (Scheme 5.10). Under optimized conditions, however, the 
Fe(acac)3 catalyzed vinyl addition reaction on a 7.7 g (19 mmol) scale of iodide 5.21 
became complex. Here, β-hydride elimination and hydride substitution reactions 
competed with the intended Csp2-Csp3 cross-coupling reaction. As a result, 
disproportionation products, i.e., the alkane 5.22 and alkene 5.23 accompanied the 
desired cross-coupling product 5.20 (Scheme 5.11).9 
 
 
Scheme 5.11: Mechanistic Basis for Cross-coupling Verses Disproportionation Reactions 




Unfortunately, separation of products 5.20 and 5.22 in pure form was impractical at this 
stage. The mixture was therefore treated with 60% aqueous acetone (Scheme 5.12), the 
resulting diols (5.26/5.27) were oxidatively cleaved, and the crude aldehydes (5.28/5.29) 
directly homologated to give (E)-trisubstituted alkenes (5.30/5.31). These conjugated 
esters were then reduced by DIBALH, and the allylic alcohol 5.12 was separated from the 




Scheme 5.12: Synthesis of Allylic Alcohol 5.12 
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5.3 Synthesis of Macrocyclic Framework of Bielschowskysin 
5.3.1 Assembly of Building Blocks: RMgX Mediated Addition of Alkyne  
 
Having practical quantities of alkyne and aldehyde building blocks in hand, new 
anionic/basic methods were explored for acetylide addition that circumvented the [2,3]-
Wittig rearrangement of 3.3 (Scheme 5.13). To this end, Grignard reagents RMgX 































Scheme 5.13: Assembly by EtMgBr 
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Following Sarpong’s protocol11, the alkyne 3.3 should be heated with EtMgBr at reflux 
for 1h in THF prior to addition of the aldehyde 5.4 as a solution at -20 °C and warming to 
room temperature. Conveniently, the diastereomeric propargylic alcohols 5.33a and 
5.33b could be separated in pure form by column chromatography. The absolute 
stereochemistry at the C5-epimeric centers was not defined at this stage. Although still 
somewhat ambiguous, these were deduced later, based on ‘NOE’ correlations in 
combination with ab intio minimum energy conformations of downstream products. 
Nevertheless, 127 mg of 5.33a and 90 mg of 5.33b could be generated using this 
procedure (Scheme 5.13). 
 
5.3.1 RCM Study 
 
Although the optimal C5-epimeric configuration was unknown for RCM 
macrocyclization studies at this critical point, both diastereomers in hand were put 
forward to cyclize to macrocycles.  
Initially, to prevent possible alkyne co-ordination by Grubbs-type catalysts, a relatively 
bulky triethylsilyl (TES) was chosen to be put on the C5-propargylic alcohols. Both 
diastereomeric dienes 5.33a/5.33b were thus silylated separately as their corresponding 
TES ethers 5.34a/5.34b using TESOTf in the presence of Et3N (Scheme 5.14).  
 




Scheme 5.14: RCM Reaction of ‘Dienes with TES Ethers’ 
Table 5.3: RCM Reaction of Diene with TES Ethers 
 X 
Catalyst (mol%)/ 
Addition time Temp(°C)/Time Remarks 
1 5.34a 
1) 1.50 (20%)/ direct 
2) …………………. 




1) No new spot; 
2) No new spot; 
3) complex reaction 
2 5.34b 5.36 (20%)/direct 100/3h 
No new spot; 
SM Recovered 
3 5.34b 
5.36 (20%)  
PhOH (50eq)/3h 
60/3h 
No new spot; 
SM Recovered 
 
As can be seen Table 5.3, either Grubbs II or Hoveyda-Grubbs II catalysts gave no 
reaction or complex mixtures (even when used close to stoichiometry). Even the excess 
use of PhOH that may promote [Ru]-catalytic cycles (c.f. Forman et al.12 and Fukayama 
et al.13) was found ineffective. Eventually, we decided to reduce possible transannular 
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Scheme 5.15: RCM Reaction of Diene with Methyl Ether 5.37a 





Temp (°C)/Time Remarks 
1 
Grubbs II (10) 
Ti(Oi-Pr)4 (30 mol%) 
DCM (1 mM)/60/3h 
No reaction 
SM recovered 
2 Grubbs II 
   a) 100 mol%
Toluene (1 mM)/ 
125/2h 
SM disappeared 
2 new spots; trace 
macrocycle 5.38a 
   b) 50 mol% 
   c) 20 mol% 
3 Hoveyda Grubbs II (20) 
Toluene (0.15 mM)/ 
120/2h 
2 New spots; trace 
macrocycle 5.38a 
4 Grubbs II (20)/ 2h addition Toluene (0.1 mM)/ 
120/30min 
2 new spots; 5% 
macrocycle 5.38a 
 
Table 5.4 summarizes further RCM study on the methyl ether of diene 5.37a. Grubbs II 
catalyst (10 mol%) in DCM (1 mM) under reflux (60 °C), resulted in no reaction after 3h 
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even with the addition of Ti(Oi-Pr)4 (entry 1). Grubbs II catalyst (1 eq) in refluxing 
toluene (1 mM, 125 °C) for 2h was found to produce two new spots with complete 
consumption of the diene 5.37a (entry 2a), one of which was characterized to be the 
macrocycle 5.38a based on LC-MS and NMR data. Purification attempts at this stage 
however suffered from very low yields. Reaction optimization was then sought to 
improve the yield, but both 20 mol% and 50 mol% catalysts gave similar results (entry 
2b, 2c). Switching to the Hoveyda-Grubbs II catalyst gave very similar reaction pattern at 
20 mol% in refluxing toluene (0.1 mM) for 2h (entry 3). Adding the catalyst slowly to a 
refluxing diene solution of 5.37a in toluene (0.1 mM) under Grubbs II catalyst (20 mol% 
total) generated the macrocycle 5.38a in an isolated yield of 5% (entry 4). 
5.3.2 Prediction of Stereochemistry at C5-Propargylic Ether 
The major macrocyclic product 5.38a was purified and characterized by NMR (1D and 
2D), MS and HRMS analysis. Then, we sought methods to deduce the stereochemistry at 
C5 position. 
Other work in the our group has attempted to establish the stereochemical configuration 
at the C5 position by means of Mosher’s method and CBS reduction of ynones to give 
stereoselective propargylic ethers similar to 5.33a and 5.33b. However Mosher’s method 
was not conclusive due to insufficient protons in the proximity of the C5 chiral center.  
Alternatively, NOE correlation analysis from NOESY experiment of synthesized 
macrocycle was observed as shown in Fig 5.2. The NOE correlation between HC11-HC12 
was characterized to the newly formed Δ11,12 double bond in a Z-configuration. 
 




Fig 5.1: Ab initio Calculated Minimum Energy Conformers of Macrocycles and Tentative 
Diagnostic NOE Correlations 
 
 
Fig 5.2: Observed Diagnostic NOE Correlations in Macrocycle 5.38a by NOESY 
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In the meantime, in parallel to the synthetic progress, we evaluated the proposed 
transannular driven synthetic route and intermediates by means of ab initio/DFT 
calculations. Geometry optimization was performed and minimum energy obtained at the 
B3LYP/6-31G(d) level. Here, the Geometrical orientation of the key protons in the 
minimum energy conformations of Z-Δ11,12 macrocycles 5.38a and 5.38b (Fig 5.1) were 
compared to those of the observed NOE correlations (Fig 5.2) in the synthetic material 
5.38a. The key difference between the epimeric macrocycles in minimum energy 
conformations was in the orientation of HC5 at chiral center. HC5 aligns in the same plane 
as HC18 in the ‘R’-configured macrocycle (dihedral angle, θ = 26.1°; nonbonding 
distance, d = 2.62Å), whereas in the ‘S’-configured macrocycle, HC5 and HC3 arranges in 
the same spatial plane (dihedral angle, θ = 14.9°; nonbonding distance, d = 2.19Å). 
Hence, the R-configured Z-Δ11,12 macrocycle 5.38a is most likely to display HC5↔HC18 
NOE correlation while the ‘S’-configured Z-Δ11,12 macrocycle 5.38b would generate an 
HC5↔HC3 NOE interaction. Analytically, the synthesized macrocycle has a prominent 
HC5↔HC18 NOE interaction that implicates the RC5 configuration in the macrocycle 5.38a 
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5.4 Summary: Chapter 5 (Part B) 
In this chapter, I explored synthetic studies aiming at transannular [2+2] cycloaddition 
towards a macrocycle core of bielschowskysin (1.1). A Convergent synthesis of the 
macrocycle was designed by disconnecting the C5-C6 and C11-C12 bonds. Routes to the 
modified conjugated aldehyde synthon 5.4 were explored from D-Glucose by Witting 























































R = TES: No reaction/decomposed





4 steps 8 steps
 
Eventually, the acetylide addition onto aldehyde 5.4 was effected with EtMgBr by the in 
situ generation of the organomagnesium compound of alkyne 3.3 to give the separable 
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propargylic alcohols 5.33a and 5.33b. This method prevented [2,3]-Wittig rearrangement 
of benzyl-allyl ether of the alkyne unit 3.3. 
Finally, the RCM method was studied on a linear framework of bielschowskysin. 
Although RCM was unsuccessful under C5-TES protection with 5.34a and 5.34b, the 
methyl propargylic ether 5.37a underwent macrocyclization with [Ru]-precatalysts. The 
slow addition of Grubbs II catalyst to diene 5.36a eventually gave 5% isolable yield of a 
macrocycle 5.38a with a Z-configuration at the newly formed Δ11,12 bond. The absolute 
configuration at the C5 propargylic position in macrocycle 5.38a was predicted by 
comparing experimentally observed NOE correlations with the conformational 
orientation of macrocycles obtained by ab-initio energy minimization. Further 
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General Techniques and Methods 
All non aqueous reactions were performed in flame dried glassware under nitrogen or 
argon atmosphere unless stated otherwise. All solvents used in the reactions were purified 
before use. Dichloromethane (CH2Cl2) was distilled over CaH2 and dry diethyl ether 
(Et2O), tetrahydrofuran (THF) was distilled from sodium/benzophenone. All 
commercially available compounds were used as received without further purification. 
4Å molecular sieves were activated by heating at 120-140 °C under high vacuum for 4h 
before storing in a dry desiccator. The reactions were monitored by thin layer 
chromatography (TLC) carried out on 0.25 mm 2E Merck silica gel plates (60F-254) 
under 254 nm UV lamp and stained by aqueous ceric ammonium molybdate solution or 
KMnO4 solution. Flash chromatography was performed on silica gel 60 (0.040 – 0.063 
mm). 1H and 13C NMR spectra were recorded on Bruker ACF (300 MHz) and Bruker 
AMX500 (500 MHz) NMR spectrometer at ambient atmosphere. 2D NMR was 
performed on a Bruker AMX500 (500 MHz) NMR spectrometer. Chemical shifts are 
reported in δ (ppm) and calibrated using residual undeuterated solvents as an internal 
reference. The following abbreviations were used to explain the multiplicities: s = singlet, 
d = doublet, t = triplet, q = quartet, dd = doublet of doublet, do = doublet of triplet, td = 
triplet of doublet, m = multiplet, br = broad. 1H NMR coupling constants (J) are reported 
in Hertz (Hz), Mass spectra were obtained on Finnigan MAT95XL-T and Micromass 
VG7035 double focusing mass spectrometer. High resolution ESI mass spectra were 
obtained on a Shimadzu LCMS-IT-TOF spectrometer. Infra-red spectra were recorded on 
Perkin-Elmer FT 1600 spectrometer. 
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4-(tert-butyldiphenylsilyloxy)butan-1-ol (2.12): To the 
stirring solution of 1,4-butanediol 2.11 (10 mL) in dry 
DCM (30 mL) was added imidazole (1.2 g, 16.5 mmol) 
and TBDPSCl (3.17 g, 10.9 mmol) at room temperature and the reaction continued 
overnight. The reaction contents were diluted with ether, washed with H2O and the layers 
were separated. The aqueous layer was extracted with ether (2x) and the combined 
organic fractions were washed with brine, dried over anhydrous Na2SO4, The solvent was 
removed under reduced pressure and the crude residue was purified by flash column 
chromatography (gradient 10-15% EtOAc/hexanes) to afford 4-(tert-
butyldiphenylsilyloxy)butan-1-ol 2.12 (2.14 g, 60%) as a colorless syrup. The NMR data 
is in agreement with that reported in the literature.1 1H NMR (CDCl3, 300 MHz): δ 7.72-
7.69 (m, 4H), 7.43-7.40 (m, 6H), 3.72 (t, J = 9.85 Hz, 2H), 3.67 (t, J = 10.15 Hz, 2H), 
2.29 (s, br, 1H, OH), 1.73-1.63 (m, 4H), 1.08 (s, 9H). 13C NMR (CDCl3, 75 MHz): δ 
135.49, 133.60, 129.57, 127.60, 63.94, 62.65, 29.69, 29.18, 26.77, 19.10. 
Ethyl 7-(tert-butyldiphenylsilyloxy)-4-hydroxyhept-2-ynoate (2.14): To the stirring 
solution of 4-(tert-butyldiphenylsilyloxy)butan-1-ol 2.12 (1.86 g, 
5.67 mmol) in anhydrous DCM (25 mL) at RT was added PCC 
(1.6 g, 7.37 mmol) and stirred for 2.5h. Then, the dark orange-
black reaction mixture was directly purified by flash column 
chromatography (gradient 5-10% EtOAc/hexanes) to give aldehyde 2.13 (1.4 g, 76%) as 
a viscous yellow liquid. 
                                                            
1 Erkkilä, A.; Pihko, P. M. J. Org. Chem. 2006, 71, 2538-2541. 
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Ethylpropiolate (571 µL, 5.64 mmol) was taken in THF (5 mL) cooled to –78 °C, and 
LHMDS (5.6 mL, 1M in hexane, 5.6 mmol) was added slowly drop-wise. After 30 min, 
aldehyde 2.13 (1.4 g, 4.33 mmol) in THF (5 mL) was added and stirred for 2h at –78 °C. 
Then the reaction was quenched by slow addition of saturated NH4Cl and extracted with 
ether (3x). The combined organic fractions were washed with brine, dried over anhydrous 
Na2SO4, filtered and concentrated under reduced pressure. The crude residue was purified 
by flash column chromatography (gradient 10-20% EtOAc/hexane) to afford racemic 
propargylic alcohol 2.14 (1.43 g, 60%) as a faint yellow oil. 1H NMR (CDCl3, 500 
MHz): δ 7.68-7.67 (m, 4H), 7.45-7.38 (m, 6H), 4.57 (dd, J = 6.3, 11.95 Hz, 1H), 4.24 (q, 
J = 6.9 Hz, 2H), 3.74-3.69 (m, 2H), 3.27 (s, br, 1H, OH), 1.96-1.85 (m, 2H), 1.84-1.80 
(m, 1H), 1.75-1.70 (m, 1H), 1.31 (t, J = 6.9 Hz, 3H), 1.07 (s, 9H). 13C NMR (CDCl3, 125 
MHz): δ 153.41, 135.56, 135.53, 133.28 129.77, 127.73, 87.77, 76.59, 63.75, 62.02, 
61.81, 34.27, 27.94, 26.79, 19.11, 13.97. MS (ESI): m/z 395.2 [M-C2H5]-; 447.1 (100%) 
[M+Na]+. HRMS (ESI): m/z calcd for C25H32O4SiNa 447.1968 [M+Na]+; found 
447.1979. 
6-(Methoxymethoxy)hex-1-ene (2.18): To a stirring solution of hex-5-
enol 2.17 (1 g, 9.8 mmol) and DIPEA (2.5 mL, 25 mmol) in DCM (15 
mL) at 0 °C, was added MOMCl (500 μL, 2.93 mmol). After overnight 
stirring at room temperature, the reaction mixture was quenched by addition of H2O. The 
layers were separated and the aqueous layer was extracted with ether (3x). The combined 
organic fractions were washed with brine, dried over anhydrous Na2SO4, filtered and and 
concentrated in vacuo and the oily residue was purified by flash column chromatography 
(gradient 2% EtOAc/hexanes) to give 2.18 (850 mg, 60%) as a colorless oily liquid. 1H 
OMOM
2.18
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NMR (CDCl3, 500 MHz): δ 5.78-5.72 (m, 1H), 4.95 (d, J = 17 Hz, 1H), 4.89 (d, J = 
10.75 Hz, 1H), 4.55 (s, 2H), 3.48 (t, J = 6.3 Hz, 2H), 3.30 (s, 3H), 2.05-2.01 (m, 2H), 
1.57-1.52 (m, 2H), 1.44-1.38 (m, 2H); 13C NMR (CDCl3, 125 MHz): δ 138.47, 114.40, 
96.24, 67.44, 54.86, 33.37, 29.07, 25.42; MS (ESI): m/z 144.8 [M]+. 
6-(Methoxymethoxy)hex-1-en-3-ol (2.19): To a stirring solution of 
alkene 2.98 (0.66 g, 4.5 mmol) in DCM (10 mL), SeO2 (1.2 g, 7 mmol) 
and t-BuOOH (70% aq. solution, 5 mL, 27 mmol) were added and 
refluxed for 13h. The reaction was cooled to room temperature and 
quenched by careful drop wise addition of saturated NaHCO3 aqueous solution until 
effervescence ceased. The aqueous layer was extracted with ether (3x) and the combined 
organic fractions were washed with aq.1M KOH solution, brine and dried over anhydrous 
Na2SO4, filtered and the solvent was removed under vacuum. The crude residue was 
purified by flash column chromatography (gradient 10-30% EtOAc/hexanes) to give 
racemic allylic alcohol 2.19 (360 mg, 50%) and over oxidized product 2.20 (140 mg, 
20%) both as transparent colorless oils. 1H NMR (CDCl3, 500 MHz): δ 5.88-5.81 (m, 
1H), 5.23-5.19 (m, 1H), 5.08 (dd, J = 1.25, 8.8 Hz, 1H), 4.59 (s, 2H), 4.13-4.08 (m, 1H), 
3.54 (t, J = 6.3 Hz, 2H), 3.33 (s, 1H), 1.73-1.54 (m, 4H). 13C NMR (CDCl3, 125 MHz): δ 
141.03, 114.51, 96.30, 72.67, 67.64, 55.14, 33.89, 25.59. 
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Oct-7-ynal (2.23): The 7-octyn-1-ol 2.22 was obtained by 
following alkyne isomerization procedure reported by Macaulay.2 
To NaH (60% in mineral oil, 4 g, 100 mmol, washed free of oil 
three times with distilled hexane) in a two neck round bottom flask (RBF) equipped with 
a guard tube, was added ethylenediamine (70 mL) and stirred vigorously. Initially, gas 
evolution was slow and become vigorous to result a brinjal-purple solution. After 15-20 
min of vigorous stirring at RT, foaming subsided and the mixture was stirred in a 
constant-temperature oil bath at 70 °C for 1h. To the resulted brinjal-brown solution, 3-
octyn-1-ol 2.21 (2 g, 15.84 mmol) in ethylenediamine (15 mL) was added. The purple 
brown mixture was stirred at 55 °C overnight and then cooled to 0 °C, quenched with 
slow addition of ice-cold water (50 mL) with stirring. The aqueous layer was extracted 
with ether (4x) and the combined ether phases were washed successively with water, 
dilute HC1 and brine solutions and then dried over anhydrous Na2SO4. Solids were 
filtered and the solvents distilled under reduced pressure. The crude product was 
chromatographed over silica gel (gradient 10-20% EtOAc/hexane) to give 7-octyn-1-ol 
2.22 (1.5 g, 75%) as a smelly faint yellow oil. 
PCC oxidation: PCC (2.58 g, 12 mmol) was added to the stirring solution of alkynol 
2.22 (1 g, 7.92 mmol) in anhydrous DCM (10 mL). After stirring for 2.5h at room 
temperature, the reaction mixture was directly purified by flash column chromatography 
(gradient 2-5% EtOAc/hexanes) to give 2.23 (690 mg, 70%) as a smelly, transparent faint 
yellow oil. The NMR data is in agreement with that reported in the literature.3 1H NMR 
                                                            
2 Macaulay, S. R. J. Org. Chem. 1980, 45, 734-735. 
3 Hopf, H.; Krüger, A. Chem. Eur. J. 2001, 7, 4378-4385. 
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(CDCl3, 300 MHz): δ 9.70 (t, J = 1.62 Hz, 1H), 2.39 (dt, J = 1.62, 7.23 Hz, 2H), 2.13 (dt, 
J = 2.64, 6.75 Hz, 2H), 1.89 (t, J = 2.64 Hz, 1H), 1.64-1.35 (m, 6H). 13C NMR (CDCl3, 
75 MHz): δ 202.35, 84.04, 68.32, 43.55, 28.01, 27.98, 21.38, 18.03. 
2-(Hept-6-ynyl)-1,3-dioxolane (2.24): Alkynal 2.23 (1.44 g, 
11.59 mmol), ethyleneglycol (2 mL) and p-TSA (50 mg, 0.58 
mmol) were dissolved in toluene (50 mL) in a side neck round 
bottom flask and refluxed for 12h with removal of water as an 
azeotroph by using Dean-Stark apparatus. Contents were cooled to room temperature and 
neutralized by addition of Et3N and the solvent was removed under reduced pressure. 
Ether was added and washed successively with saturated NaHCO3 solution and brine. 
The organic layer was concentrated under reduced pressure and the crude reside was 
purified by flash column chromatography (gradient 1-5% EtOAc/hexane) to give acetal 
2.24 (1.9 g, quantitative) as a colorless clear liquid. 1H NMR (CDCl3, 500 MHz): δ 4.84 
(t, J = 4.73 Hz, 1H), 3.99-3.92 (m, 2H), 3.87-3.80 (m, 2H), 2.18 (dt, J = 2.55, 6.95 Hz, 
2H), 1.93-1.92 (m, 1H), 1.68-1.64 (m, 2H), 1.57-1.51 (m, 2H), 1.46-1.42 (m, 4H). 13C 
NMR (CDCl3, 125 MHz): δ 104.32, 84.29, 68.11, 64.64, 33.57, 28.45, 28.22, 23.33, 
18.10. 
Methyl 3-hydroxy-2-methylenedec-9-ynoate (2.25): Methyl 
acrylate (3 mL) and DABCO (931 mg, 8.3 mmol) were added to a 
solution of aldehyde 2.23 (343 mg, 2.7 mmol) in MeOH (1-2 drops) 
and the homogenous solution was stirred at RT for 2 days. The 
reaction was diluted with 1M HCl, the aqueous phase was extracted with ether and the 
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filtered and concentrated. The residue was purified by flash column chromatography 
(gradient 10-20% EtOAc/hexanes) to furnish Baylis-Hillman adduct 2.25 (425 mg, 75 %) 
as a colorless clear liquid. 1H NMR (CDCl3, 300 MHz): δ 6.20 (s, 1H), 5.78 (s, 1H), 4.37 
(t, br, J = 6.09 Hz, 1H), 3.76 (s, 3H), 2.61 (s, br, 1H, OH), 2.16 (dt, J =  2.64, 6.75 Hz, 
2H), 1.92 (t, J = 2.64 Hz, 1H), 1.65-1.60 (m, 2H), 1.56-1.32 (m, 6H). 13C NMR (CDCl3, 
75 MHz): δ 166.97, 142.44, 124.91, 84.52, 71.59, 68.16, 51.82, 36.01, 28.42, 28.30, 
25.25, 18.28. 
6-(Methoxymethoxy)hex-1-en-3-yl 3-methoxy-2-
methylenedec-9-ynoate (2.16a): NaH (60% in mineral oil, 224 
mg, 5.4 mmol) was added to a stirring solution of 2.25 (1.02 g, 
4.55 mmol) and MeI (0.5 mL, 7 mmol) in dry THF (20 mL) at 0 
°C. After 2h at room temperature, the reaction was diluted with ether (20 mL), quenched 
with 20 mL of H2O. The aqueous layer was extracted with ether (2x) and the combined 
organic fractions were washed with brine, dried over anhydrous Na2SO4, solids were 
filtered and the solvent was removed under reduced pressure. The crude residue was 
purified by flash column chromatography (gradient 4-8% EtOAc/hexanes) to provide 
2.27 (65 mg, 7%) as a yellow oil. Ester 2.27 (96 mg, 0.43 mmol) was dissolved in i-
PrOH/H2O (1:1 v/v, 4 mL) and treated with LiOH (30 mg, 1.25 mmol). The resulting 
yellow reaction mixture was stirred at room temperature for 6h. Then the reaction content 
was diluted with water and the aqueous layer was extracted with Et2O (2x) and the 
combined organic factions were washed with brine, dried over anhydrous Na2SO4 and the 
solvent removed under reduced pressure. The residue was purified by flash column 
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chromatography (gradient 10-20% EtOAc/hexane) to obtain acid 2.29 (45 mg, 50%) as a 
faint yellow oily liquid. 
A solution of alcohol 2.22 (91 mg, 0.57 mmol) and Ph3P (124 mg, 0.48 mmol) in THF (2 
mL) was added drop wise at 0 °C to a stirring solution of acid 2.29 (100 mg, 0.48 mmol) 
and DEAD (75 µL, 0.48 mmol) in THF (2 mL). The reaction was allowed to continue at 
RT overnight and the mixture was concentrated and the residue purified by flash column 
chromatography (gradient 5-10% EtOAc/hexanes) to afford the title ester 2.16a (70 mg, 
40%) as a clear liquid. 1H NMR (CDCl3, 300 MHz): δ 6.29 (s, 1H), 5.85-5.71 (m, 2H), 
5.36-5.15 (m, 2H), 4.58 (s, 2H, OCH2O), 4.06-3.97 (m, 1H), 3.54-3.45 (m, 3H), 3.32 (s, 
3H, OMe), 3.24 (s, 3H, OMe), 2.16-2.12 (m, 2H), 1.91-1.89 (t, 1H), 1.76-1.18 (m, 12H). 
13C NMR (CDCl3, 75 MHz): δ 165.57, 141.04, 136.12, 124.40, 116.93, 116.71, 106.58, 
96.32, 84.52, 79.37, 74.72, 74.63, 68.09, 67.14, 56.95, 55.06, 35.77, 30.92, 28.42, 28.30, 
25.31, 24.97. MS (ESI): m/z 375.1 (100%). HRMS (ESI): m/z calcd for C20H32NaO5 
375.2147 [M+Na]+; found 375.2159. 
(2S,4S)-4-(Hydroxymethyl)-2-phenyl-1,3-dioxane (2.37): (S)-
malic acid was acylated following a procedure adapted from work 
by Ley et al.4 Acetyl chloride (15.5 mL) was added dropwise to 
MeOH (300 mL) for 15 min at RT with constant stirring and after 10 min, (S)-malic acid 
(47.0 g, 0.35 mol) was added. The reaction mixture was stirred at RT for 20h and 
concentrated in vacuo. Flash column chromatography eluting with CH2Cl2:MeOH (95:5) 
afforded the title compound as pale yellow oil. The resulting malic acid ester in absolute 
                                                            
4 Gaunt, M. J.; Jessiman, A. S.; Orsini, P.; Tanner, H. R.; Hook, D. F.; Ley, S. V. Org. Lett. 2003, 5, 4819-
4822 
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ethanol (60 mL) was added drop wise to a solution of NaBH4 (20 g, 0.53 mmol) in THF 
at 0 °C over 1h with vigorous stirring and the reaction was continued for a further 5h at 
room temperature with stirring. Then the reaction was quenched by addition of conc. HCl 
until pH = 7 during which a white solid cake formed. Solids were filtered through a celite 
pad, the celite was washed thoroughly with methanol and concentrated on a rotary 
evaporator. The crude residue was purified by flash column chromatography (gradient 5-
15% DCM/MeOH) to provide (S)-butane-1,2,4-triol (2.36) as a colorless viscous semi 
solid. 
Triol 2.36 was then converted to beznylidene acetal following a procedure adapted from 
reported method.5 (S)-1,2,4-butanetriol 2.36 (13.5 g, 127 mmol) and benzaldehyde 
dimethyl acetal (23 mL, 152 mmol) in dry DCM (50 mL) were stirred at room 
temperature in the presence of camphorsulfonic acid (1.5 g, 6.45 mmol). The reaction 
mixture was stirred for 20h and the contents were neutralized with triethylamine (5 mL) 
and concentrated under reduced pressure. Flash column chromatography (gradient 25-
40% EtOAc in hexanes) of the resulting residue afforded pure (2-phenyl-1,3-dioxan-4-
yl)methanol 2.37 (19.7 g, 80%) as a colorless oil. 1H NMR (CDCl3, 500 MHz): δ 7.50 (d, 
J = 6.3 Hz, 2H), 7.39-7.33 (m, 3H), 5.51 (s, 1H), 4.26 (dd, J =  5.05, 11.35 Hz, 1H), 3.96-
3.90 (m, 2H), 3.61 (s, 2H), 2.63 (s, br, 1H, OH), 1.90-1.81 (m, 1H), 1.39 (d, J =  13.25 
Hz, 1H). 13C NMR (CDCl3, 100 MHz): 138.29, 128.75, 128.08, 126.02, 101.08, 77.45, 
66.45, 65.36, 26.71. MS (ESI): m/z 217.1 [M+Na]+. HRMS (ESI): m/z calcd for 
C11H14NaO3 217.0841 [M+Na]+; found 217.0842. 
                                                            
5 Flögel, O.; Okala Amombo, M. G.; Reißig, H.-U.; Zahn, G.; Brüdgam, I.; Hartl, H. Chem. Eur. J. 2003, 9, 
1405-1415. 





(2S,4S)-2-phenyl-4-vinyl-1,3-dioxane (2.39):  
Swern oxidation: To the stirring dry DCM (10 mL) was added 
(COCl)2 (2.1 mL, 24.8 mmol) under argon and cooled to –78 °C. 
Anyhydrous DMSO (3.3 mL, 46 mmol) was added drop wise to the above solution and 
after 20 min, (2-phenyl-1,3-dioxan-4-yl)methanol 2.37 (3 g, 15.4 mmol) in DCM (5 mL) 
added. After 30 min, Et3N (10 mL, 72 mmol) was added at –78 °C and the resulting 
cloudy solution was stirred for 15 min after which quenched by slow addition of H2O. 
The mixture was allowed to warm to room temperature and the layers were separated. 
The aqueous layer was extracted with DCM (3x) and the combined organic fractions 
were washed with brine (20 mL), dried over anhydrous Na2SO4 and concentrated under 
reduced pressure. The crude 2-phenyl-1,3-dioxane-4-carbaldehyde 2.38 was dried 
azeotropically by dry THF (2x) before being carried forward for the next Nozaki-Takai 
olefenation. 
Nozaki-Takai Olefenation: CH2I2 (12 mL, 152 mmol) was added slowly drop wise to a 
solution of freshly activated Zn dust (10 g, 152 mmol) and PbCl2 (0.43 g, 1.54 mmol) in 
THF (40 mL) for 15 min with constant stirring under argon. The reaction become 
vigorous with effervescence and reached reflux within 10 min from the point CH2I2 
addition begins. Then the reaction was cooled by arranging an external ice-bath as soon 
as effervescence begins and the grayish solution stirred at room temperature after 
effervescence ceases. After 1h, Ti(i-OPr)4 (4.5 mL, 15.2 mmol) was added; and after 30 
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min at room temperature the crude 2-phenyl-1,3-dioxane-4-carbaldehyde (2.38) in THF 
(6 mL) was added to the greenish reaction solution. The reaction was allowed to continue 
overnight, diluted with ether, quenched by addition of 1M HCl (50 mL). The layers were 
separated, the aqueous layer was extracted with ether (2x30 mL) and the combined 
organic fractions were washed with brine (50 mL), dried over anhydrous Na2SO4, 
filtered, concentrated and purified by flash column chromatography (gradient 1-5% 
Et2O/hexane) to furnish 2-phenyl-4-vinyl-1,3-dioxane 2.39 (40-60%) exclusively as a 
transparent colorless oil. 
 
1H NMR (CDCl3, 500 MHz): δ 7.55-7.52 (m, 2H), 7.40-7.34 (m, 3H), 6.00-5.93 (m, 1H), 
5.59 (s, 1H), 5.38-5.34 (m, 1H), 5.21-5.18 (m, 1H), 4.41-4.36 (m, 1H), 4.30 (ddd, J = 
1.25, 5.05, 11.35 Hz, 1H), 4.04-3.99 (m, 1H), 1.99-1.91 (m, 1H), 1.64-1.60 (m, 1H). 13C 
NMR (CDCl3, 125 MHz): δ 138.58, 137.81, 128.71, 128.15, 126.11, 115.50, 101.12, 
77.54, 66.84, 31.12. 
 
(S)-3-(benzyloxy)pent-4-en-1-ol (2.45): DIBALH (25 mL, 1M in 
cyclohexane, 25 mmol) was added slowly drop wise to a solution of 2-
phenyl-4-vinyl-1,3-dioxane 2.39 (3.2 g, 16.8 mmol) in DCM (40 mL) at 0 °C and the 
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reaction was allowed to warm gradually to room temperature through 5h. Upon 
completion, the reaction was quenched by slow addition of 1M HCl solution and after 
15min of stirring, cloudy clumps disappeared from the organic phase. The aqueous phase 
was extracted with ether (2x) and the combined extracts were washed with brine, dried 
over anhydrous Na2SO4, filtered, concentrated and purified by flash column 
chromatography (gradient 15-30% EtOAc/hexane) to furnish (S)-3-(benzyloxy)pent-4-en-
1-ol 2.45 (2.9 g, 90%) exclusively as a transparent oil. 1H NMR (CDCl3, 500 MHz): δ 
7.36-7.27 (m, 5H), 5.84-5.77 (m, 1H), 5.29-5.28 (m, 1H), 4.63 (d, J = 11.5 Hz, 1H), 4.37 
(d, J = 11.5 Hz, 1H), 4.02 (dt, J = 4.4, 8.2 Hz, 1H), 3.81-3.71 (m, 2H), 2.45 (s, br, 1H, 
OH), 1.92-1.85 (m, 1H), 1.82-1.76 (m, 1H). 13C NMR (CDCl3, 125 MHz): δ 138.17, 
138.10, 128.43, 127.77, 127.65, 117.48, 79.78, 70.27, 60.47, 37.76. MS (ESI): m/z 215.1 
(100%) [M+Na]+. HRMS (ESI): m/z calcd for C12H16NaO2 215.1048 [M+Na]+; found, 
215.1036. 
(S)-3-(benzyloxy)pent-4-enal (2.50): To the stirring solution of (S)-3-
(benzyloxy)pent-4-en-1-ol 2.45 (2.5 g, 13 mmol) and NaHCO3 (10 g, 
130 mmol) in dry DCM (40 mL) was added DMP (11 g, 26 mmol) at 
room temperature and the reaction was continued for 2h at room temperature. The 
reaction contents were filtered through a celite pad and concentrated on a rotary 
evaporator and the crude residue was purified by flash column chromatography (gradient 
2-5% EtOAc in hexanes) to provide (S)-3-(benzyloxy)pent-4-enal 2.50 (2.12 g, 86%) as a 
colorless syrup. 1H NMR (CDCl3, 500 MHz): δ 9.76-9.75 (m, 1H), 7.36-7.27 (m, 5H), 
5.85-5.78 (m, 1H), 5.36-5.30 (m, 2H), 4.62 (d, J = 11.35 Hz, 1H), 4.40 (d, J = 12 Hz, 
1H), 4.36-4.32 (m, 1H), 2.74 (ddd, J = 2.5, 8.2, 16.35 Hz, 1H), 2.56 (ddd, J = 1.87, 5.0, 
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16.35 Hz, 1H). 13C NMR (CDCl3, 125 MHz): δ 200.65, 137.90, 136.97, 128.36, 128.33, 
127.76, 127.67, 118.20, 75.31, 70.32, 49.05. 
(S)-4-(benzyloxy)hex-5-enal (2.35): To the stirring solution of MeOCH2PPh3Cl (6.7 g, 
19.5 mmol) in THF was added LHMDS (19.5 mL, 1M in THF, 19.5 
mmol) at 0 °C and after 1h, (S)-3-(benzyloxy)pent-4-en-1-ol 2.50 
(2.12 g, 11.1 mmol) in THF was added at 0 °C. The orange color reaction mixture was 
allowed to continue with stirring at room temperature overnight. The reaction was diluted 
with ether and the solids were filtered, washed with 10% K2CO3 and the aqueous phase 
was extracted with ether (2x). The combined organic extracts were washed with brine, 
dried over anhydrous Na2SO4, filtered, concentrated and purified by flash column 
chromatography (gradient 2-5% EtOAc/hexane) to yield (S)-((6-methoxyhexa-1,5-dien-
3-yloxy)methyl)benzene (mixture of E, Z isomers) which was subsequently hydrolyzed 
by refluxing (60 °C) with 1M HCl/THF (1:1 v/v, 10 mL) for 1h. Then the reaction was 
diluted with ether and the aqueous phase was extracted with ether (2x) and the combined 
organic fractions were washed with brine, dried over anhydrous Na2SO4, filtered, 
concentrated and the residue was purified by flash column chromatography (gradient 5-
10% Et2O/hexanes) to accomplish homologated aldehyde, (S)-4-(benzyloxy)hex-5-enal 
2.35 (50%, 2 steps) as a colorless oily liquid. 1H NMR (CDCl3, 500 MHz): δ 9.74 (t, J = 
1.58 Hz, 1H, CHO), 7.36-7.26 (m, 5H, Ph), 5.78-5.71 (m, 1H), 5.28-5.23 (m, 2H), 4.58 
(d, J = 11.95 Hz, 1H), 4.33 (d, J = 11.95 Hz, 1H), 3.79 (dd, J = 7.55, 12.6 Hz, 1H), 2.54-
2.50 (m, 2H), 1.98-1.86 (m, 2H). 13C NMR (CDCl3, 125 MHz): δ 202.13, 138.31, 
138.07, 128.31, 127.73, 127.51, 117.74, 79.23, 70.17, 39.90, 27.99. 
 




(2.34): To a solution of 2-(hept-6-ynyl)-1,3-dioxolane 2.24 (321 
mg, 1.9 mmol) in THF at –78 °C, n-BuLi (1.80 mL, 1M in 
hexane, 1.8 mmol) was added and the reaction stirred for 2h. Then 
(S)-4-(benzyloxy)hex-5-enal 2.35 (195 mg, 0.95 mmol) in THF 
was added and continued for a further 2h at –78 °C and the reaction was quenched by 
slow addition of saturated NH4Cl and extracted with ether (3x). The combined organic 
fractions were washed with brine, dried over anhydrous Na2SO4, filtered and the solvent 
removed under reduced pressure. The crude residue was purified by flash column 
chromatography (gradient 10-20% EtOAc in hexanes) to afford (3S)-3-(benzyloxy)-13-
(1,3-dioxolan-2-yl)tridec-1-en-7-yn-6-ol 2.34 (350 mg, quantitative) as a colorless syrup 
while recovering unreacted alkyne. 1H NMR (CDCl3, 500 MHz): δ 7.33-7.24 (m, 5H), 
5.79-5.72 (m, 1H), 5.25-5.21 (m, 2H), 4.85-4.83 (t, J = 4.73 Hz, 1H), 4.59 (d, J = 12 Hz, 
1H), 3.98-3.93 (m, 2H), 3.91-3.76 (m, 2H), 2.39 (s, br, 1H), 2.21-2.17 (m, 2H) 1.85-1.63 
(m, 6H), 1.52-1.49 (m, 1H), 1.43-1.42 (m, 1H). 13C NMR (CDCl3, 125 MHz)6: δ 138.63 
and 138.52, 138.43, 138.42, 128.3, 127.75, 127.72, 127.46, 117.34, 104.51, 85.3, 81.23, 
80.18 and 80.06, 70.08, 64.79, 62.40 and 62.35, 34.03, 33.93, 33.68, 31.09, 28.68, 28.41, 
23.43, 18.54. MS (ESI): m/z 395.2 [M+Na]+. HRMS (ESI): m/z calcd for C23H32NaO4 
395.2198 [M+Na]+; found, 395.2188. 
 
                                                            
6 The Multiple C-signals appearing in the spectra are due to diastereotopic carbon centers present in the 
inseparable mixture of diastereomers. 




(2.51): DEAD (106 µL, 0.67 mmol) was added to a solution of 
Ph3P (176 mg, 0.67 mmol) in THF (2 mL) at –15 °C. After 15 
min, a solution of propargylic alcohol 2.34 (125 mg, 0.336 
mmol) in THF (2 mL) was added to the yellow reaction mixture, 
15 min later a solution of NBSH (0.145 g, 0.67 mmol) in THF 
(2.0 mL) was added. The resulting suspension was held at –15 °C for 1h, after which time 
TLC analysis indicated complete consumption of the starting alcohol. The reaction 
mixture was warmed to ambient temperature and allowed to stand overnight. 
Concentration of the reaction mixture and purification of the residue by flash column 
chromatography (gradient 5-10% Et2O in hexanes) afforded the title allene, 2-((11S)-11-
(benzyloxy)trideca-6,7,12-trienyl)-1,3-dioxolane 2.51 as a colorless oil (170 mg, 84%). 
1H NMR (CDCl3, 500 MHz): δ 7.35-7.31 (m, 4H), 7.28-7.24 (m, 1H), 5.78-5.71 (m, 1H), 
5.24-5.20 (m, 2H), 5.10-5.03 (m, 2H), 4.84 (dt, J = 1.9, 5.05 Hz, 1H), 4.59 (d, J = 12 Hz, 
1H), 4.35 (d, J = 12 Hz, 1H), 3.99-3.92 (m, 2H), 3.87-3.78 (m, 2H), 2.14-2.02 (m, 2H), 
1.97-1.94 (m, 2H), 1.81-1.73 (m, 1H), 1.68-1.56 (m, 2H), 1.44-1.36 (m, 7H). 13C NMR 
(CDCl3, 125 MHz)7: δ 203.86, 203.84, 138.92, 138.76, 128.26, 127.72, 127.68, 127.36, 
117.12, 104.61, 91.29, 91.27, 90.46, 90.40, 79.97, 79.78, 70.13, 70.11, 64.78, 38.81, 
34.76, 34.75, 33.84, 29.07, 29.06, 28.98, 28.96, 28.79, 24.67, 24.64, 23.86. MS (ESI): 
m/z 379.1 [M+Na]+. HRMS (ESI): m/z calcd for C23H32NaO3 379.2249 [M+Na]+; found, 
379.2244. 
                                                            
7  Multiple C-signals appearing in the spectra are due to diastereotopic carbon centers present in the 
inseparable mixture of diastereomers. 




methylenehexadeca-9,10,15-trienoate (2.53): A solution of 2-
((11S)-11-(benzyloxy)trideca-6,7,12-trienyl)-1,3-dioxolane 
2.51 (450 mg, 1.26 mmol) in 2M HCl:THF (1:1 v/v, 15 mL) 
was stirred overnight at 45 °C and then diluted with Et2O. The 
aqueous phase was extracted with Et2O (2x) and the combined extracts were washed with 
brine, dried over anhydrous Na2SO4, filtered and concentrated. The crude aldehyde 2.52 
(450 mg) was subjected to Baylis-Hillman conditions by adding methyl acrylate (0.5 mL, 
4.32 mmol) and DABCO (323 mg, 2.88 mmol) and a drop of MeOH to make 
homogenous solution. After being stirred at ambient temperature for 5 days, the reaction 
was diluted with 1M HCl and was extracted with ether (2x). The combined extracts were 
washed with brine, dried over anhydrous Na2SO4, filtered and concentrated in vacuo. The 
residue was purified by flash column chromatography (gradient 10-20% EtOAc/hexanes) 
to furnish the Baylis-Hillman adduct, (12S)-12-(benzyloxy)tetradeca-7,8,13-trienal 2.53 
(351 mg, 70 %, 2 steps) as a colorless syrup. 1H NMR (CDCl3, 500 MHz): δ 7.34-7.24 
(m, 5H), 6.2 (s, 1H), 5.78 (s, 1H), 5.76-5.71 (m, 1H), 5.24-5.20 (m, 2H), 5.10-5.03 (m, 
2H), 4.58 (d, J = 12 Hz, 1H), 4.39-4.37 (m, 1H), 4.35 (d, J = 12 Hz, 1H), 3.81-3.77 (m, 
1H), 3.77 (s, 3H), 2.59 (s, br, 1H, OH), 2.12-2.01 (m, 2H), 1.98-1.93 (m, 2H), 1.81-1.73 
(m, 1H), 1.68-1.57 (m, 3H), 1.46-1.34 (m, 6H). 13C NMR (CDCl3, 125 MHz)8: δ 203.84, 
166.98, 142.53, 138.89, 138.72, 128.27, 127.74, 127.69, 127.37, 124.83, 117.15, 91.32, 
91.28, 90.46, 90.39, 79.99, 79.83, 79.80, 71.60, 70.12, 70.10, 51.79, 36.16, 34.78, 34.74, 
                                                            
8  Multiple C-signals appearing in the spectra are due to diastereotopic carbon centers present in the 
inseparable mixture of diastereomers 
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29.05, 28.82, 28.80, 25.62, 25.61, 25.58, 24.65. MS (ESI): m/z 421.2 [M+Na]+. HRMS 
(ESI): m/z calcd for C25H34NaO4 421.2355 [M+Na]+; found, 421.2350. 
(14S)-methyl 14-(benzyloxy)-3-(methoxymethoxy)-2-
methylenehexadeca-9,10,15-trienoate (2.54): To a stirring 
solution of the Baylis-Hillman adduct, (14S)-methyl 14-
(benzyloxy)-3-hydroxy-2-methylenehexadeca-9,10,15-
trienoate 2.53 (390 mg, 0.98 mmol) in dry DCM (10 mL) were 
added (i-Pr)2EtN (1 mL, 4.90 mmol) and MOMCl (500 μL, 2.93 mmol) at 0 °C. After 
overnight at room temperature, the reaction was quenched with addition of H2O. The 
aqueous layer was extracted with ether (3x) and the combined organic fractions were 
washed with brine, dried over anhydrous Na2SO4 and filtered. The solvent was removed 
under vacuum and the resulting residue was purified by flash column chromatography 
(gradient 2-7% EtOAc in hexanes) to give the MOM ether, (14S)-methyl 14-(benzyloxy)-
3-(methoxymethoxy)-2-methylenehexadeca-9,10,15-trienoate 2.54 (370 mg, 86%) as an 
oily liquid. 1H NMR (CDCl3, 500 MHz): δ 7.33-7.25 (m, 5H), 6.29 (s, 1H), 5.83 (d, J = 
1.25 Hz, 1H,) 5.78-5.71 (m, 1H), 5.24-5.20 (m, 2H), 5.10-5.03 (m, 2H), 4.60-4.55 (m, 
3H), 4.50-4.48 (t, br, J = 5.63 Hz, 1H), 4.36-4.34 (d, J = 11.35, 1H), 3.82-3.78 (dd, J = 
6.3, 13.25 Hz, 1H), 3.75 (s, 3H), 3.37 (s, 3H), 2.13-2.04 (m, 2H), 1.97-1.93 (m, 2H), 
1.79-1.73 (m, 1H), 1.69-1.57 (m, 3H), 1.45-1.34 (m, 6H). 13C NMR (CDCl3, 125 MHz)9: 
δ 203.84, 166.51, 141.36, 138.93, 138.75, 128.24, 127.70, 127.64, 127.34, 125.14, 
117.05, 94.85, 91.31, 91.28, 90.43, 90.36, 79.95, 79.77, 74.56, 70.12, 70.11, 55.68, 51.71, 
                                                            
9  Multiple C-signals appearing in the spectra are due to diastereotopic carbon centers present in the 
inseparable mixture of diastereomers. 
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35.67, 34.81, 34.76, 29.10, 29.08, 28.87, 25.38, 24.65, 24.63. MS (ESI): m/z 465.2 
[M+Na]+. HRMS (ESI): m/z calcd for C27H38NaO5 465.2617, found, 465.2612 [M+Na]+. 
 
DDQ Reaction: Benzyl ether, (14S)-methyl 14-(benzyloxy)-3-(methoxymethoxy)-2-
methylenehexadeca-9,10,15-trienoate 2.54 (360 mg, 0.81 mmol) was dissolved in 
DCM/H2O (9:1 v/v, 15 mL) and DDQ (760 mg, 3.34 mmol; 200 mg portions/2h) was 
added and stirred at room temperature for 9h. The reaction was monitored to be 
incomplete with orange-red clumps formation. While the allylic oxidation product is 
accumulating with time, solids were filtered-off through a celite pad, diluted with DCM 
(15 mL) and washed with saturated NaHCO3. The aqueous layer was extracted with 
DCM (2x) and the combined organic fractions were washed with brine (30 mL), dried 
over anhydrous Na2SO4 and filtered. The solvent was removed under reduced pressure 
and flash column chromatography (gradient 10-20% EtOAc/hexane) of the resulting 
orange-red residue furnished the title allylic alcohol, (14S)-methyl 14-hydroxy-3-
(methoxymethoxy)-2-methylenehexadeca-9,10,15-trienoate 2.32 (127 mg, 50%) as a 
colorless syrup in addition to allylic oxidation product, methyl 3-(methoxymethoxy)-2-
methylene-14-oxohexadeca-9,10,15-trienoate 2.55 (25 mg, 10%) while recovering 27 mg 
of unreacted starting material, 2.54. 




trienoate (2.32): Debenzylation product. 
1H NMR (CDCl3, 500 MHz): δ 6.27 (s, 1H), 5.88-5.83 (m, 
1H), 5.82 (s, 1H), 5.22-5.19 (d, J = 17.65 Hz, 1H), 5.09-5.05 
(m, 3H), 4.57-4.56 (d, J = 16.35 Hz, 1H), 4.56-4.53 (d, J = 
15.75 Hz, 1H) 4.48-4.45 (m, 1H), 4.16-4.12 (q, J = 6.3 Hz, 
1H), 3.74 (s, 3H), 3.35 (s, 3H), 2.08-2.02 (m, 2H), 1.98-1.93 (m, 2H), 1.83 (s, br, 1H, 
OH), 1.68-1.52 (m, 4H), 1.43-1.30 (m, 6H). 13C NMR (CDCl3, 125 MHz)10: δ 203.85, 
166.57, 141.29, 141.10, 141.07, 141.03, 125.22, 114.52, 94.81, 91.43, 91.41, 90.32, 
74.56, 72.45, 72.43, 55.70, 51.76, 36.22, 36.21, 36.19, 35.68, 35.65, 28.98, 28.95, 28.78, 
28.74, 28.71, 25.38, 24.68. MS (ESI): m/z 375.2 (100%) [M+Na]+. HRMS (ESI): m/z 
calcd for C20H32NaO5 375.2147 [M+Na]+; found, 375.2139. 
Methyl 3-(methoxymethoxy)-2-methylene-14-oxohexadeca-
9,10,15-trienoate (2.55): Allylic oxidation product:  
1H NMR (CDCl3, 500 MHz): δ 6.39-6.20 (m, 3H), 5.83-5.80 
(m, 2H), 5.17-5.07 (m, 2H, allene), 4.59-4.56 (d, J = 16.35 Hz, 
1H), 4.58-4.54 (d, J = 17 Hz, 1H), 4.48 (dd, J = 4.4, 7.55 Hz, 1H), 3.76 (s, 3H), 3.37 (s, 
3H), 2.71-2.68 (t, J = 7.25 Hz, 2H), 2.32-2.27 (m, 2H), 1.97-1.92 (m, 2H), 1.68-1.64 (m, 
1H), 1.58-1.53 (m, 1H), 1.45-1.30 (m, 6H). 13C NMR (CDCl3, 125 MHz)11: δ 203.70, 
                                                            
10  Multiple C-signals appearing in the spectra are due to diastereotopic carbon centers present in the 
inseparable mixture of diastereomers. 
11  Multiple C-signals appearing in the spectra are due to diastereotopic carbon centers present in the 
inseparable mixture of diastereomers. 
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199.97, 166.58, 141.34, 136.57, 127.85, 125.24, 94.88, 92.39, 89.83, 74.60, 55.74, 51.79, 
38.50, 35.71, 29.06, 28.90, 28.89, 28.82, 25.42, 22.80. MS (ESI): m/z 373.1 [M+Na]+. 
(14S)-14-hydroxy-3-(methoxymethoxy)-2-methylenehexadeca-9,10,15-trienoic acid 
(2.31): (14S)-methyl 14-hydroxy-3-(methoxymethoxy)-2-
methylenehexadeca-9,10,15-trienoate, 2.32 (120 mg, 0.35 
mmol) was dissolved in i-PrOH/H2O (1:1 v/v, 6 mL) which 
was subsequently treated with LiOH (30 mg, 1.25 mmol). 
The yellow color reaction mixture was allowed to stand at room temperature for 6h, after 
which was diluted with water. The aqueous layer was extracted with Et2O (2x) and the 
combined organic factions were washed with brine solution, dried over anhydrous 
Na2SO4 and filtered. The solvent was distilled under reduced pressure and the orange-
yellow residue was purified by flash column chromatography (gradient 30-50% EtOAc in 
hexanes) to furnish seco-acid, (14S)-14-hydroxy-3-(methoxymethoxy)-2-
methylenehexadeca-9,10,15-trienoic acid 2.31 (41 mg, 35%) as a faint yellow oily liquid. 
1H NMR (CDCl3, 500 MHz): δ 6.40 (s, 1H), 5.88-5.83 (m, 1H), 5.23 (d, J = 17 Hz, 1H), 
5.13-5.08 (m, 3H), 4.62-4.58 (d, J = 18.3 Hz, 1H), 4.60-4.57 (d, J = 18.95 Hz, 1H), 4.50-
4.48 (m, 1H), 4.22-4.17 (m, 1H), 3.39 (s, 3H), 2.08-2.02 (m, 2H), 2.00-1.96 (m, 2H), 
2.00-1.96 (m, 2H), 1.73-1.54 (m, 4H), 1.45-1.38 (m, 6H). 13C NMR (CDCl3, 125 
MHz)12: δ 203.92, 169.39, 140.89, 140.70, 140.62, 140.57, 127.07, 126.96, 115.09, 
115.06, 91.62, 91.60, 91.51, 91.48, 90.43, 90.40, 90.37, 90.33, 74.50, 72.95, 72.93, 72.87, 
55.82, 36.05, 36.93, 35.43, 35.36, 35.31, 28.79, 28.73, 28.67, 28.65, 28.57, 28.39, 28.34, 
                                                            
12  Multiple C-signals appearing in the spectra are due to diastereotopic carbon centers present in the 
inseparable mixture of diastereomers. 
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25.24, 25.22, 25.18, 24.76, 24.68, 34.64. MS (ESI): m/z 337.3 [M-H]; 361.1 [M+Na]+. 
HRMS (ESI): m/z calcd for C19H30NaO5 361.1991 [M+Na]+; found, 361.1992. 
 
(15R)-4-(methoxymethoxy)-3-methylene-15-vinyloxacyclopentadec-10,11-dien-2-one 
(2.33): Et3N (100 μL, 0.71 mmol) and 2,4,6-trichlorobenzoyl 
chloride (14 µL, 0.09 mmol) were added sequentially to the 
stirring solution of pre-dried seco-acid 2.31 (6 mg, 0.0177 
mmol) in DCM (30 mL, 0.61 mM dilution) at room temperature. 
The reaction was held stirring for 20h and then DMAP (22 mg, 0.177 mmol) added and 
the yellow solution was allowed to continue for 4h at room temperature. Then the 
reaction mixture was quenched by addition of H2O, washed with saturated NH4Cl and the 
aqueous phase was extracted with DCM (2x) and the combined extracts were washed 
with brine, dried over anhydrous Na2SO4, filtered and concentrated in vacuo. The yellow 
residue was purified by flash column chromatography (gradient 2-5% EtOAc in hexanes) 
to furnish macrolactone 2.33 (4 mg, 63%) as yellow liquid. 1H NMR (CDCl3, 500 MHz): 
δ 6.33-6.29 (m, 1H), 5.87-5.77 (m, 2H), 5.34-5.31 (m, 1H), 5.27-5.16 (m, 3H), 5.06-4.96 
(m, 2H, allene), 4.62-4.53 (m, 2H), 3.42-3.38 (m, 3H, CH3), 2.17-2.06 (m, 4H), 1.80-1.69 
(m, 4H), 1.61-1.49 (m, 2H), 1.43-1.37 (m, 4H). 13C NMR (CDCl3, 125 MHz)13: δ 206.86, 
205.66, 205.40, 204.86, 165.98, 165.70, 165.47, 142.46, 142.18, 142.14, 136.59, 136.22, 
136.11, 135.65, 125.22, 124.80, 124.67, 124.57, 116.58, 116.47, 116.28, 116.15, 95.05, 
94.89, 94.68, 94.65, 90.82, 90.62, 90.53, 90.26, 89.56, 89.39, 89.19, 88.99, 75.31, 74.67, 
                                                            
13  Multiple C-signals appearing in the spectra are due to diastereotopic carbon centers present in the 
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74.60, 74.57, 74.26, 73.70, 73.42, 72.76, 55.86, 55.78, 55.67, 38.18, 36.83, 36.07, 36.00, 
35.13, 35.11, 34.30, 33.88, 30.90, 29.69, 29.07, 28.80, 28.18, 27.97, 27.95, 27.82, 27.58, 
27.22, 27.20, 27.15, 27.09, 26.08, 25.71, 25.04, 24.92, 24.45, 24.38, 23.97. MS (ESI): 
m/z 320.9 (20%) [M]+; 343.1 (100%) [M+Na]+. HRMS (ESI): m/z calcd for C19H28NaO4 
343.1885 [M+Na]+; found 343.1880. 
 
(2S,4S,6S)-4-ethynyl-4-methyl-2-phenyl-6-vinyl-1,3-dioxane (3.9): 
Acetonide Protection: Triol 2.36 (4 g, 37.7 mmol), p-TSA (0.8 g, 4.2 
mmol) and CuSO4 (4g, 26 mmol) were taken in acetone (60 mL) and 
the mixture was held stirring at room temperature for 24h. After the 
reaction was completed, solids were filtered and the solvent was removed in vacuo and 
the residue was purified by flash column chromatography (gradient 20-30% 
EtOAc/hexanes) to give alcohol 3.5 as a faint yellow syrup. 
Swern Oxidation: At –78°C, DMSO (3.6 mL, 51.2 mmol) was added slowly to a 
solution of oxalyl chloride (2.6 mL, 30.75 mmol) in 60 mL of CH2Cl2 and the mixture 
was stirred for 30 min. A solution of alcohol 3.5 (3 g, 20.5 mmol) in CH2Cl2 (15 mL) was 
then added to above mixture and after additional stirring for 30 min at –78° C, 
triethylamine (10.0 mL, 71.5 mmol) was added and the reaction mixture was allowed to 
warm to room temperature. The mixture was diluted with CH2Cl2 and then quenched by 
addition of water. The organic layer was separated and the aqueous layer was extracted 
with CH2Cl2. The combined organic extracts were dried over Na2SO4 and concentrated to 
afford the crude aldehyde. 
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At –78° C, MeMgBr (10.3 ml, 30.75 mmol, 3.0 M solution in diethyl ether) was added to 
the above obtained aldehyde in dry Et2O (60 mL). After stirring for 3h, the reaction 
mixture was quenched with saturated NH4Cl and the aqueous layer was extracted with 
ether. The combined organic extracts were dried over Na2SO4 and concentrated to give 
the crude alcohol. 
The above crude alcohol in 10 mL of CH2Cl2 was added to the flask containing a PCC 
reactant-mixture (1:1:1 mixture by weight of PCC : 4Å MS : NaOAc, 25 g, 37.5 mmol) 
in 45 mL of CH2Cl2. The resulting dark solution was stirred for 3h at room temperature 
and then quenched with ether. The mixture was filtered and washed with ether. The 
combined organic filtrate was dried and concentrated. The residue was purified through 
flash column chromatography (gradient 5-10% EtOAc/hexanes) to afford the methyl 
ketone 3.6 (45%, 3 steps) as a colorless oil. 
To a solution of methyl ketone 3.6 (0.5 g, 3.16 mmol) in anhydrous ether (15 mL) was 
added ethynylmagnesium bromide (16 mL, 8 mmol, 0.5M solution in THF) at –78° C. 
The resulting reaction mixture was stirred for 15 min at this temperature and then 
warmed to room temperature and continued for a further 5h. After completion, the 
reaction was quenched with saturated NH4Cl and extracted with Et2O. The organic 
extracts were combined and washed with brine and dried over Na2SO4, filtered and 
concentrated. The resulting residue was purified by flash column chromatography 
(gradient 15-20% EtOAc/hexanes) to afford ethynylcarbinol 3.7 (410 mg, 70%, dr = 4:1) 
as a colorless oil. 
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To a solution of 3.7 (0.4 g, 2.17 mmol) in dry CH2Cl2 (10 mL) were added benzaldehyde 
dimethyl acetal (630 µL, 4.2 mmol) and camphorsulfonic acid (0.116 g, 0.5 mmol) at 
0°C. The resulting reaction mixture was allowed to warm to room temperature and stirred 
overnight. After completion of the reaction, solid NaHCO3 was added to quench the 
reaction and the solvent was removed in vacuo and the resulting residue was purified by 
flash column chromatography (gradient 10-20%, EtOAc/hexanes) to afford alcohol 3.8 
(0.4 g, 80%) as a pale yellow oil. 
To the stirring dry DCM (20 mL) was added oxalyl chloride (0.765 mL, 9 mmol) under 
argon and cooled to –78 °C then anhydrous DMSO (1.28 mL, 18.08 mmol) was added 
drop wise slowly. After 20 min, alcohol 3.8 (1.4 g, 6.03 mmol) was added in DCM (6 
mL) and 30 min later Et3N (10 mL, 72 mmol) was added at –78 °C, the resulting cloudy 
solution was stirred for 15 min, Then the reaction was quenched by slow addition of H2O 
(20 mL) and allowed to warm to room temperature. The aqueous layer was extracted with 
DCM (3x) and the combined organic fractions were washed with brine, dried over 
anhydrous Na2SO4, filtered and the solvent was removed under reduced pressure. The 
crude aldehyde was dried azeotropically with dry THF (2x) before being carried forward 
for the Nozaki-Takai olefenation. 
To a stirring solution of freshly activated Zn dust (3.94 g, 60.27 mmol) and PbCl2 (85 
mg, 0.3 mmol) in THF (20 mL) was added CH2I2 (2.45 mL, 30.13 mmol) slowly drop 
wise under argon for 15 min, where a vigorous exothermic reaction with effervescence 
started within 10 min from the point CH2I2 addition began. The reaction was cooled by 
arranging an external ice-bath as soon as effervescence began and the grayish solution 
was stirred at room temperature for 1h after effervescence ceased. Ti(i-OPr)4 (2.7 mL, 6 
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mmol) was added; and after 30 min at room temperature the greenish solution was added 
with freshly synthesized crude aldehyde in THF (6 mL). After stirring overnight, the 
reaction was diluted with ether (30 mL) and quenched by slow addition of 1M HCl (25 
mL). The aqueous layer was extracted with ether (2x) and the combined organic fractions 
were washed with brine solution, dried over anhydrous Na2SO4, filtered, concentrated 
and purified by flash column chromatography (gradient 2-5% Et2O in hexanes) to furnish 
(2S,4S,6S)-4-ethynyl-4-methyl-2-phenyl-6-vinyl-1,3-dioxane 3.9 (0.7 g, 50%, 2 steps) 
exclusively as a colorless liquid. 1H NMR (CDCl3, 500 MHz): δ 7.55-7.37 (m, 2H, Ph), 
7.35-7.31 (m, 3H, Ph), 6.06 (s, 1H), 5.96-5.89 (m, 1H), 5.39-5.35 (m, 1H), 5.21-5.18 (m, 
1H), 4.68-4.64 (m, 1H), 2.64 (s, 1H), 1.86 (dd, J = 2.55, 13.25 Hz), 1.74 (dd, J = 12.65, 
11.35 Hz), 1.62 (s, 3H). 13C NMR (CDCl3, 125 MHz): δ 138.37, 137.37, 128.75, 128.19, 
126.38, 115.84, 96.82,83.94, 74.96, 74.45, 70.19, 42.44, 29.78. MS (ESI): m/z 267.2 
[M+K]+. HRMS (ESI): m/z calcd for C15H16NaO2 251.1048; found 251.1039 [M+Na]+ . 
(3S,5S)-5-hydroxy-5-methylhept-1-en-6-yn-3-yl pivalate (3.13): A 
solution of benzylidene acetal 3.9 (120 mg, 0.53 mmol) in THF/H2O 
(1:1 v/v, 5 mL) was treated with conc. H2SO4 until pH = 1 and 
refluxed overnight at 65 °C. The solvent was removed in vacuo and the residue was 
purified by flash column chromatography (gradient 20-30% EtOAc/hexanes) to furnish 
diol 3.12 (52 mg, 70%). 
To a stirring solution of above diol 3.12 (53 mg, 0.38 mmol) and Et3N (235 μL, 1.9 
mmol) in dry DCM (5 mL) at 0 °C was added pivaloyl chloride (230 μL, 1.25 mmol). 
The reaction was allowed to continue overnight at room temperature then diluted with 
ether and quenched with H2O (15 mL). The aqueous layer was extracted with ether (3x) 
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and the combined organic fractions were washed with brine, dried over anhydrous 
Na2SO4 and filtered. The solvent was removed under reduced pressure and the resulting 
residue was purified by flash column chromatography (gradient 5-10% EtOAc/hexane) to 
give pivaloyl ester 3.13 (70 mg, 82%) as yellow liquid. 1H NMR (CDCl3, 500 MHz): δ 
5.85-5.78 (m, 1H), 5.65-5.61 (m, br, 1H), 5.25 (d, J = 15.05, 5.14 (d, J = 10.05, 1H), 2.47 
(s, 3H), 2.07 (dd, J = 9.45, 15.15 Hz, 1H), 1.97 (dd, J = 3.8, 15.15 Hz, 1H), 1.49 (s, 3H, 
Me), 1.20 (s, 1H, Piv). 13C NMR (CDCl3, 125 MHz): δ 177.39, 136.43, 116.20, 86.39, 
72.74, 72.26, 66.63, 46.97, 38.68, 30.09, 27.03. 
(4S)-4-(benzyloxy)hex-5-en-2-ol (3.15): To a stirring solution of (S)-
3-(benzyloxy)pent-4-enal 3.50 (541 mg, 2.84 mmol) in anhydrous 
ether (15 mL) at –78 °C was added MeMgBr (2 mL, 3M in Et2O, 6 mmol). After 2h of 
stirring the reaction mixture was quenched by slow addition of 1M HCl (15 mL). The 
aqueous phase was extracted with ether (2x10 mL) and the combined extracts were 
washed with brine, dried over anhydrous Na2SO4, filtered and concentrated in vacuo. The 
resulting residue was purified by flash column chromatography (gradient 10-15% 
EtOAc/hexane) to furnish (4S)-4-(benzyloxy)hex-5-en-2-ol 3.15 (2 diasteriomers, 440 
mg, 75%) as a faint yellow liquid. 1H NMR (CDCl3, 500 MHz): δ 7.36-7.27 (m, 5H), 
5.87-5.72 (m, 1H), 5.30-5.25 (m, 2H), 4.66-4.62 (m, 1H), 4.38-4.35 (m, 1H), 4.12-4.06 
(m, 1H), 1.82-1.67 (m, 2H), 1.82-1.15 (m, 1H). 13C NMR (CDCl3, 125 MHz): δ 138.13, 
138.06, 138.05, 128.43, 128.38, 127.81, 127.75, 127.67, 127.62, 117.57, 117.09, 81.09, 
77.98, 70.33, 70.11, 67.28, 64.52, 44.15, 43.70, 23.37, 23.33. ESI (m/z): calcd for 
C13H18NaO2 229.1204 [M+Na]+; found, 229.1. 
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(S)-4-(benzyloxy)hex-5-en-2-one (3.16): Alcohol 3.15 (440 mg, 2.13 
mmol) was dissolved in anhydrous DCM (10 mL) and PCC (690 mg, 
3.2 mmol) was added. After stirring overnight at room temperature, the 
resulting dark orange-black reaction mixture was filtered through a celite pad and the 
filtrate was concentrated. The thick darker reside was purified by flash column 
chromatography (gradient 10-15% EtOAc/hexane) to furnish (S)-4-(benzyloxy)hex-5-en-
2-one 3.16 (410 mg, 95%) as colorless syrup. 1H NMR (CDCl3, 500 MHz): δ 7.34-7.27 
(m, 5H, Ph), 5.81-5.74 (m, 1H), 5.33-5.25 (m, 2H), 4.57 (d, J = 11.35 Hz, 1H), 4.37 (d, J 
= 11.35 Hz, 1H), 2.85-2.80 (m, 1H), 2.53 (dd, J = 4.4, 15.78 Hz, 1H), 2.16 (s, 3H). 13C 
NMR (CDCl3, 125 MHz): δ 206.45, 138.15, 137.42, 128.30, 127.79, 127.56, 117.66, 
76.58, 70.58, 49.46, 31.06. MS (ESI): m/z 204.9 [M]; 227.0 [M+Na]+. HRMS (ESI): m/z 
calcd for C13H16NaO2 227.1048 [M+Na]+; found, 227.1045. 
 
(S)-5-(benzyloxy)hept-6-en-1-yn-3-one 3.21): Ethynylmagnesium bromide (3.6 mL, 0.5 
M in Et2O, 1.8 mmol) was added to the solution of aldehyde 2.50 (172 mg, 0.9 mmol) in 
anhydrous ether (6 mL) at –78 °C. After 3h of stirring, the reaction mixture was 
quenched by addition of 1M HCl (15 mL). The aqueous phase was extracted with ether 
(2x10 mL) and the combined extracts were washed with brine, dried over anhydrous 
Na2SO4, filtered, concentrated and purified by flash column chromatography (gradient 5-
10% EtOAc/hexane) to furnish proargylic alcohol 3.20 (2 diasteriomers, 135 mg, 70%). 
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To the stirring solution of above propargylic alcohol 3.20 (120 mg, 0.55 mmol) in dry 
DCM (6 mL) was added DMP (398 mg, 0.94 mmol) at room temperature and the reaction 
was allowed to stand for 2h at room temperature. Upon complete consumption of alcohol, 
the reaction contents were filtered through a celite pad and concentrated on a rotary 
evaporator. The crude residue was purified by flash column chromatography (gradient 1-
5% EtOAc in hexanes) to provide (S)-5-(benzyloxy)hept-6-en-1-yn-3-one 3.21 (52 mg, 
42%) as a colorless syrup. 1H NMR (CDCl3, 500 MHz): δ 7.35-7.27 (m, 5H), 5.82-5.75 
(m, 1H), 5.37-5.29 (m,2H), 4.59 (d, J = 11.95 Hz, 1H) 4.46-4.42 (m, 1H), 4.41 (d, J = 
11.35 Hz), 4.46-4.42 (m, 1H), 4.41 (d, J = 11.35 Hz, 1H), 3.21 (s, 1H), 2.97 (dd, J = 8.8, 
15.75 Hz), 2.72 (dd, J = 4.4, 15.75 Hz, 1H). 13C NMR (CDCl3, 125 MHz): δ 184.17, 
137.91, 136.73, 128.27, 127.85, 127.59, 118.30, 81.47, 78.88, 76.05, 70.61, 51.11. MS 
(ESI): m/z 237.0 [M+Na]+. HRMS (ESI): m/z calcd for C14H14NaO2 237.0891 [M+Na]+; 
found, 237.0881. 
 
(5S)-5-(benzyloxy)-3-methylhept-6-en-1-yn-3-ol (3.17/3.18): To a stirring solution of 
methyl ketone 3.21 (410 mg, 2.0 mmol) in anhydrous ether (20 mL) at –78 °C was added 
ethynylmagnesium bromide (20 mL, 0.5 M in THF, 10 mmol). Then the reaction mixture 
was allowed to warm slowly to room temperature over 2h and quenched by addition of 
1M HCl (15 mL). The aqueous phase was extracted with ether (2x) and the combined 
extracts were washed with brine, dried over anhydrous Na2SO4, filtered, concentrated and 
purified by flash column chromatography (gradient 10-15% EtOAc in hexanes) to furnish 
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diastereomeric ethynyl carbinols, (3S,5S)-5-(benzyloxy)-3-methylhept-6-en-1-yn-3-ol 
3.17 (311 mg) and (3R,5S)-5-(benzyloxy)-3-methylhept-6-en-1-yn-3-ol 3.18 (100 mg) (dr 
= 31:10 by 1H NMR integration, 410 mg, 90%) as a colorless syrup. 
1H NMR (CDCl3, 500 MHz): δ 7.36-7.26 (m, 5H, Ph), 5.83-5.75 (m, 
1H), 5.35-5.28 (m, 2H), 4.91 (s 1H, OH), 4.63 (d, J = 11.35 Hz, 1H), 
4.56-4.52 (m, 1H), 4.44 (d, J = 10.75 Hz, 1H), 2.43 (s, 1H), 1.97 (dd, J 
= 14.5, 11.5 Hz, 1H), 1.78 (dd, J = 14.5, 2.5 Hz, 1H), 1.48 (s, 3H). 13C NMR (CDCl3, 
125 MHz): δ 137.33, 137.30, 128.46, 128.24, 127.88, 117.91, 87.31, 80.32, 71.42, 40.75, 
67.45, 47.14, 30.40. MS (ESI): m/z 230.8 [M]+, 253.1 [M+Na]+. HRMS (ESI): m/z calcd 
for C15H18NaO2 253.1204 [M+Na]+; found, 253.1196. 
1H NMR (CDCl3, 500 MHz): δ 7.34-7.29 (m, 5H), 5.90-5.84 (m, 
1H), 5.34-5.29 (m, 2H), 4.62 (d, J = 12 Hz, 1H), 4.36 (d, J = 11.35 
Hz, 1H), 4.23-4.19 (m, 1H), 3.68 (s, 1H), 2.43 (s, 1H), 2.23 (dd, J = 
14.5, 8.8 Hz, 1H), 1.92 (dd, J = 14.5, 3.8 Hz, 1H) 1.51 (s, 3H). 13C NMR (CDCl3, 125 
MHz): δ 138.08, 137.59, 128.46, 128.05, 127.82, 118.21, 87.99, 78.28, 70.89, 70.20, 
66.96, 47.31, 29.60. 
(2S,4S,6S)-4-ethynyl-4-methyl-2-phenyl-6-vinyl-1,3-dioxane (3.9): To a stirring 
solution of benzyl ether 3.17 (7 mg, 0.03 mmol) in dry DCM, was 
added DDQ (18 mg, 0.09 mmol) and the reaction mixture was held at 
room temperature for 3h. The reaction solution was filtered through a 
celite pad, diluted with DCM (10 mL), washed with saturated NaHCO3. The aqueous 
layer was extracted with DCM (2x) and the combined organic fractions were washed 
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with brine (15 mL), dried over anhydrous Na2SO4. The solvent was removed under 
reduced pressure and the orange-red residue was purified by flash column 
chromatography (gradient 2-5% Et2O in hexane) to furnish benzylidene acetal 3.9. 
Analytical data was in good agreement with the compound that was previously 
synthesized by Nozaki-Takai olefination from 3.8. 
(2S,4R,6S)-4-ethynyl-4-methyl-2-phenyl-6-vinyl-1,3-dioxane 
(3.22): This compound as a colorless syrup was synthesized from 
3.18 by following the same procedure as for the synthesis of 3.9 
from 3.17. 1H NMR (CDCl3, 500 MHz): δ 7.54-7.37 (m, 2H), 7.36-
7.32 (m, 3H), 6.06 (s, 1H), 5.95-5.89 (m, 1H), 5.39-5.35 (m, 1H), 5.21-5.18 (mm, 1H), 
4.68-4.64 (m, 1H), 4.25-4.18 (m, 1H), 2.63 (s, 1H), 2.17 (s, 1H), 1.88-1.84 (m, 1H), 1.76-
1.62 (m, 1H), 1.54 (s, 1H). 
((3S,5S)-5-(benzyloxy)-3-methylhept-6-en-1-yn-3-yloxy)trimethylsilane (3.3): To a 
stirring solution of (3S,5S)-5-(benzyloxy)-3-methylhept-6-en-1-yn-
3-ol 3.17 (115 mg, 0.50 mmol) and Et3N (340 μL, 2.5 mmol) in dry 
DCM (5 mL) at 0 °C, was added TMSOTf (230 μL, 1.25 mmol) 
and after stirring overnight at room temperature, the reaction was quenched with H2O. 
The mixture was diluted with ether (25 mL) and the layers were separated. The aqueous 
layer was extracted with ether (3x) and the combined organic fractions were washed with 
brine, dried over anhydrous Na2SO4, solids were filtered and the solvent was removed 
under reduced pressure. The yellow residue was purified by flash column 
chromatography (gradient 0-5% EtOAc/hexane) to give TMS ether 3.3 (145 mg, 96%) 
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exclusively as a yellow oil. 1H NMR (CDCl3, 500 MHz): δ 7.37-7.31 (m, 4H, Ph), 7.28-
7.25 (m, 1H, Ph), 5.87-5.79 (m, 2H), 4.57-4.55 (d, J = 11.35 Hz, 1H), 4.40-4.38 (d, J = 
11.35 Hz), 4.13-4.08 (m, 1H), 2.44 (s, 1H), 2.13 (dd, J = 6.3, 14.5 Hz), 1.95 (dd, J = 5.05, 
14.5 Hz), 1.54 (s, 3H), 0.19 (s, 9H). 13C NMR (CDCl3, 125 MHz): δ 139.21, 138.71, 
128.24, 127.31, 116.33, 88.48, 77.28, 72.31, 70.0, 67.78, 50.18, 31.20, 1.88. MS (ESI): 
m/z 230.7 [(M-TMS)+H]+; 253.0 [(M-TMS)+H+Na]+. HRMS (ESI): m/z calcd for 
C15H18NaO2 253.1204 [(M-TMS)+H+Na]+; found, 253.1188. 
((3R,5S)-5-(benzyloxy)-3-methylhept-6-en-1-yn-3-yloxy)trimethylsilane (3.19):  
The same procedure was followed as described for synthesis of 
3.3. TMS ether 3.19 was obtained as a yellow oil from 3.18. 
1H NMR (CDCl3, 500 MHz): δ 7.35-7.30 (m 4H), 7.25-7.23 (m, 1H),5.83-5.76 (m, 1H), 
5.28-5.18 (m, 2H), 4.54 (d, J = 11.35 Hz, 1H), 4.37 (d, J = 12 Hz, 1H), 2.43 (s, 1H), 2.07-
2.03 (m, 1H), 1.91-1.87 (m, 1H), 1.53 (s, 3H, Me), 0.17 (s, 9H,TMS). 13C NMR (CDCl3, 
125 MHz): δ 139.17, 138.65, 128.21, 127.85, 127.31, 116.08, 87.75, 78.00, 72.76, 70.28, 
68.51, 50.52, 30.07, 1.94. MS (ESI): m/z 230.8 [M-TMS+H], 325.1 [M+Na]+. HRMS 
(ESI): m/z calcd for C18H26NaO2Si 325.1600 [M+Na]+; found, 325.1599. 
1,2:5,6-Di-O-isopropylidene-alpha-D-glucofuranose (3.24): 
Glucose was acetylated following a procedure described in 
Preparative carbohydrate chemistry.14 To a stirring solution of 
α-D-glucose (50 g) in acetone at ice bath temperature, conc. 
                                                            
14 Hanessian, S.; NetLibrary Inc., Preparative carbohydrate chemistry. Marcel Dekker: New York, 1996; p 
18, Chapter 1. 
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H2SO4 (96%, 40 mL) was added in 5 mL portions at 15 min intervals. After addition was 
completed, contents were allowed to gradually warm-up to ambient temperature over 5h 
with constant stirring. The solution was cooled again (ice bath) and 50% NaOH (61 g in 
75 mL H2O) was slowly added with vigorous stirring to near neutrality (pH = 7). A pinch 
of NaHCO3 was added to maintain near neutrality. After standing overnight, solids were 
removed by filtration and the solution was concentrated on a rotary-evaporator to thick 
syrup. This mixture was dissolved in DCM (100 mL) and washed with H2O (100 mL). 
The organic layer was concentrated and the crude product was recrystallized from 
hexanes to give white, shiny, needle-like crystals of diacetal glucose 3.24 (28 g, 40%). 1H 
NMR (CDCl3, 500 MHz): δ 5.94 (d, J = 3.75 Hz, 1H), 4.53 (d, J = 3.15 Hz, 1H), 4.34-
4.10 (m, 2H), 4.18-4.15 (m, 1H), 4.06 (dd, J = 2.5, 7.55, 1H), 3.99-3.96 (m, 1H), 2.58-
2.57 (m, 1H, OH), 1.49 (s, 3H), 1.44 (s, 3H), 1.36 (s, 3H). 13C NMR (CDCl3, 125 MHz): 
δ 111.81, 109.64, 105.28, 85.07, 81.12, 75.22, 73.49, 67.66, 26.83, 26.74, 26.16, 25.12. 
MS (ESI): m/z 259.0 [M-H]-, 282.9 [M+Na]+. HRMS (ESI): m/z calcd for C12H20NaO6 
283.1158 [M+Na]+; found 283.1161. 
Diacetonide ester 3.28: 1,2:5,6-di-O-isopropylidene-α-D-
glucofuranose 3.24 (14 g, 53.8 mmol), acetic anhydride (20 
mL, 215 mmol) and pyridine (8.6 mL, 107 mmol) were 
dissolved in dry DCM (150 mL) and cooled to ice-bath 
temperature with stirring. Solid CrO3 (21 g, 215 mmol) was 
added in 4 portions with 15 min intervals and let the reaction warm gradually to room 
temperature over 3h. When starting material was found to be completely consumed (by 
TLC), the reaction mixture was filtered through a celite bed, solids were washed with 
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DCM and the filtrate was washed with saturated aq.NaHCO3 solution (2x), brine, dried 
over anhydrous Na2SO4 and filtered. The ketone obtained was directly carried forward 
for the subsequent Wittig homologation with stabilized ylide. 
To the above obtained ketone 3.25 in DCM was added Wittig salt, (2-methoxy-2-
oxoethyl)(triphenyl)phosphonium bromide (31 g, 73 mmol) and Et3N (22 mL, 161 mmol) 
and stirred overnight at room temperature. The solution was concentrated to 50 mL and 
Ph3P = O was precipitated by adding Et2O (100 mL). A solid clump was filtered-off 
through a celite bed. The filtrate was concentrated and purified by flash column 
chromatography (gradient 10-20% EtOAc/hexane) to furnish an E/Z mixture of 
diastereomers of 3.27. 
Pd/C (1.84 g, 20% w/w) was added carefully to the E/Z diastereomeric mixture 3.27 (9.52 
g, 30.3 mmol) in MeOH (100 mL) and subsequently shaken by parr hydrogenator under a 
H2 atmosphere (50 psi) for 5h at room temperature after which all the starting material 
was consumed (by TLC analysis) with 5 psi consumption of H2. The reaction mixture 
was filtered through a celite bed and concentrated under reduced pressure. The colored 
residue was purified by flash column chromatography (30% EtOAc/hexane) to furnish 
diacetonide ester 3.28 (9.4 g, quantitative) as a single diastereomer. 1H NMR (CDCl3, 
500 MHz): δ 5.74 (d, J = 3.75 Hz, 1H), 4.77 (t, J = 4.4 Hz, 1H), 4.06 (dd, J = 5.7, 8.2 Hz, 
1H), 3.95-3.88 (m, 2H), 3.67 (s, 3H), 3.65-3.63 (m, 1H), 2.79 (dd, J = 4.45, 17.65 Hz, 
1H), 2.63 (dd, J = 10.1, 17.65, 1H), 2.32-2.27 (m, 1H), 1.46 (s, 3H), 1.37 (s, 3H), 1.29 (s, 
3H), 1.27 (s, 3H). 13C NMR (CDCl3, 125 MHz): δ 172.65, 111.76, 109.56, 104.96, 81.38, 
80.85, 67.82, 51.54, 44.52, 29.67, 26.65, 26.52, 26.27, 25.15. MS (ESI): m/z 339.1 
[M+Na]+. HRMS (ESI): m/z calcd for C15H24NaO7 339.1420 [M+Na]+; found 339.1416. 





yl)ethanol (3.29): To the ice cold stirring solution of ester 
3.28 (9.3 g, 30 mmol) in THF (150 mL) was added LiAlH4 
(1.34 g, 35 mmol) portion wise for 30 min. The reaction mixture was allowed to warm to 
room temperature over 1h after which TLC analysis indicated all the ester was consumed. 
The reaction mixture was cooled to 0 °C and quenched by drop wise addition of saturated 
aqueous Na2SO4 solution (30 mL) with stirring. White solid cake thus formed was 
refluxed with EtOAc (2x) for 10 min and then filtered. The collective filtrate fractions 
were washed with brine (40 mL), dried over anhydrous Na2SO4, filtered and concentrated 
under reduced pressure. Flash column chromatography (gradient 30-50% EtOAc/hexane) 
of the resulting residue yielded the title compound 3.29 as colorless liquid (8.3 g, 98%). 
1H NMR (CDCl3, 500 MHz): δ 5.4 (d, J = 3.75 Hz, 1H), 4.68 (t, J = 4.45 Hz, 1H), 4.07 
(dd, J = 6.3, 8.2 Hz, 1H), 3.98 (dd, J = 6.3, 13.25, 1H), 3.91 (dd, J = 5.65, 8.8 Hz, 1H), 
3.76 (d, J = 6.9, 9.45 Hz, 1H), 3.76-3.71 (m, 2H), 2.05-1.8 (m, 4H), 1.48 (s, 3H), 1.39 (s, 
3H), 1.32 (s, 3H), 1.30 (s, 3H). 13C NMR (CDCl3, 125 MHz): δ 111.71, 109.57, 104.98, 
81.95, 81.75, 77.87, 67.55, 61.21, 45.59, 28.23, 26.76, 26.46, 26.37, 25.23. MS (ESI): 








dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)-2-methylacrylate (3.33): To a stirring 
solution of alcohol 3.29 (4 g, 13.88 mmol) and PMBBr in 
dry THF (50 mL), was added NaH (60% in mineral oil, 0.61 
g, 15.26 mmol) at 0 °C. The reaction mixture was allowed 
to warm to room temperature and stirred for 4h. After 
complete consumption of starting alcohol (by TLC), the 
reaction was diluted with ether and quenched with addition of H2O, layers were separated 
and the aqueous layer was extracted with ether (2x). The combined organic fractions 
were washed with brine, dried over anhydrous Na2SO4, solids were filtered and the 
solvent was removed under reduced pressure. The crude residue was purified by flash 
column chromatography (gradient 20-30% EtOAc/hexanes) to give 3.23 (3.96 g, 70%) as 
a colorless syrup. 
The diacetal 3.23 (3.2 g, 7.84 mmol) was dissolved in 60% AcOH/H2O (80 mL) and the 
reaction mixture was stirred at room temperature for 12h. Upon completion of mono 
acetal cleavage (by TLC analysis), toluene was added and the solvent was distilled under 
reduced pressure. The resulting syrup was purified by flash column chromatography 
(gradient 30-50% EtOAc/hexane) to provide diol 3.30 as a colorless syrup in 75% yield. 
Ylide (3.32) Formation: Methyl 2-bromopropanoate (3.26 mL, 29.3 mmol) and PPh3 (10 
g, 38.12 mmol) were dissolved in EtOAc (50 mL) and stirred at reflux (80 °C) overnight. 
The reaction mixture was cooled to room temperature and filtered through a fritted funnel 
to obtain (1-(methoxycarbonyl)ethyl)triphenylphosphonium bromide (7 g, 56%) from 
which 4.26 g was taken into H2O (10 mL) and NaOH (0.86 g, 21.48 mmol) in H2O (20 
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mL) added slowly, where the contents instantaneously solidified. DCM (20 mL) was 
added to dissolve the sticky solids and the yellow solution stirred at room temperature. 
After 30 min, water was added to the reaction mixture and the layers were separated. The 
aqueous layer was extracted with DCM (2x) and the combined organic extracts 
containing ylide 3.32 were dried over anhydrous Na2SO4. 
Oxidative Vicinal Diol Cleavage and Wittig: The vicinal diol 3.30 (1.94 g, 5.26 mmol) 
was dissolved in MeOH (40 mL) and NaIO4 (1.46 g, 6.84 mmol) in H2O (10 mL) was 
added slowly. The white precipitate formation began with an exothermic reaction. After 
stirring for 15 min, the reaction solution was filtered through a fritted sintered funnel and 
the solid was washed with MeOH followed by DCM. The filtrate was diluted with DCM 
and washed with brine. The aqueous layer was extracted with DCM (3x) and the 
combined organic fraction was dried over anhydrous Na2SO4. The solvent was reduced 
approximately to half-volume on a rotary evaporator and treated with ylide 3.32 in DCM 
(20 mL). The reaction mixture was stirred overnight at room temperature and the solvent 
was removed under reduced pressure and the residue was purified by flash column 
chromatography (gradient 10-20% EtOAc/hexane) to give the conjugated ester 3.33 (1.5 
g, 72%) as an off-white syrup. 1H NMR (CDCl3, 500 MHz): δ 7.24 (d, J = 8.2 Hz, 2H), 
6.88-6.86 (m, 2H), 6.58 (dd, J = 1.3, 8.9 Hz, 1H), 5.82 (d, J = 3.8 Hz, 1H), 4.60-4.57 (m, 
2H),4.41 (dd, J = 11.3 Hz, 15.1 Hz, 2H), 3.80 (s, 3H, OMe), 3.73 (s, 3H, OMe), 3.51 (t, J 
= 6.9 Hz, 2H),2.02-1.96 (m, 1H), 1.90 (d, J = 1.25 Hz, 3H, Me), 1.88-1.82 (m, 1H), 1.59-
1.53 (m, 1H), 1.53 (s, 3H, Me), 1.27 (s, 3H, Me). 13C NMR (CDCl3, 125 MHz): δ 
167.88, 159.20, 138.12, 131.36, 130.39, 129.26, 113.75, 111.61, 105.37, 80.85, 77.43, 
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72.54, 67.79, 55.26, 51.94, 47.28, 26.68, 26.23, 24.46, 13.40. MS (ESI): m/z 429.1 
[M+Na]+. HRMS (ESI): m/z calcd for C22H30NaO7 429.1889 [M+Na]+; found, 429.1901. 
(E)-3-((3aR,5R,6R,6aR)-6-(2-(4-methoxybenzyloxy)ethyl)-
2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)-2-
methylprop-2-en-1-ol (3.34): To a stirring solution of 
conjugated ester 3.33 (500 mg, 1.23 mmol) in dry THF (8 mL) 
at –78 °C, was added DIBALH (3.1 mL, 1M in cyclohexane, 
3.1 mmol) over 10 min. The reaction contents were allowed to warm to room temperature 
in a dry-ice bath over 4h. After complete consumption of ester, the reaction was 
quenched by addition of saturated Rochelle salt (potassium sodium tartrate) dropwise (15 
mL) and stirred vigorously for 30 min at room temperature during which the initially 
formed gray-cloud in the organic phases was disappeared slowly and appeared in the 
water layer. The solution was diluted with ether and the layers were separated. The 
aqueous layer was extracted with ether (3x) and the combined organic fractions were 
washed with brine, dried over anhydrous Na2SO4, filtered and concentrated. The resulting 
syrup was purified by flash column chromatography (gradient 20-30% EtOAc/hexane) to 
provide allylic alcohol 3.34 (426 mg, 92%) as a colorless syrup along with a trace 
conjugate reduction product. 1H NMR (CDCl3, 500 MHz): δ 7.24 (d, J = 8.8 Hz, 2H), 
6.87 (d, J = 8.2 Hz, 2H), 5.78 (d, J = 3.75 Hz, 1H), 5.36 (d, J = 8.8 Hz, 1H), 4.57-4.51 
(m, 2H), 4.42 (s, 2H), 3.99 (s, 2H), 3.79 (s, 3H), 3.54-3.50 (m, 2H), 1.87-1.80 (m, 3H), 
1.71 (s, 3H), 1.59-1.55 (m, 1H), 1.52 (s, 3H), 1.31 (s, 3H). 13C NMR (CDCl3, 125 MHz): 
δ 159.14, 141.34, 130.46, 129.22, 122.38, 113.72, 111.24, 104.90, 80.90, 77.38, 72.46, 
67.99, 67.71, 55.23, 47.18, 26.65, 26.23, 24.48, 14.30. MS (ESI): m/z 401.1 [M+Na]+.  





methylacrylaldehyde (3.4): To the stirring solution of 
allylic alcohol 3.34 (220 mg, 0.58 mmol) in dry DCM (10 
mL) was added DMP (370 mg, 0.87 mmol) at room 
temperature and the reaction was stirred for 2h at room temperature. Upon complete 
consumption of allylic alcohol, the contents were filtered through a celite bed and 
concentrated on a rotary evaporator. The crude residue was purified by flash column 
chromatography (gradient 20-30% EtOAc/hexanes) to provide conjugated aldehyde 3.4 
(190 mg, 90%) as a colorless syrup. 1H NMR (CDCl3, 500 MHz): δ 9.43 (s, 1H), 7.23 
(m, 2H) 6.89-86 (m, 2H) 6.29 (dd, J = 1.3, 8.85 Hz, 1H), 5.86 (d, J = 3.15 Hz, 1H), 4.74 
(dd, J = 8.8, 18.9 Hz, 1H), 4.62 (t, J = 4.4 Hz, 1H), 4.41 (s, 2H), 3.80 (s, 3H), 3.53-3.51 
(m, 2H), 2.10-2.04 (m, 1H), 1.92-1.85 (m, 1H), 1.79 (d, J = 1.25 Hz, 1H), 1.58-1.51 (m, 
1H), 1.54 (s, 3H), 1.33 (s, 3H). 13C NMR (CDCl3, 125 MHz): δ 194.63, 159.20, 148.89, 
141.09, 130.24, 129.21, 113.74, 111.79, 105.44, 80.77, 77.25, 72.54, 67.47, 55.20, 47.37, 
26.62, 26.16, 24.51, 10.07. 
 
Alkyne Addition by BuLi: To a solution of alkyne 3.3 (140 mg, 0.46 mmol) in THF (2 
mL) at –78 °C, n-BuLi (0.9 mL, 0.5M in hexane, 0.46 mmol) was added. The reaction 
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was allowed to continue for 2h at –78 °C then, aldehyde 3.4 (191 mg, 0.509 mmol) in 
THF (2 mL) was added. After 2h at –78 °C, the reaction was quenched by slow addition 
of saturated NH4Cl and extracted with ether (3x). The combined organic fractions were 
washed with brine, dried over anhydrous Na2SO4, filtered and concentrated. The crude 
residue was purified by flash column chromatography (gradient 15-50% EtOAc/hexane) 
to afford coupling product, alkynol 3.35 (65 mg) and [2,3]-Wittig rearrangement product 





(3.35): Alkyne addition product. 
1H NMR (CDCl3, 500 MHz): δ 7.35-7.31 (m, 4H), 7.25-7.22 (m, 3H), 6.86 (d, J = 6.86 
Hz, 2H), 5.76-5.73 (m, 1H), 5.66-5.53 (m, 3H), 4.76 (s, 1H), 4.71-4.67 (m, 1H), 4.55-
4.49 (m, 2H), 4.43-4.38 (m, 2H), 3.79 (m, 3H, OMe), 3.52 (m, 2H), 2.6 (s, br, 1H, OH), 
2.53-2.48 (m, 1H), 2.43-2.34 (m, 2H), 2.32-2.27 (m, 1H), 1.89-1.81 (m, 2H), 1.82 (s, 3H, 
Me), 1.53 (s, 3H, Me), 1.44-1.43 (m, 1H), 1.43 (s, 3H, Me), 0.19-0.17 (m, 9H, TMS). 13C 
NMR (CDCl3, 125 MHz)15: δ 159.11, 143.88, 143.95, 140.29, 140.17, 130.39, 129.94, 
129.90, 129.78, 129.22, 128.26, 127.24, 125.70, 124.64, 124.37, 113.70, 111.28, 104.94, 
89.61, 83.92, 83.77, 80.81, 80.76, 77.44, 77.37, 73.20, 73.06, 72.41, 69.57, 67.95, 67.93, 
                                                            
15 Multiple C-signals appearing in the spectra are due to diastereotopic carbon centers present in the 
inseparable mixture of diastereomers. 
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67.11, 66.94, 55.21, 48.41, 48.30, 47.27, 47.23, 42.78, 30.73, 29.62, 26.63, 26.21, 24.35, 
13.53, 13.42, 1.91. MS (ESI): m/z 701.2 [M+Na]+. 
(1R,6R,E)-6-methyl-1-phenyl-6-(trimethylsilyloxy)oct-3-
en-7-yn-1-ol (3.44): [2,3] Wittig rearrangement product 
1H NMR (CDCl3, 500 MHz): δ 7.39-7.28 (m, 5H, Ph), 5.74-
5.68 (m, 1H), 4.74-4.72 (m, 1H), 2.59-2.54 (m, 1H), 2.39-
2.35 (m, 1H), 2.31 (s, br, 1H, OH), 1.47 (s, 3H), 0.23 (s, 9H). 13C NMR (CDCl3, 125 
MHz): δ 143.84, 129.95, 129.33, 128.26, 127.28, 125.75, 87.78, 73.05, 72.88, 69.00, 
48.23, 42.81, 30.56, 1.87. MS (ESI): m/z 325.1 [M+Na]+. HRMS (ESI): m/z calcd for 




dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)-2-methylpent-1-en-4-yn-3-ol (4.6):  
To a solution of alkyne 4.5 (469 mg, 1.35 mmol) in THF 
(6 mL) at –78 °C, n-BuLi (1.35 mL, 1M in hexane, 1.35 
mmol) was added. After stirring 30min at –78 °C, 
aldehyde 3.4 (340 mg, 0.903 mmol) in THF (6 mL) was 
added. After 2h at –78 °C, the reaction was quenched by 
slow addition of saturated NH4Cl and extracted with ether (3x). The combined organic 
fractions were washed with brine, dried over anhydrous Na2SO4, filtered and 
concentrated. The crude residue was purified by flash column chromatography (gradient 
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15-25% EtOAc/hexane) to afford coupling product, alkynol 4.6 (386 mg, 75%) as a pale 
yellow syrup with different diastereomeric ratio in different column fractions. 1H NMR 
(CDCl3, 500 MHz): δ 7.53-7.52 (m, 2H, Ph), 7.38-7.33 (m, 3H, Ph), 7.25-7.23 (m, 2H, 
PMB), 6.88-6.85 (m, 2H, PMB), 5.96 (s, 1H), 5.78 (d, J = 3.8 Hz, 1H), 5.61-5.55 (m, 
1H), 4.84 (d, J = 5.65 Hz, 1H, epimeric), 4.57-4.4.51 (m, 2H), 4.43-4.38 (m, 2H, 
CH2PMP), 4.18-4.14 (m, 1H), 3.81-3.78 (m, 4H), 3.63 (dd, J = 5.7, 10.7 Hz, 1H), 3.52-
3.49 (m, 2H), 2.09 (s, br, 1H, OH), 1.90-1.82 (m, 5H), 1.7-1.64 (m, 2H), 1.60 (s, 3H, 
Me), 1.59-1.56 (m, 1H), 1.54 (s, 3H, Me), 1.32 (s, 3H, Me), 0.90 (s, 9H, TBS), 0.07-0.06 
(d, 6H, TBS). 13C NMR (CDCl3, 125 MHz)16: δ 159.17, 140.03, 138.39, 130.44, 129.24, 
128.64, 128.10, 126.35, 125.42, 124.96, 113.76, 111.39, 105.01, 96.89, 96.84, 86.45, 
85.47, 77.42, 77.36, 74.65, 72.49, 70.45, 67.91, 67.46, 67.13, 65.91, 55.25, 47.27, 39.47, 
29.94, 26.69, 26.26, 25.89, 24.52, 18.35, 13.58, 13.24, -5.24, -5.30. 
(6S,E)-7-((S)-2,2-dimethyl-1,3-dioxolan-4-yl)-1-((3aR,5R,6R,6aR)-6-(2-(4-
methoxybenzyloxy)ethyl)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)-2,6-
dimethyl-6-(triethylsilyloxy)hept-1-en-4-yn-3-ol (4.16): To a solution of alkyne 4.15 
(394 mg, 1.53 mmol) in THF (10 mL) at –78 °C, n-BuLi 
(1.35 mL, 0.9M in hexane, 1.53 mmol) was added. Dry-ice 
bath was removed, stirred for 30min, and again cooled to –
78 °C, then aldehyde 3.4 (480 mg, 1.28 mmol) in THF (10 
mL) was added. After 3h of stirring in a dry-ice bath, the reaction was quenched by slow 
addition of saturated NH4Cl and extracted with ether (3x). The combined organic 
                                                            
16 Multiple C-signals appearing in the spectra are due to diastereotopic carbon centers present in the 
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fractions were washed with brine, dried over anhydrous Na2SO4, filtered and 
concentrated. The crude residue was purified by flash column chromatography (gradient 
20-30% EtOAc/hexane) to afford coupling product, alkynol 4.16 (610 mg, 76%) as a pale 
yellow viscous syrup. 1H NMR (CDCl3, 500 MHz): δ 7.23 (d, J = 8.2 Hz, 2H, PMB), 
6.86 (d, J = 8.2 Hz, 2H, PMB), 5.77 (d, J = 3.8 Hz, 1H), 5.50 (d, J = 8.85 Hz, 1H), 4.74-
4.73 (d, 1H, epimeric), 4.56-4.55 (m, 1H), 4.52-4.48 (t, 1H), 4.44-4.38 (m, 2H, 
CH2PMP), 4.31-4.26 (m, 1H), 4.11-4.08 (m, 1H), 3.78 (s, 3H, OMe), 3.59-3.55 (m, 1H), 
3.53-3.51 (m, 2H), 2.12-2.07 (m, 1H), 1.93-1.83 (m, 3H), 1.81-1.80 (d, 3H, Me), 1.59-
1.54 (m, 1H), 1.52 (s, 3H, Me), 1.48 (s, 3H, Me), 1.36 (s, 3H, Me), 1.33 (s, 3H, Me), 1.30 
(s, 3H, Me), 0.95-0.92 (t, 9H, TES), 0.67-0.62 (m, 9H, TES). 13C NMR (CDCl3, 125 
MHz)17: δ 159.13, 140.11, 139.84, 130.44, 129.20, 129.18, 124.88, 113.70, 111.29, 
107.77, 104.97, 90.15, 90.12, 82.35, 82.33, 80.85, 80.82, 77.36, 77.31, 72.59, 72.44, 
72.42, 70.28, 67.96, 67.93, 67.22, 67.10, 55.19, 48.59, 47.27, 47.24, 30.83, 30.78, 26.77, 
26.63, 26.21, 25.78, 24.39, 13.26, 13.24, 6.92, 5.98. 
(S,E)-7-((S)-2,2-dimethyl-1,3-dioxolan-4-yl)-1-((3aR,5R,6R,6aR)-6-(2-(4-
methoxybenzyloxy)ethyl)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)-2,6-
dimethyl-6-(triethylsilyloxy)hept-1-en-4-yn-3-one (4.19): To a stirring solution of 
propargylic alcohol 4.16 (85 mg, 0.0126 mmol) in DCM (6 
mL) was added solid MnO2 portion wise (3 x 38 mg, 0.126 
mmol) with 3h interval. After stirring overnight at room 
temperature, the reaction mixture was filtered through a pad 
                                                            
17 Multiple C-signals appearing in the spectra are due to diastereotopic carbon centers present in the 
inseparable mixture of diastereomers. 
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of celite and the solvent was removed in vacuo. The crude residue was purified by flash 
column chromatography (gradient 10-20% EtOAc/hexanes) to give alkynone 4.19 (77 
mg, quantitative) as a colorless liquid. 1H NMR (CDCl3, 500 MHz): δ 7.23-7.22 (d, 2H, 
PMB), 6.86-6.85 (d, 2H, PMB), 5.84 (d, J = 3.75 Hz, 1H), 4.68 (dd, J = 8.8, 10.0 Hz, 
1H), 4.62-4.60 (t, 1H), 4.44-4.4.42 (dd, 2H, CH2PMP), 4.35-4.30 (m, 1H), 3.78 (s, 3H, 
OMe), , 3.59-3.57 (t, 1H), 3.53-3.50 (t, 2H), 2.15 (dd, J = 4.4, 13.85 Hz, 1H), 2.04-1.99 
(m, 1H), 1.99 (s, 3H, Me), 1.58-1.53 (m, 7H), 1.37 (s, 3H, Me), 1.34 (s, 3H, Me), 1.32 (s, 
3H, Me), 0.96-0.93 (t, 9H, TES), 0.69-0.64 (m, 6H, TES).13C NMR (CDCl3, 125 MHz): 
δ 179.23, 159.21, 144.95, 140.01, 130.28, 129.23, 113.73, 111.79, 108.07, 105.46, 96.30, 
80.77, 80.58, 72.57, 72.22, 70.17, 67.64, 67.33, 55.20, 47.99, 47.64, 30.10, 26.80, 26.66, 
26.21, 25.77, 24.52, 11.58, 6.89, 5.92.  
 
Common procedure for CBS/BH3 Reduction: To a stirring solution of alkynol 2.204 (1 
eq) in dry THF (8 mL) at 0 °C was added CBS solution (1M in toluene 2 eq) and 
BH3·SMe2 (1M in THF, 3 eq). The reaction was allowed to warm gradually to room 
temperature through 2h, and then quenched by slow addition methanol followed by water 
at 0 °C. After 15min of vigorous stirring the aqueous phase was extracted with ether (3x) 
and the combined extracts were washed with brine, dried over anhydrous Na2SO4, 
filtered, concentrated and purified by flash column chromatography (gradient 15-25% 
EtOAc/hexane) to furnish alkynol as a transparent oil. 
 






1H NMR (CDCl3, 500 MHz): δ 7.25-7.24 (d, 2H, PMB), 
6.87-6.86 (d, 2H, PMB), 5.78 (d, J = 3.15 Hz, 1H), 5.50 (d, 
J = 8.85 Hz, 1H), 4.74 (s, 1H), 4.57-4.56 (m, 1H), 4.52-4.48 
(m, 1H), 4.45-4.40 (m, 2H, CH2PMP), 4.32-4.26 (m, 1H), 
4.10 (dd, J = 5.7, 8.2 Hz, 1H), 3.79 (s, 3H, OMe), 3.59-3.53 
(m, 3H), 2.10 (dd, J = 4.4, 13.85 Hz, 1H), 2.02 (s, br, 1H, OH), 1.93-1.84 (m, 3H), 1.81 
(s, 3H, Me), 1.60-1.57 (m, 1H), 1.52 (s, 3H, Me), 1.49 (s, 3H, Me), 1.37 (s, 3H, Me), 1.34 
(s, 3H, Me), 1.31 (s, 3H, Me), 0.96-0.93 (t, 9H, TES), 0.69-0.61 (m, 6H, TES). 13C NMR 
(CDCl3, 125 MHz): δ 159.19, 139.86, 130.53, 129.23, 125.02, 113.76, 107.84, 105.03, 
90.29, 82.33, 80.92, 77.35, 72.63, 72.47, 70.34, 67.98, 67.35, 67.17, 55.25, 48.66, 47.30, 
30.82, 26.82, 26.68, 26.26, 25.83, 24.49, 13.27, 6.95, 6.04. MS (ESI): m/z 697.4 





1H NMR (CDCl3, 500 MHz): δ 7.25-7.24 (d, 2H, PMB), 
6.87-6.86 (d, 2H, PMB), 5.79 (d, J = 3.15 Hz, 1H), 5.51 (d, J 
= 8.8 Hz, 1H), 4.57 (t, J = 3.8 Hz, 1H), 4.51 (t, J = 9.45 Hz, 
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1H), 4.44-4.40 (m, 2H, CH2PMP), 4.32-4.27 (m, 1H), 4.12-4.09 (m, 1H), 3.80 (s, 3H), 
3.60-3.57 (m, 1H), 3.54-3.51 (m, 1H), 2.11 (dd, J = 4.4, 13.25 Hz, 1H), 1.94-1.1.83 (m, 
4H), 1.81 (s, 3H, Me), 1.58-1.54 (m, 1H), 1.53 (s, 3H, Me), 1.49 (s, 3H, Me), 1.37 (s, 3H, 
Me), 1.34 (s, 3H, Me), 1.31 (s, 3H, Me), 0.96-0.93 (t, 9H, TES), 0.69-0.61 (m, 6H, TES). 
13C NMR (CDCl3, 125 MHz): δ 159.17, 140.09, 130.48, 129.23, 124.93, 113.74, 111.36, 
107.82, 105.02, 90.29, 82.33, 80.86, 77.39, 72.63, 72.49, 70.32, 68.00, 67.28, 67.14, 
55.25, 48.64, 47.31, 30.86, 26.82, 26.67, 26.26, 25.83, 24.44, 13.32, 6.97, 6.02. 
(2S,5S,E)-1-((S)-2,2-dimethyl-1,3-dioxolan-4-yl)-5-methoxy-7-((3aR,5R,6R,6aR)-6-
(2-(4-methoxybenzyloxy)ethyl)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)-
2,6-dimethylhept-6-en-3-yn-2-ol (4.17a) ): NaH (60% in mineral oil, 3 mg, 0.07 mmol) 
was added to a stirring solution of alcohol 4.16a (100 mg, 
0.15 mmol) and MeI (22 µL, 0.3 mmol) in dry THF (4 mL) 
at 0 °C. After 2h of stirring at room temperature, the 
reaction mixture was diluted with ether (10 mL) and 
quenched by addition of H2O. The aqueous layer was 
extracted with ether (2x) and the combined organic fractions were washed with brine, 
dried over anhydrous Na2SO4, filtered and concentrated under reduced pressure. The 
crude methyl ether product was dissolved in dry THF (4 mL) and TBAF (160 µL, 1M in 
THF, 0.16 mmol) was added. After stirring at room temperature for 30 min, the reaction 
mixture was diluted by addition of ether (10 mL) and quenched by 10 mL of H2O and the 
layers were separated. The aqueous layer was extracted with ether (2x) and the combined 
organic fractions were washed with brine, dried over anhydrous Na2SO4, filtered and 
concentrated. The crude residue was purified by flash column chromatography (gradient 
Experimental Procedures (Part B) 
219 
 
40-50% EtOAc/hexane) to give 4.17a (49 mg, 55%, 2 steps) as a colorless syrup. 1H 
NMR (CDCl3, 500 MHz): δ 7.25-7.24 (d, 2H, PMB), 6.88-6.86 (m, 2H, PMB), 5.78 (d, J 
= 3.65 Hz, 1H), 5.49 (d, J = 8.9 Hz, 1H), 4.63-4.51 (m, 3H), 4.45-4.39 (m, 3H), 4.13-4.09 
(m, 2H), 3.80 (s, 3H, OMe), 3.58-3.51 (m, 3H), 3.30 (s, 3H, OMe), 1.91-1.81 (m, 4H), 
1.78-1.177 (d, 3H), 1.63-1.56 (m, 1H), 1.53 (s, 3H, Me), 1.50 (s, 3H, Me), 1.42 (s, 3H, 
Me), 1.36 (s, 3H, Me), 1.31 (s, 3H, Me). 13C NMR (CDCl3, 125 MHz): 159.14, 137.95, 
130.46, 129.24, 126.57, 113.72, 111.36, 109.73, 105.00, 89.96, 80.81, 80.36, 77.37, 
76.02, 74.36, 72.46, 69.48, 67.93, 67.51, 55.51, 55.25, 47.25, 45.65, 30.51, 26.88, 26.67, 
26.23, 25.66, 24.46, 13.14. MS (ESI): m/z 597.3 [M+Na]+. HRMS (ESI): m/z calcd for 
C32H46NaO9 597.3040 [M+Na]+; found, 597.3048. 
(2S,5R,E)-1-((S)-2,2-dimethyl-1,3-dioxolan-4-yl)-5-methoxy-7-((3aR,5R,6R,6aR)-6-
(2-(4-methoxybenzyloxy)ethyl)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)-
2,6-dimethylhept-6-en-3-yn-2-ol (4.17b): The same 
procedure was followed as described for the synthesis of 
2.01a. 1H NMR (CDCl3, 500 MHz): δ 7.25-7.24 (d, 2H, 
PMB), 6.88-6.86 (m, 2H, PMB), 5.78 (d, J = 3.15 Hz, 1H), 
5.52 (d, J = 8.8 Hz, 1H), 4.63-4.51 (m, 3H), 4.45-4.38 (m, 
3H), 4.11-4.08 (m, 2H), 3.79 (s, 3H, OMe), 3.57-3.52 (m, 3H), 3.29 (s, 3H, OMe), 1.91-
1.81 (m, 4H), 1.77 (s, 3H, Me), 1.59-1.54 (m, 1H), 1.52 (s, 3H, Me), 1.49 (s, 3H, Me), 
1.41 (s, 3H, Me), 1.35 (s, 3H, Me), 1.31 (s, 3H, Me). 13C NMR (CDCl3, 125 MHz): δ 
159.19, 137.95, 130.52, 129.25, 113.76, 111.36, 109.69, 105.03, 90.09, 80.91, 80.60, 
77.46, 75.93, 74.37, 72.47, 69.50, 67.94, 67.50, 55.60, 55.25, 47.27, 45.66, 30.50, 26.87, 
26.67, 26.26, 25.67, 24.51, 13.19.  






dimethylhepta-3,4,6-trien-2-ol (4.18a): To a stirring 
solution of ethynyl carbinol 4.17a (35 mg, 0.609 mmol) in 
dry Et2O (5 mL) was added LiAlH4 (9 mg, 0.244 mmol) at room temperature. After 5 h at 
room temperature, the reaction was quenched by slow addition of saturated solution of 
sodium potassium tartrate (Rochelle salt) followed by a saturated solution of NaS2O3. 
The contents were stirred for 1h and then extracted with ether (2x). The combined 
organic fractions were washed with brine, dried over anhydrous Na2SO4, solids were 
filtered and the crude residue was purified by flash column chromatography (gradient 20-
25% EtOAc/hexane) to give the title allene 4.18a (10 mg, 34%) as a colorless liquid 
along with an unidentified product. 1H NMR (CDCl3, 500 MHz): δ 7.26-7.24 (d, 2H, 
PMB), 6.88-6.87 (d, 2H, PMB), 6.00 (d, 1H, J = 6.3 Hz), 5.79 (d, J = 3.8 Hz, 1H), 5.62 
(d, J = 3.8 Hz, 1H), 5.29 (d, J = 9.45 Hz, 1H), 4.59-4.55 (m, 2H0, 4.47-4.42 (m, 3H), 
4.11-4.09 (m, 1H), 3.80 (s, 3H, Me), 3.58 -3.51 (m, 4H), 1.90-1.76 (m, 7H), 1.62-1.59 
(m, 1H), 1.53 (s, 3H, Me), 1.43 (s, 3H, Me), 1.36 (s, 3H, Me), 1.34 (s, 3H, Me), 1.32 (s, 
3H, Me). 13C NMR (CDCl3, 125 MHz): δ 202.62, 159.23, 135.52, 135.20, 130.57, 
129.26, 126.36, 125.05, 113.80, 111.32, 109.59, 104.98, 103.15, 102.16, 81.02, 77.91, 
73.74, 72.53, 71.83, 69.98, 68.02, 55.29, 47.37, 45.07, 32.21, 29.72, 29.69, 26.89, 26.72, 
26.40, 26.30, 25.81, 24.64, 23.41, 14.43. MS (ESI): m/z 567.3 [M+Na]+. HRMS (ESI): 
m/z calcd for C31H44NaO8 567.2934 [M+Na]+; found, 567.2939. 






(4.23): To a stirring solution of propargylic alcohol 3.37 (32 
mg, 0.047 mmol) in DCM was added solid MnO2 portion 
wise (10 x 5 mg) with 10-15 minutes interval. After stirring 
overnight at room temperature, the reaction mixture was filtered through a fritted funnel 
and the solvent was removed in vacuo. The crude residue was purified by flash column 
chromatography (gradient 20-25% EtOAc/hexanes) to give alkynone 4.23 (30 mg, 
quantitative).1H NMR (CDCl3, 500 MHz): δ 7.36-7.31 (m, 4H), 7.25-7.23 (m, 1H), 7.21 
(d, J = 8.85 Hz, 2H), 6.88-6.85 (m, 2H), 5.72 (d, J = 3.8 Hz, 1H), 5.67-5.40 (m, 2H) 4.69-
4.65 (m, 2H), 4.54 (t, J = 4.4 Hz, 1H), 4.40 (dd, J = 11.35, 16.4 Hz, 2H), 3.79 (s, 3H, 
Me), 3.50 (dd, J = 5.7, 6.9 Hz) 2.52-2.36 (m, 5H), 2.07-2.01 (m, 1H), 1.88-1.81 (m, 1H), 
1.85 (s, 3H, Me), 1.56-1.51 (m, 4H), 1.48 (s, 3H, Me), 1.30 (s, 3H, Me), 0.18 (s, 9H, 
TMS). 13C NMR (CDCl3, 125 MHz): δ 179.58, 159.22, 144.80, 144.24, 140.19, 130.57, 
130.25, 129.26, 128.49,128.31, 127.32, 125.76, 125.73, 113.75, 111.72, 105.39, 96.46, 
81.57, 80.68, 73.35, 72.55, 69.45, 67.61, 55.24, 47.87, 47.57. 42.92, 30.02, 29.65, 26.63, 
26.16, 24.47, 11.60, 1.81. MS (ESI): m/z 699.2 (100%) [M+Na]+. HRMS (ESI): m/z 
calcd for C39H52NaO8Si 699.3329 [M+Na]+; found, 699.3330. 
 





5,9-dimethyldeca-1,9-dien-6-yn-5-ol (4.25): NaH (60% in 
mineral oil, 3 mg, 0.07 mmol) was added to a stirring solution 
of alcohol 3.35 (27 mg, 0.032 mmol) and MeI (5 µL, 0.07 
mmol) in dry THF (2 mL) at 0 °C. After 2h of stirring at room 
temperature, the reaction mixture was diluted with ether (10 mL) and quenched with 10 
mL of H2O. The aqueous layer was extracted with ether (2x) and the combined organic 
fractions were washed with brine (15 mL), dried over anhydrous Na2SO4, filtered and 
concentrated under reduced pressure. The crude methyl ether product 4.24 was dissolved 
in dry THF and TBAF (40 µL, 1M in THF, 0.038 mmol) was added. After stirring at 
room temperature for 30 min, the reaction mixture was diluted by addition of ether (10 
mL) and quenched with 10 mL of H2O and the layers were separated. The aqueous layer 
was extracted with ether (2x) and the combined organic fractions were washed with 
brine, dried over anhydrous Na2SO4, filtered and concentrated. The crude residue was 
purified by flash column chromatography (gradient 40-50% EtOAc/hexane) to give 4.25 
(9 mg, 50%, 2 steps) as a colorless syrup. 1H NMR (CDCl3, 500 MHz): δ 7.34-7.32 (m, 
4H), 7.27-7.22 (m, 3H), 6.87-85 (m, 2H), 5.72,-5.70 (m, 1H), 5.69-5.61 (m, 1H), 5.59-
5.49 (m, 2H), 4.70-4.67 (m, 1H), 4.55-4.50 (m, 2H), 4.43-4.36 (m, 3H), 3.79 (s, 3H, Me), 
3.53-3.50 (m,2H), 3.28 (s, 3H), 2.51-2.39 (m, 4H), 2.32-2.28 (m, 1H), 1.91-1.80 (m, 2H), 
1.77 (s, 3H, Me),1.59-1.57 (m, 1H), 1.56 (s, 3H, Me), 1.52 (s, 3H), 1.44 (s, 3H). 13C 
NMR (CDCl3, 125 MHz) 18: δ 159.19, 144.18, 144.14, 138.20, 137.98, 131.41, 131.37, 
                                                            
18 Multiple C-signals appearing in the spectra are due to diastereotopic carbon centers present in the 
inseparable mixture of diastereomers. 
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130.44, 130.38, 129.33, 129.26, 128.47, 128.39, 128.37, 128.31, 127.45, 127.42, 126.81, 
126.59, 125.83, 125.78, 113.75, 111.38, 111.35, 104.97, 104.95, 90.78, 80.81, 80.24, 
77.48, 77.37, 75.98, 75.81, 73.40, 73.29, 72.43, 72.41, 67.89, 67.85, 67.24, 67.14, 55.55, 
55.43, 55.27, 47.19, 46.88, 46.86, 42.61, 42.54, 29.67, 29.23, 26.65, 26.21, 24.46, 13.28, 
13.12. MS (ESI): m/z 643.2 [M+Na]+. HRMS (ESI): m/z calcd for C37H48NaO8 643.3247 
[M+Na]+; found, 643.3226. 
((3S,5S,E)-3-(benzyloxy)-10-((3aR,5R,6R,6aR)-6-(2-(4-methoxybenzyloxy)ethyl)-2,2-
dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)-5,9-dimethyldeca-1,6,7,9-tetraen-5-
yloxy)trimethylsilane (4.26): To a stirring suspension of 
LiAlH4 (8 mg, 0.193 mmol) in dry Et2O (1 mL), a solution of 
ethynyl carbinol 4.25 (15 mg, 0.05 mmol) in dry Et2O (1 mL) 
was added dropwise at room temperature. After 10 min at 
room temperature, the reaction was quenched by slow 
addition of saturated solution of sodium potassium tartrate (Rochelle salt) followed by a 
saturated solution of NaS2O3. The contents were stirred for 1h and then extracted with 
ether (2x). The combined organic fractions were washed with brine, dried over anhydrous 
Na2SO4, solids were filtered and the crude residue was purified by flash column 
chromatography (gradient 20-25% EtOAc/hexane) to give the title allene 4.26 (18%) as a 
faint yellow liquid along with an unidentified product. 1H NMR (CDCl3, 500 MHz): δ 
7.35-7.33 (m, 3H), 7.25-7.23 (m, 5H), 6.88-6.85 (m, 2H, allene), 6.02-6.00 (m, 1H), 5.79-
5.78 (m, 1H), 5.60-5.48 (m, 3H), 5.31-5.29 (d, J = 8.85 Hz, 1H), 4.73-4.70 (m, 1H), 
4.58-4.55 (m, 2H), 4.42-4.41 (m, 2H), 3.80-3.79 (d, J = 3.15 Hz, 3H, OMe), 3.53-3.51 
(m, 2H), 2.53-2.48 (m, 2H), 2.33-2.22 (m, 2H), 1.88-1.82 (m, 3H), 1.53 (s, 3H, Me), 1.43 
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(s, 3H, Me), 1.31 (s, 3H, Me), 1.25 (s, 3H, Me). MS (ESI): m/z 613.2 [M+Na]+. HRMS 
(ESI): m/z calcd for C36H46NaO7 614.3219 [M+Na]+; found, 613.3144. 
 
tert-Butyl((E)-3-((3aR,5R,6R,6aR)-6-(2-(4-methoxybenzyloxy)ethyl)-2,2-dimethyl 
tetrahydrofuro[2,3-d][1,3]dioxol-5-yl)-2-methylallyloxy)dimethylsilane: To the 
stirring solution of allylic alcohol 3.34 (161 mg, 0.42 mmol) 
in dry DCM (5 mL) was added imidazole (58 mg, 0.84 
mmol) and TBSCl (100 mg, 0.84 mmol) at room temperature 
and stirred overnight. The reaction contents were diluted 
with ether (15 mL) and H2O (15 mL) was added and the layers were separated. The 
aqueous layer was extracted with ether (2x15 mL) and the combined organic fractions 
were washed with brine (20 mL), dried over anhydrous Na2SO4, filtered and the solvent 
was removed under reduced pressure. The crude residue was purified by flash column 
chromatography (gradient 5-10% EtOAc/ hexanes) to afford TBS ether (188 mg, 90%) as 
a colorless syrup. 1H NMR (CDCl3, 500 MHz): δ 7.27 (d, J = 8.8 Hz, 2H), 6.89 (d, J = 
8.8 Hz, 2H), 5.81 (d, J = 3.8 Hz, 1H), 5.39 (dd, J = 1.27, 8.8 Hz, 2H), 4.60-4.55 (m, 2H), 
4.45 (dd, J = 11.35, 18.9 Hz, 2H), 4.04 (s, 2H), 3.82 (s, 3H), 3.55 (t, J = 6.3 Hz, 2H), 
1.88-1.85 (m, 2H), 1.69 (s, 3H), 1.66-1.59 (m, 1H), 1.56 (s, 3H), 1.34 (s, 3H), 0.92 (s, 
9H), 0.07 (d, J = 1.3 Hz, 6H). 13C NMR (CDCl3, 125 MHz): δ 159.08, 140.87, 130.53, 
129.13, 121.39, 113.66, 111.09, 108.87, 80.89, 77.47, 72.33, 68.10, 67.57, 55.19, 47.29, 
26.64, 26.25, 25.86, 24.43, 18.30, 14.09, -5.53, -5.41. 




dimethyltetrahydrofuro[2,3-d][1,3]dioxol-6-yl)ethanol (5.5): The above obtained 
doubly protected crude alcohol (200 mg, 0.41 mmol) was 
dissolved in DCM/H2O (10:1 v/v, 15 mL) and DDQ (700 mg, 
1.21 mmol) was added. After stirring at room temperature for 
30 min, the reaction was determined (by TLC monitoring) to 
be completed with orange-red clumps formation. The reaction mixture was filtered 
through a celite pad, diluted with DCM (15 mL), washed with saturated NaHCO3 
solution (30 mL). The aqueous layer was extracted with DCM (2x) and the combined 
organic fractions were washed with brine (30 mL), dried over anhydrous Na2SO4 and 
concentrated in vacuo. The orange-red residue was purified by flash column 
chromatography (gradient 20-30% EtOAc/hexane) to furnish the title primary alcohol 5.5 
(134 mg, 89%) as a colorless liquid. 1H NMR (CDCl3, 500 MHz): δ 5.83 (d, J = 3.8 Hz, 
1H), 5.37 (dd, J = 1.25, 8.85 Hz, 1H), 4.68 (t, J = 3.8 Hz, 1H), 4.56 (t, J =  9.45 Hz, 1H), 
4.00 (s, 2H), 3.72-3.70 (m, 2H), 1.86-1.78 (m, 2H), 1.73-1.70 (m, 1H), 1.67 (s, 3H), 1.59-
1.56 (m, 1H), 1.54 (s, 3H), 1.33 (s, 3H), 0.89 (s, 9H), 0.05 (s, 6H). 13C NMR (CDCl3, 
125 MHz): δ 141.17, 121.22, 111.18, 104.98, 80.99, 77.41, 67.52, 61.30, 47.62, 27.51, 
26.62, 26.31, 25.89, 18.36, 14.19, -5.31, -5.39. 
2-((3aR,5R,6R,6aR)-5-((E)-3-(tert-butyldiphenylsilyloxy)-2-methylprop-1-enyl)-2,2-
dimethyltetrahydrofuro[2,3-d][1,3]dioxol-6-yl)ethanol (5.9): To the stirring solution of 
allylic alcohol 3.34 (220 mg, 0.58 mmol) in dry DCM (10 mL) 
was added imidazole (370 mg, 0.87 mmol) and TBDPSCl (0.47 
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temperature overnight. The reaction mixture was diluted with ether and the layers were 
separated. The aqueous layer was extracted with ether (3x) and the combined organic 
fractions were washed with brine (20 mL), dried over anhydrous Na2SO4 and 
concentrated under reduced pressure. The crude residue was carried forward for 
subsequent oxidative cleavage of PMB ether. 
The above obtained protected crude alcohol (800 mg) was dissolved in DCM/H2O (10:1 
v/v, 15 mL) and DDQ (700 mg, 3.08 mmol) was added and stirred at room temperature. 
After 30 min, the reaction was determined (TLC monitoring) to be completed with 
orange-red clumps formation. Then the reaction mixture was filtered through a celite pad, 
washed with saturated NaHCO3 solution (30 mL). The aqueous layer was extracted with 
DCM (2x) and the combined organic fractions were washed with brine, dried over 
anhydrous Na2SO4 and the solvent was removed under reduced pressure. The orange-red 
residue was purified by flash column chromatography (gradient 20-40% EtOAc/hexane) 
to furnish the title primary alcohol 5.9 (481 mg, 82%, 2 steps) as a colorless liquid. 1H 
NMR (CDCl3, 500 MHz): δ 7.67-7.65 (m, 4H), 7.44-7.36 (m, 6H), 5.85 (d, J = 3.8 Hz, 
1H), 5.49 (dd, J = 1.25, 8.85 Hz, 1H), 4.70 (t, J = 3.8 Hz, 1H), 4.58 (t, J = 9.45 Hz, 1H), 
4.10-4.04 (m, 2H), 3.74-3.72 (m, 2H), 1.87-1.79 (m, 2H), 1.68 (s, 3H), 1.55 (s, 2H), 1.34 
(s, 3H), 1.06 (s, 9H). 13C NMR (CDCl3, 125 MHz): δ 140.80, 135.50, 135.56, 129.64, 
127.65, 121.40, 111.21, 105.02, 81.02, 77.40, 68.05, 61.36, 47.71, 27.57, 26.80, 26.64, 
26.32, 19.27, 14.27. MS (ESI): m/z 519.1 [M+Na]+. 
 




d][1,3]dioxol-5-yl)-2-methylallyloxy)diphenylsilane (5.10): Triphenylphosphine (260 
mg, 0.99 mmol) and imidazole (100 mg, 1.48 mmol) were 
dissolved in DCM (90 mL) and stirred for 10 min at room 
temperature. The stirring mixture was cooled to ice-bath 
temperature and iodine as solid was added and stirred at 
room temperature for 10-15 min after which alcohol 5.9 (246 mg, 0.5 mmol) was added 
in DCM (10 mL). The reaction mixture was stirred for 1h at room temperature to 
complete the reaction. The volume was reduced approximately to half and Et2O was 
added to remove Ph3P = O by precipitation. The precipitate was filtered and the solvent 
was concentrated in vacuo. The residue was purified by flash column chromatography 
(gradient 5-10% EtOAc/hexane) to afford the title iodide 5.10 (280 g, 93%) as a colorless 
liquid. 1H NMR (CDCl3, 500 MHz): δ 7.68 (d, J = 6.9 Hz, 4H), 7.45 (m, 6H), 5.87 (d, J 
= 3.8 Hz, 1H), 5.54 (d, 8.8 Hz,4.66 (t, J = 4.4 Hz, 1H), 4.61 (t, 9.5 Hz, 1H), 4.08 (dd, 
14.5, 19.5 Hz, 2H), 3.36-3.32 (m, 1H), 3.25-3.20 (m, 1H), 2.15-2.08 (m, 1H), 1.95-1.89 
(m, 1H), 1.85-1.77 (m, 1H), 1. 67 (s, 3H, Me), 1.55 (s, 3H, Me), 1.35 (s, 3H, Me), 1.08 (s, 
9H, t-Bu). 13C NMR (CDCl3, 125 MHz): δ 141.10, 135.48, 135.46, 133.51, 129.62, 
127.67, 120.90, 111.36, 104.87, 79.99, 76.77, 50.81, 28.75, 26.82, 26.61, 26.28, 19.26, 
14.22, 4.03. MS (ESI): m/z 628.9 [M+Na]+. HRMS (ESI): m/z calcd for C29H39INaO4Si 
629.1560 [M+Na]+; found, 629.1570. 





dioxol-5-yl)-2-methylallyloxy)(tert-butyl)diphenylsilane (5.11): Iodide 5.10 (670 mg, 
1.1 mmol) was azeotropically dried with THF (2x) and flushed with argon gas. To the 
RBF with compound was added freshly pre-dried Fe(acac)3 (77 mg, 0.22 mmol), HMTA 
(31 mg, 0.22 mmol) and equipped with a magnetic stirring bar. The septum sealed-RBF 
with contents inside was kept under high vacuum for 5 min and subsequently flushed 
with argon. The vacuum-Argon cycles were repeated thrice and the flask was equipped 
with an argon balloon. TMEDA (66 μL, 0.44 mmol) was added and the contents were 
dissolved in THF (10 mL) and cooled to –20 °C. Vinylmagnesium bromide (1M in THF, 
2.2 mL, 2.2 mmol) was added over 15 min to the stirring solution at –20 °C with the aid 
of a syringe pump. After complete addition, stirring was continued for a further 1h at 0 
°C, diluted with ether, quenched by slow addition of 1M HCl (5 mL). The aqueous layer 
was separated and extracted with ether. The combined organic fractions were washed 
with brine and dried over anhydrous Na2SO4. The solvent was removed under reduced 
pressure to give the crude oil. The crude product was purified by the flash column 
chromatography (gradient 2-8% EtOAc in hexanes) to provide sp2-sp3 cross-coupling 
product 5.11 exclusively (360 mg, 62%) as a yellow syrup. 1H NMR (CDCl3, 500 MHz): 
δ 7.69-7.67 (d, J = 6.9 Hz, 4H) 7.44-7.37 (m, 6H), 5.88-5.79 (m, 1H), 5.84-5.83 (d, J = 
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3.15 Hz, 1H), 5.49 (d, J = 9.45 Hz, 1H), 5.06 (dd, J = 1.85, 17 Hz, 1H), 5.99 (dd, J = 1.3, 
10.1 Hz, 1H), 4.65 (td, J = 3.8, 13.05 Hz, 1H), 4.59-4.54 (m, 1H), 4.11-4.05 (dd, J = 
14.5, 18.9 Hz, 2H), 2.30-2.23 (m, 1H), 2.14-2.07 (m, 1H), 1.73-1.70 (m, 1H), 1.68 (s, 3H, 
Me), 1.65-1.59 (m, 1H), 1.56 (s, 3H, Me), 1.39-1.35 (s, 1H), 1.35 (s, 3H, Me). 13C NMR 
(CDCl3, 125 MHz): δ 140.47, 140.18, 138.40, 135.48, 135.46, 133.61, 133.58, 129.60, 
127.62, 121.87, 121.67, 114.85, 111.17, 111.13, 104.90, 104.88, 80.75, 77.59, 77.52, 
68.10, 68.04, 52.45, 49.85, 31.86, 26.77, 26.70, 26.32, 26.21, 23.51, 19.27, 17.49, 14.25, 
14.22, 12.42. MS (ESI): m/z 529.1 [M+Na]+. HRMS (ESI): m/z calcd for C31H42NaO4Si 
529.2750 [M+Na]+; found, 529.2765. 
(E)-3-((3aR,5R,6R,6aR)-6-(But-3-enyl)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-
5-yl)-2-methylprop-2-en-1-ol (5.12): To the stirring solution of 
silyl ether 5.11 (220 mg, 0.58 mmol) in dry THF (10 mL) was 
added TBAF (1M in THF, 0.87 mL, 0.87 mmol) at room 
temperature and the reaction was stirred at room temperature for 
4h. The solution was diluted with ether and quenched with water. The biphasic mixture 
was separated and the aqueous layer was extracted with ether (3x). The combined organic 
fractions were washed with brine, dried over anhydrous Na2SO4, filtered and 
concentrated in vacuo. The crude residue was purified by flash column chromatography 
(gradient 20-35% EtOAc/hexanes) to provide desilylated allylic alcohol 5.12 (50 mg, 
56%) as a colorless syrup. 1H NMR (CDCl3, 500 MHz): δ 5.84-5.76 (m, 1H), 5.81-5.80 
(d, J = 3.8 Hz, 1H), 5.37 (dd, J = 1.25, 8.85 Hz, 1H), 5.04 (dd, J = 1.25, 17.05 Hz, 1H), 
4.98-4.96 (m, 1H), 4.62 (t, J = 4.4 Hz, 1H), 4.53 (t, J = 9.45 Hz, 1H), 4.05 (s, 2H), 2.27-
2.22(m, 1H), 2.10-2.03 (m, 1H), 1.74 (s, 3H, Me), 1.72-1.63 (m, 2H), 1.54 (s, 3H, Me), 
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1.37-1.30 (m, 1H), 1.34 (s, 3H, Me). 13C NMR (CDCl3, 125 MHz): δ 141.35, 138.36, 




d][1,3]dioxol-5-yl)-2-methylacrylate (5.13):  
PMB ether 3.35 (112 mg, 0.275 mmol) was dissolved in 
DCM/H2O (10:1 v/v, 4 mL) and DDQ (137 mg, 0.6 mmol) was 
added and stirred at room temperature during which orange-red clumps formation was 
observed. After 30 min, the reaction was determined to be completed (TLC monitoring). 
The reaction mixture was filtered through a celite pad and the filtrate diluted with DCM, 
washed with saturated NaHCO3 (30 mL). The aqueous layer was extracted with DCM 
(3x) and the combined organic fractions were washed with brine (30 mL), dried over 
anhydrous Na2SO4 and the solvent was removed under reduced pressure. The orange-red 
residue was purified by flash column chromatography (gradient 40-50% EtOAc/hexane) 
to furnish primary alcohol (85 mg, quantitative) as a viscous colorless oil. 1H NMR 
(CDCl3, 500 MHz): δ 6.58 (dd, J = 1.25, 8.8 Hz, 1H), 5.87 (d, J = 3.8 Hz, 1H), 4.73 (t, J 
= 3.75 Hz, 1H), 4.60 (t, J = 9.4Hz, 1H), 3.75 (s, 3H, OMe), 3.73-3.72 (m, 2H), 2.01-1.95 
(m, 1H), 1.92 (d, J = 1.25 Hz , 3H, Me), 1.88-1.81 (m, 1H), 1.57-1.52 (m, 1H) 1.54 (s, 
3H, Me), 1.34 (s, 3H, Me). 13C NMR (CDCl3, 125 MHz): δ 167.89, 137.90, 131.57, 
111.60, 105.48, 80.82, 77.41, 61.07, 51.99, 47.50, 27.27, 26.63, 26.26, 13.44. MS (ESI): 
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m/z 309.1 (100%) [M+Na]+. HRMS (ESI): m/z calcd for C14H22NaO6 309.1314 
[M+Na]+; found, 309.1315. 
The above obtained alcohol was used for iodination as follows: 
Triphenylphosphine (77 mg, 0.30 mmol) and imidazole (25 mg, 0.36 mmol) were 
dissolved in DCM (3 mL) and stirred for 10 min at room temperature. The contents were 
cooled to ice-bath temperature and iodine as solid was added and stirred at room 
temperature for 10-15 min. Then alcohol (65 mg, 0.22 mmol) was added in DCM (3 mL) 
and the reaction mixture stirred for 1h at room temperature to complete the reaction. The 
volume was reduced approximately to half and Et2O was added to remove Ph3P = O by 
precipitation. The precipitate was filtered and the solvent was concentrated in vacuo. The 
residue was purified by flash column chromatography (gradient 5-10% EtOAc/hexane) to 
afford the title iodide 5.13 (80 mg, 90%) as a colorless oil. 1H NMR (CDCl3, 500 MHz): 
δ 6.57 (dd, J = 1.3, 8.85 Hz, 1H), 5.86 (d, J = 3.75 Hz, 1H), 4.67-4.66 (m, 1H), 4.61 (t, J 
= 9.45 Hz, 1H), 3.75 (s, 3H), 3.32-3.28 (m, 1H), 3.19-3.14 (m, 1H), 2.13-2.06 (m, 1H), 
2.03-1.97 (m, 1H), 1.89 (d, J = 1.25 Hz, 3H), 1.79-1.72 (m, 1H), 1.52 (s, 3H), 1.32 (s, 
3H). 13C NMR (CDCl3, 125 MHz): δ 167.72, 137.37, 131.79, 111.82, 105.29, 79.77, 
52.02, 50.74, 28.37, 26.58, 26.21, 13.41, 3.23.MS (ESI): m/z 418.9 [M+Na]+. HRMS 
(ESI): m/z calcd for C14H21INaO5 419.0331 [M+Na]+; found, 419.0330. 
(3aR,5R,6S,6aR)-5-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-2,2-
dimethyl tetrahydrofuro[2,3-d][1,3]dioxol-6-yl 4-
methylbenzenesulfonate (5.18): Diacetal glucose 3.24 (500 mg, 
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mmol) were dissolved in DCM (15 mL) and stirred overnight at room temperature. After 
completion of reaction, the mixture was diluted with ether (20 mL) and the organic layer 
was washed with dil.HCl (2x). The aqueous layer was extracted with ether (2x) and the 
combined organic fractions were washed with H2O, brine and dried over anhydrous 
Na2SO4, filtered and concentrated. The residue was purified by flash column 
chromatography (gradient 20-30% EtOAc/hexanes) to give (3aR,5R,6S,6aR)-5-((R)-2,2-
dimethyl-1,3-dioxolan-4-yl)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-6-yl-4-
methylbenzenesulfonate 5.18 (700 mg, 89%) as a white solid. 1H NMR (CDCl3, 500 
MHz): δ 7.82 (d, J = 8.2 Hz, 2H), 7.32 (d, J = 8.2 Hz), 5.91 (d, J = 3.15 Hz, 1H), 4.82 (d, 
J = 6.3 Hz, 1H), 4.78 (d, J = 1.9 Hz, 1H), 4.06-3.97 (m, 3H), 3.91-3.88 (m, 1H), 2.44 (s, 
3H), 1.47 (s, 3H), 1.30 (s, 3H), 1.18 (s, 3H), 1.14 (s, 3H). 13C NMR (CDCl3, 125 MHz): 
δ 145.05, 132.68, 129.64, 128.40, 112.47, 109.02, 105.07, 83.27, 82.03, 79.83, 71.75, 
67.05, 26.58, 26.52, 26.17, 24.86, 21.60. MS (ESI): m/z 414.8 [M]+, 437.0 [M+Na]+. 




Diacetal glucose 3.24 (0.5 g, 1.92 mmol), PPh3 (1.5 g, 5.76 
mmol), imidazole (0.4 g, 5.76 mmol) and iodine (0.97 g, 3.84 
mmol) were together taken into toluene (30 mL) and the reaction mixture was refluxed 
(125 °C) overnight. The solvent was reduced to half volume by distillation on a rotary 
evaporator and diluted with ether. Solids were filtered and washed with brine solution 
and concentrated in vacuo. The residue was purified by flash column chromatography 
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(gradient 15-25% EtOAc/hexanes) to obtain the iodo compound 5.19 (0.5 g, 70%) as a 
solid. 1H NMR (CDCl3, 500 MHz): δ 5.80 (d, J = 3.8 Hz, 1H), 4.58 (t, J = 3.8 Hz, 1H), 
4.31-4.28 (m, 1H), 4.24 (dd, J = 3.8, 10.05 Hz, 1H), 4.12-4.09 (m, 1H), 4.06-4.03 (m, 
1H), 3.76-3.73 (m, 1H), 1.54 (s, 3H, Me), 1.47 (s, 3H, Me), 1.35 (s, 6H, 2xMe). 13C 
NMR (CDCl3, 125 MHz): δ 111.66, 109.99, 103.12, 81.73, 81.46, 75.47, 65.75, 26.59, 
26.53, 26.39, 25.17, 19.19. 
(3aR,5S,6R,6aR)-5-((R)-2,2-Dimethyl-1,3-dioxolan-4-yl)-6-
(2-iodoethyl)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxole 
(5.21): Triphenylphosphine (7 g, 27 mmol) and imidazole (2.3 
mg, 32.3 mmol) were dissolved in DCM (90 mL) and stirred for 
10 min at room temperature. The contents were cooled to ice-bath temperature then, 
iodine as solid was added and stirred at room temperature for 10-15 min. Then alcohol 
3.29 (6 g, 20.8 mmol) was added in DCM (10 mL) and the reaction mixture stirred for 1h 
at room temperature to complete the reaction. The volume was reduced approximately to 
half and Et2O was added to remove Ph3P = O by precipitation. The precipitate was 
filtered and the solvent was distilled in vacuo. The residue was purified by flash column 
chromatography (gradient 5-10% EtOAc/hexane) to afford iodide 5.21 (7.8 g, 95%) as a 
colorless liquid. 1H NMR (CDCl3, 500 MHz): δ 5.77 (d, J = 3.5 Hz, 1H), 4.66 (t, J = 4.4 
Hz, 1H), 4.08 (dd, J = 6.3, 8.2 Hz, 1H), 4.01 (dd, J = 6.9, 12 Hz, 1H), 3.91 (dd, J = 5.0, 
8.2 Hz, 1H), 3.80-3.77 (m, 1H), 3.43-3.38 (m, 1H), 3.28-3.23 (m, 1H), 2.26-2.18 (m, 1H), 
2.14-2.04 (m, 2H), 1.49 (s, 3H), 1.41 (s, 3H), 1.34 (s, 3H), 1.31 (s, 3H). 13C NMR 
(CDCl3, 125 MHz): δ 111.92, 109.64, 104.91, 81.35, 80.68, 77.58, 67.47, 48.87, 29.07, 
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26.75, 26.61, 26.39, 25.23, 4.68. MS (ESI): m/z 421.0 [M+Na]+. HRMS (ESI): m/z calcd 
for C14H23INaO5 421.0488 [M+Na]+; found, 421.0477. 
 
 
Cross-Coupling Reaction: Iodide 5.21 (7.7 g, 19.34 mmol) was charged into a 250 mL 
RBF and azeotropically dried by anhydrous THF (2x) and flushed with argon gas. To the 
RBF was added freshly pre-dried Fe(acac)3 (1.36 g, 3.9 mmol), HMTA (0.54 g, 3.9 
mmol) and it was equipped with a magnetic stirring bar. The septum sealed-RBF with 
contents inside was kept under high vacuum for 5 min and subsequently flushed wih 
argon. The vacuum-argon cycles were repeated thrice and equipped with an argon 
balloon. TMEDA (1.17 mL, 7.74 mmol) was added and the contents were dissolved in 
THF (10 mL) and cooled to –20 °C. Vinylmagnesium bromide (1M in THF, 29 mL, 29 
mmol) was added over 15 min (10 mL/h) to the stirring solution at –20 °C with the aid of 
syringe pump. After addition being completed, stirring was continued for a further 1h at 0 
°C and diluted with ether and quenched by slow addition of 1M HCl (5 mL). The 
aqueous layer was separated and extracted with ether. The combined organic fractions 
were washed with brine and dried over anhydrous Na2SO4 filtered and concentrated 
under reduced pressure to give a crude oil. The crude product was purified by flash 
column chromatography (gradient 5-10% EtOAc/hexane) to provide β-Hydride-
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elimination product 5.23 and inseparable mixture of sp2-sp3 coupling product 5.20, along 
with hydride substitution product 5.22 as oily liquids. 
(3aR,5S,6R,6aR)-5-((R)-2,2-Dimethyl-1,3-dioxolan-4-yl)-2,2-dimethyl-6-
vinyltetrahydrofuro[2,3-d][1,3]dioxole (2.235): β-Hydride elimination by-product. 
1H NMR (CDCl3, 500 MHz): δ 5.89-5.81 (m, 1H), 5.79 (d, J = 
3.8 Hz, 1H), 5.27-5.19 (m, 2H), 4.60 (t, J = 3.8 Hz, 1H), 4.25-
4.21 (m, 1H), 4.08 (dd, 3.75, 10.05 Hz, 1H), 3.96 (dd, J = 6.35, 
8.15 Hz, 1H), 3.87 (dd, 6.95, 8.2 Hz, 1H), 2.62-2.57 (m, 1H), 1.51 
(s, 3H, Me), 1.41 (s, 3H, Me), 1.33 (s, 3H, Me), 1.29 (s, 3H, Me). 13C NMR (CDCl3, 125 
MHz): δ 132.20, 119.03, 111.83, 109.51, 104.68, 83.68, 79.77, 65.27, 50.50, 26.65, 
26.34, 26.16, 25.16. 
 
Acetal Cleavage: The mixture of 5.20 and 5.22 (3.2 g) was dissolved in 60% AcOH/H2O 
(100 mL) and the reaction mixture was stirred at room temperature for 12h. Upon 
completion of terminal acetal hydrolysis (TLC monitoring), toluene was added and 
concentrated in vacuo. The resulting syrup was purified by flash column chromatography 
(gradient 30-50% EtOAc/hexane) to provide 5.26 and 5.27 as a partially separable 
mixture. 






1H NMR (CDCl3, 500 MHz): δ 5.85-5.77 (m, 1H), 5.74 (d, J = 
3.15 Hz, 1H) 5.07-5.03 (m, 1H), 4.98 (d, J = 10.1 Hz, 1H), 4.62 
(t, J = 4.4 Hz, 1H), 3.89 (dd, J = 3.8, 10.1 Hz, 1H), 3.72-3.69 
(m, 2H) 2.87 (s, br, 1H, OH), 2.62 (s, br, 1H, OH), 2.31-2.24 
(m, 1H), 2.13-2.05 (m, 1H), , 1.98-1.90 (m, 1H), 1.78-1.70 (m, 1H), 1.63-1.57 (m, 1H), 
1.49 (s, 3H), 1.32 (s, 3H). 13C NMR (CDCl3, 125 MHz): δ 138.23, 115.01, 111.77, 
104.64, 82.84, 81.06, 72.77, 63.22, 45.60, 31.76, 26.73, 26.37, 24.23. MS (ESI): m/z 
Calcd for C13H22O5: 258.1467; found 257.1 [M-H]-; 282.2 [M+Na]+. 
 
Oxidative Vicinal Diol Cleavage and Wittig: The mixture of 5.26 and 5.27 (3.2 g, 7.16 
mmol) was dissolved in MeOH (60 mL) and NaIO4 (2 g, 10.74 mmol) in H2O (15 mL) 
was added slowly. White precipitate formation began with an exothermic reaction. After 
stirring for 15 min, the solution was filtered through fritted sintered funnel and the solid 
was washed with MeOH (20 mL) and DCM (20 mL). The filtrate was diluted with DCM 
(50 mL) and washed with brine. The aqueous layer was extracted with DCM (3x) and the 
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approximately to half-volume under reduced pressure. Ylide 3.34 in DCM (20 mL) was 
then added and the reaction mixture was stirred overnight at room temperature. The 
solvent was removed under reduced pressure and the residue was purified by flash 
column chromatography (gradient 10-15% EtOAc/hexanes) to isolate 5.30 and 5.31 (1.7 




1H NMR (CDCl3, 500 MHz): δ 6.53, (d, J = 8.8 Hz, 1H), 5.80 
(d, J = 3.8 Hz, 1H), 5.78-5.70 (m, 1H), 5.00-4.93 (m, 2H), 4.61 (t, J = 4.4 Hz, 1H), 4.54 
(t, J = 10.1 Hz, 1H), 3.71 (s, 3H), 2.23-2.16 (m, 1H), 2.06-1.99 (m, 1H), 1.88 (s, 3H), 
1.81-1.75 (m, 1H), 1.50 (s, 3H), 1.30-1.26 (m, 4H). 13C NMR (CDCl3, 125 MHz): δ 
167.83, 138.19, 137.93, 131.24, 114.99, 111.52, 105.29, 80.54, 77.44, 51.82, 49.72, 
31.61, 26.60, 26.18, 23.37, 13.31. MS (ESI): m/z 296.9 [M], 319.1 [M+Na]+. HRMS 
(ESI): m/z calcd for C16H24NaO5 319.1521 [M+Na]+; found, 319.1546. 
 
(E)-3-((3aR,5R,6R,6aR)-6-(but-3-enyl)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-
5-yl)-2-methylprop-2-en-1-ol (5.12): To a stirring solution of conjugated esters 5.30 and 
5.31 (1.67 g) in dry DCM (25 mL) at –78 °C, DIBALH (15 mL, 1M in cyclohexane, 15 
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mmol) was added over 45 min. The reaction mixture was allowed to warm to room 
temperature over 4h. After completion of reaction (by TLC) the reaction was quenched 
by addition of saturated Rochelle salt (sodium potassium tartrate) drop wise (30 mL) and 
stirred vigorously for 30 min at room temperature, during which the gray cloud in organic 
phase was dissolved and appeared in water layer. The solution was diluted with ether and 
the layers were separated. The aqueous layer was extracted with ether (3x) and the 
combined organic fractions were washed with brine, dried over anhydrous Na2SO4 
filtered and concentrated under reduced pressure. The crude syrup was purified by flash 
column chromatography (gradient 20-30% EtOAc/hexane) to provide desired allylic 
alcohol, (E)-3-((3aR,5R,6R,6aR)-6-(but-3-enyl)-2,2-dimethyltetrahydrofuro[2,3-
d][1,3]dioxol-5-yl)-2-methylprop-2-en-1-ol 5.12 (1 g) as a colorless syrup, along with 
trace conjugate reduced product and 5.32 (280 mg). 
Analytical data of allylic alcohol 5.12 is matching in all respects with the product 
obtained in desilylation of 5.11. 
 
(E)-3-((3aR,5R,6R,6aR)-6-(but-3-enyl)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-
5-yl)-2-methylacrylaldehyde (5.4): To the stirring solution of 
allylic alcohol 5.12 (426 mg, 1.58 mmol) in dry DCM (10 mL) 
was added DMP (1 g, 2.38 mmol) at room temperature and the 
reaction was stirred for 2h at room temperature. Upon complete 
conversion of allylic alcohol the contents were filtered through a celite bed and 
concentrated on a rotary evaporator. The crude residue was purified by flash column 
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chromatography (gradient 10-20% EtOAc/hexane) to provide the conjugated aldehyde 
5.4 (400 mg, 95%) as a colorless syrup. 1H NMR (CDCl3, 500 MHz): δ 9.46 (s, 1H), 6.29 
(dd, J = 1.4, 8.2 Hz, 1H), 5.87 (d, J = 3.15 Hz, 1H), 5.80-5.72 (m, 1H), 5.00 (dd, J = 1.9, 
1.7 Hz 1H), 4.98 (dd, J = 1.25, 10.05 Hz, 1H), 4.73 (t, 9.9 Hz, 1H), 4.68 (t, J = 4.4 Hz, 
1H), 2.27-2.20 (m, 1H), 2.10-2.02 (m, 1H), 1.90-1.84 (m, 1H), 1.81 (d, J = 1.3 Hz, 3H), 
1.78-1.70 (m, 1H), 1.54 (m, 3H), 1.35 (s, 3H), 1.33-1.26 (m, 1H). 13C NMR (CDCl3, 125 
MHz): δ 194.68, 149.08, 141.18, 137.79, 115.30, 111.87, 105.47, 80.53, 77.34, 49.95, 
31.61, 26.66, 26.24, 23.42, 10.15. 
 
 
Alkyne Addition: To a stirring solution of alkyne 3.3 (230 mg, 0.76 mmol) in THF at – 
20 °C, was added EtMgBr (250 μL, 3M in THF, 0.75 mmol) and refluxed (50 °C) for 1h. 
Then the contents were cooled to – 20 °C and aldehyde 5.4 (150 mg, 0.56 mmol) in THF 
was added. The reaction was gradually warmed to room temperature over 2h after which 
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it was quenched by slow addition of saturated NH4Cl and extracted with ether (3x). The 
combined organic fractions were washed with brine, dried over anhydrous Na2SO4, 
filtered and concentrated under reduced pressure and the crude residue was purified by 
flash column chromatography (gradient 20-35% EtOAc/hexane) to yield separable 
diastereomeric allylic alcohols 5.33a (127 mg), 5.33b (90 mg) as colorless syrups and 50 
mg of the mixture (267 mg, 87% overall yield; dr = 10:7, based on 1H NMR integration) 






1H NMR (CDCl3, 500 MHz): δ 7.34-7.24 (m, 5H), 5.83-5.74 
(m, 3H), 5.52 (d, J = 8.85 Hz, 1H), 5.25-5.19 (m, 2H), 5.03 (dd, J = 1.9, 17.05 Hz, 1H), 
4.96 (dd, J = 1.3, 10.05 Hz, 1H), 4.72 (s, br, 1H, OH), 4.62-4.60 (m, 1H), 4.54 (d, J = 
11.35 Hz, 1H) 4.50 (t, J = 9.45 Hz, 1H), 4.35 (d, J = 11.35 Hz, 1H), 4.07 (q, J = 6.3 Hz, 
1H), 2.27-2.21 (m, 1H), 2.10 (dd, J = 6.3, 14.5 Hz, 1H), 2.06-2.02 (m, 1H), 1.93-1.90 (m, 
1H), 1.80 (s, 3H, Me), 1.74-1.62 (m, 3H), 1.54 (s, 3H, Me), 1.50 (s, 3H, Me), 1.33 (s, 3H, 
Me), 0.15 (s, 9H, TMS). 13C NMR (CDCl3, 125 MHz): δ 139.86, 139.20, 138.69, 138.25, 
128.26, 127.73, 127.34, 124.75, 116.48, 114.97, 111.34, 105.00, 90.75, 82.52, 80.66, 
77.47, 77.28, 69.94, 67.88, 67.19, 50.26, 49.78, 31.78, 31.23, 26.69, 26.29, 23.45, 13.60, 
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1.92. MS (ESI): m/z 567.2 [M-H]-,591.2 [M+Na]+. HRMS (ESI): m/z calcd for 






1H NMR (CDCl3, 500 MHz): δ 7.34-7.24 (m, 5H), 5.84-5.74 (m, 3H), 5.48 (d, J = 8.85 
Hz, 1H), 5.25-5.19 (m, 3H), 5.03 (ddd, J = 1.9, 3.5, 17 Hz, 1H), 4.98-4.95 (m, 1H), 4.76 
(d, J = 4.05 Hz, 1H), 4.62-4.60 (m, 1H), 4.54 (d, J = 11.35 Hz, 1H), 4.52-4.48 (m, 1H), 
4.36 (d, J = 12 Hz, 1H), 4.07 (q, J = 6.3 Hz, 1H), 2.27-2.20 (m, 1H), 2.10 (dd, J =  6.3, 
14.5 Hz, 1H), 2.08-2.03 (m, 1H), 1.94-1.90 (m, 1H), 1.81 (s, 3H, Me), 1.72-1.63 (m, 
3H)1.54 (s, 3H, Me), 1.50 (s, 3H, Me), 1.34-1.32 (m, 4H), 0.15 (m, 9H, TMS). 13C NMR 
(CDCl3, 125 MHz): δ 140.02, 139.22, 138.70, 138.23, 128.27, 127.74, 127.35, 125.50, 
125.09, 116.48, 114.99, 111.37, 105.00, 90.75, 82.54, 80.68, 77.52, 77.28, 69.94, 67.89, 
67.43, 50.23, 49.79, 31.77, 31.26, 30.31, 29.68, 26.70, 26.30, 23.46, 13.21, 1.92. MS 
(ESI): m/z 567.1 [M-H]-,591.2 [M+Na]+. HRMS (ESI): m/z calcd for C33H48NaO6Si 
591.3118 [M+Na]+; found, 591.3124. 
 
 




Common Procedure for TES Protection of Propargylic Alcohol: To a stirring solution 
of propargylic alcohol (5.33a or 5.33b) and Et3N (5 eq.) in dry DCM, was added TESOTf 
(3 eq) at 0 °C and after 2h at room temperature, the reaction was diluted with ether and 
quenched with addition of H2O. The layers were separated and the aqueous layer was 
extracted with ether (3x) and the combined organic fractions were washed with brine, 
dried over anhydrous Na2SO4, filtered and concentrated under reduced pressure. The oily 
residue was purified by flash column chromatography (gradient 2-5% EtOAc/hexane) to 





1H NMR (CDCl3, 500 MHz): δ 7.34-7.23 (m, 5H), 5.87-5.73 
(m, 3H), 5.22 (dd, J = 1.25, 16.4 Hz, 1H), 5.18 (dd, 1.25, 10.1 
Hz), 5.02 (dd, J = 1.85, 17 Hz, 1H), 4.96 (d, J = 10.1 Hz, 1H), 
4.73 (s, 1H), 4.61 (t, J = 3.8 Hz), 4.53 (d, J = 11.35 Hz, 1H), 
4.51-4.47 (m, 1H), 4.35 (d, J = 11.35 Hz, 1H), 4.08 (dd, J = 6.3, 12 Hz), 2.27-2.21 (m, 
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1H), 2.06 (dd, J = 6.3, 14.5 Hz, 1H), 2.05-2.01 (m, 1H), 1.93-1.89 (m, 1H), 1.77 (d, J = 
1.25 Hz, 3H, Me), 1.69-1.64 (m, 2H), 1.53 (s, 3H, Me), 1.50 (s, 3H, Me), 1.33 (s, 3H, 
Me), 0.95 (t, J = 8.15 Hz, 9H, TES), 0.65-0.59 (m, 6H, TES), 0.15 (s, 9H, TMS). MS 
(ESI): m/z 705.3 (100%) [M+Na]+. HRMS (ESI): m/z calcd for C39H62NaO6Si 705.3983 





1H NMR (CDCl3, 500 MHz): δ 7.34-7.30 (m, 4H), 7.27-7.25 
(m, 1H), 5.84-5.73 (m, 3H), 5.40 (d, J = 8.85 Hz, 1H), 5.23 (d, 
J = 17.05 Hz, 1H), 5.18 (dd, J = 1.25, 10.05 Hz, 1H), 5.02 (dd, 
J = 1.9,17 Hz, 1H), 4.95 (d, 9.45 Hz, 1H), 4.74 (s, 1H), 4.60 (t, J = 3.8 Hz, 1H), 4.53 (d, J 
= 11.95 Hz, 1H), 4.49 (t, J = 9.45 Hz, 1H), 4.36 (d, J = 11.35 Hz, 1H), 4.10 (dd, 6.3, 
13.85 Hz, 1H), 2.25-2.18 (m, 1H), 2.07 (dd, 6.3, 13.85 Hz, 1H), 2.05-2.01 (m, 1H), 1.91 
(dd, J = 5, 14.5 Hz, 1H), 1.78 (d, J = 1.25 Hz, 3H, Me), 1.70-1.65 (m, 2H), 1.54 (s, 3H, 
Me), 1.49 (s, 3H, Me), 1.35-1.31 (m, 1H), 1.33 (s, 3H, Me), 0.95 (t, J = 8.2 Hz, 9H, TES), 
0.67-0.58 (m, 6H, TES), 0.14 (s, 9H, TMS). 13C NMR (CDCl3, 125 MHz): δ 140.80, 
139.27, 138.78, 138.28, 128.24, 127.70, 127.29, 123.94, 116.09, 114.93, 111.26, 105.01, 
88.90, 83.66, 77.65, 77.32, 70.03, 67.94, 67.68, 50.21, 49.92, 31.82, 31.24, 26.69, 26.31, 
23.42, 12.90, 6.78, 4.77, 1.87. MS (ESI): m/z 705.2 (100%) [M+Na]+. HRMS (ESI): m/z 
calcd for C39H62NaO6Si 705.3983 [M+Na]+; found, 705.4003. 






trimethylsilane (5.37a): NaH (60% in mineral oil, 10 mg, 0.25 
mmol) was added to the stirring solution of 5.33a (55 mg, 0.097 
mmol) and MeI (15 µL) in dry THF (3 mL) at 0 °C. The reaction mixture was stirred at 
room temperature for 3h. Upon completion, the reaction was diluted with ether (15 mL), 
quenched with H2O and the layers were separated. The aqueous layer was extracted with 
ether (2x) and the combined organic fractions were washed with brine (25 mL), dried 
over anhydrous Na2SO4, filtered and concentrated under reduced pressure. The crude 
residue was purified by flash column chromatography (gradient % EtOAc/hexane) to 
obtain methyl ether 5.37a (48 mg, 85 %) as a colorless oil. 1H NMR (CDCl3, 500 MHz): 
δ 7.33-7.30 (m, 4H), 7.27-7.24 (m, 1H), 5.82-5.74 (m, 2H), 5.80 (d, J = 3.8 Hz, 1H), 5.49 
(d, J = 8.85 Hz, 1H), 5.24-5.19 (m, 2H), 5.02 (dd, 1.9 Hz, 17.05 Hz, 1H), 4.96 (d, J = 
10.1 Hz, 1H), 4.62-4.60 (m, 1H), 4.55-4.49 (m, 2H), 4.37-4.34 (m, 2H), 4.08 (dd, J = 
6.35, 12.0 Hz, 1H), 3.30 (s, 3H, OMe), 2.27-2.21 (m, 1H), 2.10 (dd, 6.3, 14.5 Hz, 1H), 
2.06-2.02 (m, 1H), 1.93 (dd, J = 4.4, 14.5 Hz, 1H), 1.76 (s, 3H, Me), 1.73-1.65 (m, 2H), 
1.54 (s, 3H, Me), 1.52 (s, 3H, Me), 1.34-1.32 (m, 1H), 1.33 (s, 3H, Me), 0.15 (s, 9H, 
TMS). 13C NMR (CDCl3, 125 MHz): δ 139.14, 138.75, 138.28, 137.74, 128.24, 127.72, 
127.29, 126.36, 116.36, 114.94, 111.33, 105.02, 91.59, 80.62, 77.49, 75.89, 69.99, 67.97, 
55.51, 50.37, 49.81, 31.78, 31.38, 26.70, 26.30, 23.45, 13.55, 1.87. MS (ESI): m/z 605.2 
(100%) [M+Na]+. HRMS (ESI): m/z calcd for C34H50NaO6Si 605.3374 [M+Na]+; found, 
605.3271. 
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Macrocyclization by RCM: Grubbs II catalyst (122 mg, 0.0144 mmol) in degassed 
toluene (10 mL) was added to a refluxing (120 °C) 
solution of diene 5.37a (45 mg, 0.077 mmol) in degassed 
toluene (0.1 mM) over 2h via syringe pump. Upon 
complete addition, the reaction was refluxed for a further 
30 min followed by distillation of the solvent under 
reduced pressure. The residue was purified by flash column chromatography to isolate 
macrocycle 5.38a (2mg, 5%) along with other trace unidentified products.  
1H NMR (CDCl3, 500 MHz): δ 7.34-7.30 (m, 5H), 5.85 (d, J = 8.85 Hz, 1H), 5.81 (d, J = 
5.05 Hz 1H), 5.79 (d, J = 3.75 Hz, 1H), 5.58-5.52 (m, 1H), 4.60-4.54 (m, 4H), 4.50-4.44 
(m, 2H), 4.11 (s, br, 1H), 3.27 (s, 3H, OMe), 2.24 (d, J = 2.5 Hz, 1H), 2.24-2.17 (m, 2H), 
1.93-1.84 (m, 3H), 1.84 (d, J = 1.25 Hz, 3H, Me), 1.56-5.54 (m, 7H), 1.33 (s, 3H, Me).  
13C NMR (CDCl3, 125 MHz): δ 138.84, 137.02, 132.85, 129.03, 128.31, 127.99, 127.68, 
127.40, 111.39, 104.95, 93.47, 82.82, 80.95, 77.21, 75.71, 74.16, 70.73, 67.24, 53.93, 
47.47, 33.18, 29.58, 26.84, 26.34, 23.22, 15.28, 1.82. MS (ESI): m/z 577.2 [M+Na]+. 
















































































































































































































*** Acquisition  Parameters ***
BF1 :   300.1300000 MHz
LOCNUC : 2H
NS :              3
O1 :        1853.43 Hz
PULPROG : zg30
SFO1 :   300.1318534 MHz
SOLVENT : CDCl3
SW :        17.9519 ppm
*** Processing Parameters ***
LB :           0.30 Hz
PHC0 :        255.079 degree
PHC1 :          1.105 degree




































































































































*** Acquisition  Parameters ***
BF1 :     75.4677490 MHz
LOCNUC : 2H
NS :             20
O1 :        7924.11 Hz
PULPROG : zgpg30
SFO1 :     75.4756731 MHz
SOLVENT : CDCl3
SW :       238.2968 ppm
*** Processing Parameters ***
LB :           1.00 Hz
PHC0 :        121.034 degree
PHC1 :        -11.749 degree
13C Standard AC300
TBDPS






































































































































































































































































































































































*** Acquisition  Parameters ***
BF1 :   500.1300000 MHz
LOCNUC : 2H
NS :              2
O1 :        3088.51 Hz
PULPROG : zg30
SFO1 :   500.1330885 MHz
SOLVENT : CDCl3
SW :        20.6557 ppm
*** Processing Parameters ***
LB :           0.30 Hz
PHC0 :         38.953 degree

























































































































































































*** Acquisition  Parameters ***
BF1 :   125.7577890 MHz
LOCNUC : 2H
NS :             25
O1 :       13204.57 Hz
PULPROG : zgpg30
SFO1 :   125.7709936 MHz
SOLVENT : CDCl3
SW :       238.7675 ppm
*** Processing Parameters ***
LB :           1.00 Hz
PHC0 :         31.597 degree




































































































































































































































































































*** Acquisition  Parameters ***
BF1 :   500.1300000 MHz
LOCNUC : 2H
NS :              2
O1 :        3088.51 Hz
PULPROG : zg30
SFO1 :   500.1330885 MHz
SOLVENT : CDCl3
SW :        20.6557 ppm
*** Processing Parameters ***
LB :           0.30 Hz
PHC0 :         54.430 degree






























































































*** Acquisition  Parameters ***
BF1 :   125.7577890 MHz
LOCNUC : 2H
NS :             22
O1 :       13204.57 Hz
PULPROG : zgpg30
SFO1 :   125.7709936 MHz
SOLVENT : CDCl3
SW :       238.7675 ppm
*** Processing Parameters ***
LB :           1.00 Hz
PHC0 :         97.363 degree














































































































































































































































































































































*** Acquisition  Parameters ***
BF1 :   500.1300000 MHz
LOCNUC : 2H
NS :              3
O1 :        3088.51 Hz
PULPROG : zg30
SFO1 :   500.1330885 MHz
SOLVENT : CDCl3
SW :        20.6557 ppm
*** Processing Parameters ***
LB :           0.30 Hz
PHC0 :        166.837 degree















































































































































*** Acquisition  Parameters ***
BF1 :   125.7577890 MHz
LOCNUC : 2H
NS :            166
O1 :       13204.57 Hz
PULPROG : zgpg30
SFO1 :   125.7709936 MHz
SOLVENT : CDCl3
SW :       238.7675 ppm
*** Processing Parameters ***
LB :           1.00 Hz
PHC0 :         89.359 degree


























































































































































































































































*** Acquisition  Parameters ***
BF1 :    300.1300000 MHz
LOCNUC : 2H
NS :              2
O1 :        1853.43 Hz
PULPROG : zg30
SFO1 :    300.1318534 MHz
SOLVENT : CDCl3
SW :        17.9519 ppm
*** Processing Parameters ***
LB :           0.30 Hz
PHC0 :        140.573 degree
PHC1 :          0.168 degree
















































































































































































*** Acquisition  Parameters ***
BF1 :     75.4677490 MHz
LOCNUC : 2H
NS :             35
O1 :        7924.11 Hz
PULPROG : zgpg30
SFO1 :     75.4756731 MHz
SOLVENT : CDCl3
SW :       238.2968 ppm
*** Processing Parameters ***
LB :           1.00 Hz
PHC0 :        104.088 degree
PHC1 :         12.931 degree
13C Standard AC300
3105






























































































































































































































































































































































































































































































































*** Acquisition  Parameters ***
BF1 :   125.7577890 MHz
LOCNUC : 2H
NS :             15
O1 :       13204.57 Hz
PULPROG : zgpg30
SFO1 :   125.7709936 MHz
SOLVENT : CDCl3
SW :       238.7675 ppm
*** Processing Parameters ***
LB :           1.00 Hz
PHC0 :         82.866 degree











































































































































































































































































*** Acquisition  Parameters ***
BF1 :   300.1300000 MHz
LOCNUC : 2H
NS :              2
O1 :        1853.43 Hz
PULPROG : zg30
SFO1 :   300.1318534 MHz
SOLVENT : CDCl3
SW :        17.9519 ppm
*** Processing Parameters ***
LB :           0.30 Hz
PHC0 :        256.480 degree
PHC1 :          1.748 degree





















































































































































































*** Acquisition  Parameters ***
BF1 :     75.4677490 MHz
LOCNUC : 2H
NS :            156
O1 :        7924.11 Hz
PULPROG : zgpg30
SFO1 :     75.4756731 MHz
SOLVENT : CDCl3
SW :       238.2968 ppm
*** Processing Parameters ***
LB :           1.00 Hz
PHC0 :         90.894 degree





























































































































*** Acquisition  Parameters ***
BF1 :     75.4677490 MHz
LOCNUC : 2H
NS :            161
O1 :        7924.11 Hz
PULPROG : zgpg30
SFO1 :     75.4756731 MHz
SOLVENT : CDCl3
SW :       238.2968 ppm
*** Processing Parameters ***
LB :           1.00 Hz
PHC0 :        143.689 degree




















































































































































































*** Acquisition  Parameters ***
BF1 :     75.4677490 MHz
LOCNUC : 2H
NS :            200
O1 :        7924.11 Hz
PULPROG : zgpg30
SFO1 :     75.4756731 MHz
SOLVENT : CDCl3
SW :       238.2968 ppm
*** Processing Parameters ***
LB :           1.00 Hz
PHC0 :         73.994 degree
PHC1 :         52.773 degree
13C Standard AC300
SRK 3145_Mitsinobu











































































































































































































*** Acquisition  Parameters ***
BF1 :   500.1300000 MHz
LOCNUC : 2H
NS :              2
O1 :        3088.51 Hz
PULPROG : zg30
SFO1 :   500.1330885 MHz
SOLVENT : CDCl3
SW :        20.6557 ppm
*** Processing Parameters ***
LB :           0.30 Hz
PHC0 :         56.085 degree























































































































































































































































































































































































































































































































































































*** Acquisition  Parameters ***
BF1 :   500.1300000 MHz
LOCNUC : 2H
NS :              2
O1 :        3088.51 Hz
PULPROG : zg30
SFO1 :   500.1330885 MHz
SOLVENT : CDCl3
SW :        20.6557 ppm
*** Processing Parameters ***
LB :           0.30 Hz
PHC0 :        159.887 degree




























































































































































































































































































































































































































































































































































































































































































*** Acquisition  Parameters ***
BF1 :   500.1300000 MHz
LOCNUC : 2H
NS :              3
O1 :        3088.51 Hz
PULPROG : zg30
SFO1 :   500.1330885 MHz
SOLVENT : CDCl3
SW :        20.6557 ppm
*** Processing Parameters ***
LB :           0.30 Hz
PHC0 :        163.438 degree
PHC1 :          1.356 degree
1H AMX500
























































































SRK 4009_spt 2_ benzylidene opening by LAH /AlCl3 (rk1013 <y.2009> exp 2)













































































































































































































































































































































*** Acquisition  Parameters ***
BF1 :    500.1300000 MHz
LOCNUC : 2H
NS :              3
O1 :        3088.51 Hz
PULPROG : zg30
SFO1 :    500.1330885 MHz
SOLVENT : CDCl3
SW :        20.6557 ppm
*** Processing Parameters ***
LB :           0.30 Hz
PHC0 :         49.497 degree


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































*** Acquisition  Parameters ***
BF1 :    500.1300000 MHz
LOCNUC : 2H
NS :              2
O1 :        3088.51 Hz
PULPROG : zg30
SFO1 :    500.1330885 MHz
SOLVENT : CDCl3
SW :        20.6557 ppm
*** Processing Parameters ***
LB :           0.30 Hz
PHC0 :        249.869 degree




















































































































































*** Acquisition  Parameters ***
BF1 :    125.7577890 MHz
LOCNUC : 2H
NS :             20
O1 :       13204.57 Hz
PULPROG : zgpg30
SFO1 :    125.7709936 MHz
SOLVENT : CDCl3
SW :       238.7675 ppm
*** Processing Parameters ***
LB :           1.00 Hz
PHC0 :        171.499 degree
PHC1 :         32.716 degree
13C AMX500
srk 4049_Pv protection


































































































































































































































































































































































































































































































































































































































































































MeMgBr_4051_major_top (rk0315e exp 2)

























































































































































































































































































































*** Acquisition  Parameters ***
BF1 :    500.1300000 MHz
LOCNUC : 2H
NS :              8
O1 :        3088.51 Hz
PULPROG : zg30
SFO1 :    500.1330885 MHz
SOLVENT : CDCl3
SW :        20.6557 ppm
*** Processing Parameters ***
LB :           0.30 Hz
PHC0 :        158.879 degree

















































































































































































































































































































































































































































































































































































*** Acquisition  Parameters ***
BF1 :    125.7577890 MHz
LOCNUC : 2H
NS :             55
O1 :       13204.57 Hz
PULPROG : zgpg30
SFO1 :    125.7709936 MHz
SOLVENT : CDCl3
SW :       238.7675 ppm
*** Processing Parameters ***
LB :           1.00 Hz
PHC0 :         87.298 degree
PHC1 :         18.987 degree
13C AMX500
SRK 4067_DMP oxdn
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































SRK 4054 (rk0319 exp 11)












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































RK 4089_diisopropylidene glucose (rk0603 exp.22, year2010)































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































SRK 4058_Right frgmnt_wittig (rk0324 exp 2)














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































SRK 4131_Alkyne addition_(expt 1)






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































SRK 4135_(R)-CBS Reduction_(expt 2)






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































*** Acquisition  Parameters ***
BF1 :   500.1300000 MHz
LOCNUC : 2H
NS :              3
O1 :        3088.51 Hz
PULPROG : zg30
SFO1 :   500.1330885 MHz
SOLVENT : CDCl3
SW :        20.6557 ppm
*** Processing Parameters ***
LB :           0.30 Hz
PHC0 :         73.752 degree





















































































































































*** Acquisition  Parameters ***
BF1 :   125.7577890 MHz
LOCNUC : 2H
NS :             82
O1 :       13204.57 Hz
PULPROG : zgpg30
SFO1 :   125.7709936 MHz
SOLVENT : CDCl3
SW :       238.7675 ppm
*** Processing Parameters ***
LB :           1.00 Hz
PHC0 :         20.630 degree













































































































































































































































































































































































































































































*** Acquisition  Parameters ***
BF1 :    500.1300000 MHz
LOCNUC : 2H
NS :              4
O1 :        3088.51 Hz
PULPROG : zg30
SFO1 :    500.1330885 MHz
SOLVENT : CDCl3
SW :        20.6557 ppm
*** Processing Parameters ***
LB :           0.30 Hz
PHC0 :        324.580 degree



























































































































































*** Acquisition  Parameters ***
BF1 :   125.7577890 MHz
LOCNUC : 2H
NS :             66
O1 :       13204.57 Hz
PULPROG : zgpg30
SFO1 :   125.7709936 MHz
SOLVENT : CDCl3
SW :       238.7675 ppm
*** Processing Parameters ***
LB :           1.00 Hz
PHC0 :        357.838 degree












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































*** Acquisition  Parameters ***
BF1 :   125.7577890 MHz
LOCNUC : 2H
NS :            568
O1 :       13204.57 Hz
PULPROG : zgpg30
SFO1 :   125.7709936 MHz
SOLVENT : CDCl3
SW :       238.7675 ppm
*** Processing Parameters ***
LB :           1.00 Hz
PHC0 :         16.457 degree
















































































































































































































































































































































*** Acquisition  Parameters ***
BF1 :    500.1300000 MHz
LOCNUC : 2H
NS :              4
O1 :        3088.51 Hz
PULPROG : zg30
SFO1 :    500.1330885 MHz
SOLVENT : CDCl3
SW :        20.6557 ppm
*** Processing Parameters ***
LB :           0.30 Hz
PHC0 :        192.779 degree




















































































































*** Acquisition  Parameters ***
BF1 :    125.7577890 MHz
LOCNUC : 2H
NS :            635
O1 :       13204.57 Hz
PULPROG : zgpg30
SFO1 :    125.7709936 MHz
SOLVENT : CDCl3
SW :       238.7675 ppm
*** Processing Parameters ***
LB :           1.00 Hz
PHC0 :          7.799 degree




























































































































































































































































































































































































































































































































































































































RK 4090_iodination (rk0603 exp 12)


























































































































































































































































































































































































































































4093_recrystallized (rk0618, exp 22)


























































































































































































































*** Acquisition  Parameters ***
BF1 :   500.1300000 MHz
LOCNUC : 2H
NS :              4
O1 :        3088.51 Hz
PULPROG : zg30
SFO1 :   500.1330885 MHz
SOLVENT : CDCl3
SW :        20.6557 ppm
*** Processing Parameters ***
LB :           0.30 Hz
PHC0 :        166.704 degree
































































































































































































































*** Acquisition  Parameters ***
BF1 :   125.7577890 MHz
LOCNUC : 2H
NS :             66
O1 :       13204.57 Hz
PULPROG : zgpg30
SFO1 :   125.7709936 MHz
SOLVENT : CDCl3
SW :       238.7675 ppm
*** Processing Parameters ***
LB :           1.00 Hz
PHC0 :         74.653 degree






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































*** Acquisition  Parameters ***
BF1 :   500.1300000 MHz
LOCNUC : 2H
NS :              4
O1 :        3088.51 Hz
PULPROG : zg30
SFO1 :   500.1330885 MHz
SOLVENT : CDCl3
SW :        20.6557 ppm
*** Processing Parameters ***
LB :           0.30 Hz
PHC0 :        138.766 degree
PHC1 :         -0.213 degree
1H AMX500


















































































































*** Acquisition  Parameters ***
BF1 :   125.7577890 MHz
LOCNUC : 2H
NS :            130
O1 :       13204.57 Hz
PULPROG : zgpg30
SFO1 :   125.7709936 MHz
SOLVENT : CDCl3
SW :       238.7675 ppm
*** Processing Parameters ***
LB :           1.00 Hz
PHC0 :        163.135 degree




























































































































































































































































































































































































































































































*** Acquisition  Parameters ***
BF1 :    500.1300000 MHz
LOCNUC : 2H
NS :              4
O1 :        3088.51 Hz
PULPROG : zg30
SFO1 :    500.1330885 MHz
SOLVENT : CDCl3
SW :        20.6557 ppm
*** Processing Parameters ***
LB :           0.30 Hz
PHC0 :        253.471 degree













































































































*** Acquisition  Parameters ***
BF1 :    125.7577890 MHz
LOCNUC : 2H
NS :            112
O1 :       13204.57 Hz
PULPROG : zgpg30
SFO1 :    125.7709936 MHz
SOLVENT : CDCl3
SW :       238.7675 ppm
*** Processing Parameters ***
LB :           1.00 Hz
PHC0 :        162.833 degree


















































































































































































































































































































































































































*** Acquisition  Parameters ***
BF1 :   500.1300000 MHz
LOCNUC : 2H
NS :              3
O1 :        3088.51 Hz
PULPROG : zg30
SFO1 :   500.1330885 MHz
SOLVENT : CDCl3
SW :        20.6557 ppm
*** Processing Parameters ***
LB :           0.30 Hz
PHC0 :        135.313 degree

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































*** Acquisition  Parameters ***
BF1 :    125.7577890 MHz
LOCNUC : 2H
NS :           2272
O1 :       13204.57 Hz
PULPROG : zgpg30
SFO1 :    125.7709936 MHz
SOLVENT : CDCl3
SW :       238.7675 ppm
*** Processing Parameters ***
LB :           1.00 Hz
PHC0 :        353.182 degree
PHC1 :         26.677 degree
13C AMX500



























































































































































































































































































































































































































































































































































*** Acquisition  Parameters ***
BF1 :    500.1300000 MHz
LOCNUC : 2H
NS :              5
O1 :        3088.51 Hz
PULPROG : zg30
SFO1 :    500.1330885 MHz
SOLVENT : CDCl3
SW :        20.6557 ppm
*** Processing Parameters ***
LB :           0.30 Hz
PHC0 :         10.958 degree























































































































































































































































































































































































*** Acquisition  Parameters ***
BF1 :    125.7577890 MHz
LOCNUC : 2H
NS :           1415
O1 :       13204.57 Hz
PULPROG : zgpg30
SFO1 :    125.7709936 MHz
SOLVENT : CDCl3
SW :       238.7675 ppm
*** Processing Parameters ***
LB :           1.00 Hz
PHC0 :        351.820 degree
PHC1 :         25.583 degree
13C AMX500
















































































































































































































































































































































































































































































































































































*** Acquisition  Parameters ***
BF1 :    500.1300000 MHz
LOCNUC : 2H
NS :              8
O1 :        3088.51 Hz
PULPROG : zg30
SFO1 :    500.1330885 MHz
SOLVENT : CDCl3
SW :        20.6557 ppm
*** Processing Parameters ***
LB :           0.30 Hz
PHC0 :          3.758 degree
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































*** Acquisition  Parameters ***
BF1 :    125.7577890 MHz
LOCNUC : 2H
NS :            630
O1 :       13204.57 Hz
PULPROG : zgpg30
SFO1 :    125.7709936 MHz
SOLVENT : CDCl3
SW :       238.7675 ppm
*** Processing Parameters ***
LB :           1.00 Hz
PHC0 :        166.637 degree
PHC1 :         32.388 degree
13C AMX500































































































































































































































































































































































































































































































































*** Acquisition  Parameters ***
BF1 :   500.1300000 MHz
LOCNUC : 2H
NS :              3
O1 :        3088.51 Hz
PULPROG : zg30
SFO1 :   500.1330885 MHz
SOLVENT : CDCl3
SW :        20.6557 ppm
*** Processing Parameters ***
LB :           0.30 Hz
PHC0 :         71.934 degree





















































































































































































































































































































































*** Acquisition  Parameters ***
BF1 :    125.7577890 MHz
LOCNUC : 2H
NS :           1144
O1 :       13204.57 Hz
PULPROG : zgpg30
SFO1 :    125.7709936 MHz
SOLVENT : CDCl3
SW :       238.7675 ppm
*** Processing Parameters ***
LB :           1.00 Hz
PHC0 :        341.465 degree





































































































































































































































































































































































































































































































































































































































































































































































































































































































*** Acquisition  Parameters ***
BF1 :    125.7577890 MHz
LOCNUC : 2H
NS :          33205
O1 :       13204.57 Hz
PULPROG : zgpg30
SFO1 :    125.7709936 MHz
SOLVENT : CDCl3
SW :       238.7675 ppm
*** Processing Parameters ***
LB :           1.00 Hz
PHC0 :        276.474 degree









































































































































































































































































































































NAME             rk0922
EXPNO                 2
PROCNO                1
F2 - Acquisition Parameters
Date_          20100922
Time              14.52
INSTRUM           spect
PROBHD   5 mm TXI 1H-13
PULPROG          cosygs
TD                 2048
SOLVENT            C6D6
NS                   80
DS                   16
SWH            5122.951 Hz
FIDRES         2.501441 Hz
AQ            0.2000324 sec
RG                  256
DW               97.600 usec
DE                 6.00 usec
TE                298.0 K
D0           0.00000300 sec
D1           1.00000000 sec
D13          0.00000300 sec
D16          0.00020000 sec
IN0          0.00019520 sec
======== CHANNEL f1 ========
NUC1                 1H
P0                 8.20 usec
P1                 8.20 usec
PL1               -2.00 dB
SFO1        500.2320200 MHz
====== GRADIENT CHANNEL =====
P16             1500.00 usec
F1 - Acquisition parameters
ND0                   1
TD                  256
SFO1            500.232 MHz
FIDRES        20.011526 Hz
SW               10.241 ppm
FnMODE               QF
F2 - Processing parameters
SI                  512
SF          500.2300028 MHz
WDW                SINE
SSB                   0
LB                 0.00 Hz
GB                    0
PC                 1.40
F1 - Processing parameters
SI                  512
MC2                  QF
SF          500.2300045 MHz
WDW                SINE
SSB                   0
LB                 0.00 Hz











































NAME             rk0924
EXPNO                 3
PROCNO                1
F2 - Acquisition Parameters
Date_          20100924
Time              17.03
INSTRUM           spect
PROBHD   5 mm TXI 1H-13
PULPROG       noesygptp
TD                 2048
SOLVENT           CDCl3
NS                   64
DS                   16
SWH            4251.701 Hz
FIDRES         2.076026 Hz
AQ            0.2410124 sec
RG                812.7
DW              117.600 usec
DE                 6.00 usec
TE                298.2 K
D0           0.00000300 sec
D1           2.00000000 sec
D8           0.50000000 sec
D16          0.00020000 sec
d20          0.24830000 sec
IN0          0.00011760 sec
======== CHANNEL f1 ========
NUC1                 1H
P1                 8.40 usec
P2                16.80 usec
PL1               -2.00 dB
SFO1        500.2318490 MHz
====== GRADIENT CHANNEL =====
GPNAM1         SINE.100
GPNAM2         SINE.100
GPX1               0.00 %
GPX2               0.00 %
GPY1               0.00 %
GPY2               0.00 %
GPZ1              40.00 %
GPZ2             -40.00 %
P16             1500.00 usec
F1 - Acquisition parameters
ND0                   2
TD                  300
SFO1           500.2318 MHz
FIDRES        14.172336 Hz
SW                8.499 ppm
FnMODE             TPPI
F2 - Processing parameters
SI                  512
SF          500.2300071 MHz
WDW               QSINE
SSB                   2
LB                 0.00 Hz
GB                    0
PC                 1.00
F1 - Processing parameters
SI                  512
MC2                TPPI
SF          500.2300060 MHz
WDW               QSINE
SSB                   2
LB                 0.00 Hz
GB                    0
ppm












NAME             rk0924
EXPNO                 4
PROCNO                1
F2 - Acquisition Parameters
Date_          20100925
Time               7.46
INSTRUM           spect
PROBHD   5 mm TXI 1H-13
PULPROG        inv4gstp
TD                  512
SOLVENT            MeOH
NS                   96
DS                   16
SWH            4251.701 Hz
FIDRES         8.304103 Hz
AQ            0.0603788 sec
RG                32768
DW              117.600 usec
DE                 6.00 usec
TE                298.7 K
D0           0.00000300 sec
D1           1.00000000 sec
D2           0.00345000 sec
d4           0.00172500 sec
D11          0.03000000 sec
D13          0.00000300 sec
D16          0.00020000 sec
d20          0.00002500 sec
d21          0.00174600 sec
IN0          0.00000994 sec
======== CHANNEL f1 ========
NUC1                 1H
P1                 8.40 usec
P2                16.80 usec
PL1               -2.00 dB
SFO1        500.2318490 MHz
======== CHANNEL f2 ========
CPDPRG2            garp
NUC2                13C
P3                13.20 usec
P4                26.40 usec
PCPD2             70.00 usec
PL2               -2.00 dB
PL12              12.49 dB
SFO2        125.7942545 MHz
====== GRADIENT CHANNEL =====
P16             1500.00 usec
F1 - Acquisition parameters
ND0                   4
TD                  256
SFO1           125.7943 MHz
FIDRES        98.270439 Hz
SW              199.987 ppm
FnMODE             TPPI
F2 - Processing parameters
SI                  512
SF          500.2300066 MHz
WDW               QSINE
SSB                   2
LB                 0.00 Hz
GB                    0
PC                 1.40
F1 - Processing parameters
SI                  512
MC2                TPPI
SF          125.7828923 MHz
WDW               QSINE
SSB                   2
LB                 0.00 Hz
GB                    0
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